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Abstract 
The focus of this research was to develop a biomimetic, degradable vascular scaffold that 
could be considered as part of a tissue-engineered vascular graft strategy. A family of 
degradable poly(ester amide)s (PEAs) derived from naturally occurring α-amino acids, 
aliphatic diols and diacids were synthesized to yield PEAs with glass transition temperatures 
below physiologic temperature ensuring their pliability. Tri-functional amino acids L-lysine 
or L-aspartic acid were incorporated into the polymer backbone yielding complementary 
functional handles for subsequent conjugation of growth factors. Higher molecular weight 
PEAs were obtained using an interfacial polycondensation technique compared with a 
solution polymerization approach. 
Human coronary artery smooth muscle cells (HCASMCs) attached and proliferated on all 
two-dimensional (2D) PEA films. Well-spread cells were observed on the non-functional and 
aspartic acid functionalized PEAs up to 7 days, more so than on the corresponding lysine 
containing PEAs. The HCASMCs formed focal adhesions on all 2D PEA surfaces as 
illustrated by vinculin immunofluorescence, yet smooth muscle α-actin (SMαA) expression 
was not abundant, suggesting that the HCASMCs had adopted a synthetic phenotype. 
Uniform, nano-scale, fibrous PEA mats ranging in average fiber diameter from 130 to 294 
nm were prepared by electrospinning. The increased surface charge attributed to the pendant 
carboxylic acid groups decreased the average fiber diameter. HCASMCs seeded on the three-
dimensional fibrous mat revealed excellent cell attachment and spreading, but limited cell 
infiltration. In the aspartic acid containing functional PEA, the fibrous structure was lost 
post-processing due to a plasticizing effect facilitated by the aspartic acid monomer. 
The dual effect of topography and TGF-β1 on HCASMC phenotype was investigated by 
Western blot analysis. While a modest increase in the expression of both smooth SMαA and 
calponin was observed on all 2D films at four days culture, the 3D topography alone 
increased both SMαA and calponin expression suggesting the cellular microenvironment can 
modulate SMC phenotype. 
Finally, X-ray photoelectron spectroscopy and immunofluorescence demonstrated the 
successful conjugation of TGF-β1 to the pendant carboxylic acid groups suggesting that 
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functional PEAs can be used to generate degradable, biomimetic biomaterials for vascular 
tissue engineering. 
Keywords 
Functional poly(ester amide)s (PEAs), α-amino acids, cell culture, human coronary artery 
smooth muscle cells (HCASMCs), smooth muscle cell phenotype, focal adhesions, 
waveguide evanescent field fluorescence (WEFF) microscopy, Langmuir−Blodgett (LB) 
films, electrospinning, transforming growth factor-β1, Western blot analysis. 
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Chapter 1  
1 Introduction 
1.1 Overview 
Despite improved outcomes from percutaneous coronary intervention,1 the lack of 
clinically available small diameter vascular grafts (< 6 mm) remains a significant concern 
for patients who lack a suitable autologous vessel for harvest due to vascular disease, 
mechanical mismatch or previous surgery.2 Although surface modifications of prosthetic 
grafts such as Dacron and Teflon to promote their haemocompatibility or in vivo 
endothelialization have improved patency rates,2 their inability to degrade hinder 
complete tissue regeneration, thus precluding their use in pediatric patients.3 Tissue 
engineering offers great potential in developing functional vascular tissues with 
mechanical and morphological properties of the native blood vessel.4 
Although there are several approaches to engineer vascular tissues, scaffold-guided tissue 
regeneration remains the strategy most frequently adopted, in part because the porous 
scaffold can be fabricated into the desired geometry of the engineered tissue.4 In these 
cases, vascular cells adhere and populate a porous scaffold, which serves as a temporary 
three-dimensional structure enabling the infiltrating cells to secrete and assemble their 
own extracellular matrix.5 The promotion of vascular cell attachment, proliferation and 
function can be induced through the usage of biomimetic materials, where a polymeric 
scaffold can be modified with cell signaling molecules. The immobilization of these 
bioactive molecules is specifically designed to elicit a given cellular response, which 
would then mediate appropriate tissue formation.5 Transforming growth factor-β1 is a 
multi-potent cytokine that can modulate both the inflammation process6 and smooth 
muscle cell phenotype, implicating its use in vascular tissue engineering.7  
Most polymeric biomaterials currently being investigated for vascular tissue engineering, 
lack the pendant functional groups necessary for biomolecule conjugation. Poly(ester 
amide)s (PEAs) are a class of polymers, which combine the beneficial properties of both 
polyesters and polyamides. The ester linkages of the PEAs facilitate hydrolytic 
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degradation, while the amide bonds confer mechanical strength through hydrogen 
bonding.8 The PEAs evaluated in this work are derived from α-amino acids, aliphatic 
diols and diacids. Functional monomers, including amino acids such as lysine and 
aspartic acid, can be incorporated during the polymerization to introduce functional 
handles for subsequent conjugation. 
1.2 Research Outline 
The objective of this study was to synthesize and characterize a family of functional 
poly(ester amide)s to screen them for potential use in vascular tissue engineering. PEAs 
based on L-alanine and L-phenylalanine were selected to impart suitable mechanical and 
thermal properties. L-lysine and L-aspartic acid were incorporated into the PEA backbone 
to provide pendant amine and carboxylic acid functional handles for subsequent TGF-β1 
conjugation. The aliphatic diols 1,4-butanediol and 1,8-octanediol and diacid sebacic acid 
were selected to impart elasticity and hydrophobicity. The improved hydrophobicity 
facilitated processing of the PEAs in organic solvents. The selection of sebacic acid also 
permitted its polymerization at the interface of a heterogeneous mixture, which was 
compared with a conventional solution polycondensation. The PEAs were characterized 
with nuclear magnetic resonance (NMR) spectroscopy, Fourier transform infrared (FTIR) 
spectroscopy, gel permeation chromatography (GPC), thermogravimetric analysis (TGA) 
and differential scanning calorimetry (DSC). 
As potential vascular biomaterials, the PEAs were evaluated in terms of their ability to 
support human coronary artery smooth muscle cell attachment, viability and proliferation. 
Smooth muscle cell morphology, phenotype and ability to form focal adhesions were also 
investigated on two-dimensional films. In addition, the impact of nano-scale fibrous 
scaffolds obtained from electrospinning, on HCASMC attachment, morphology and 
infiltration was studied. The effect of chemical structure, architecture and exogenous 
addition of TGF-β1 on SMC contractile phenotype marker protein expression was also 
investigated. Finally, conjugation of TGF-β1 to the surface of a functional PEA was 
examined. 
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1.3 Thesis Outline 
This thesis is divided into six chapters. A broad literature review of tissue-engineered 
vascular grafts is presented in Chapter 2. Following the review of current research, the 
motivation for this work is provided. The main research findings are presented in 
Chapters 3-5. Chapter 3 focuses on the syntheses and characterizations of non-functional 
and lysine-containing functional PEAs, along with their interactions with HCASMCs.9 
Chapter 4 compares the use of waveguide evanescent field fluorescence with 
conventional immunostaining techniques for examining the interfacial area between 
HCASMCs and two-dimensional PEA films.10 Chapter 5 focuses on the introduction of 
aspartic acid into the functional PEAs, and its subsequent electrospinning into nano-scale 
fibers. Furthermore, conjugation of TGF-β1 to a functional PEA is also presented. 
Finally, a general discussion with conclusions outlining the strengths, limitations and 
future directions are presented in Chapter 6. 
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Chapter 2  
2 Literature Review 
2.1 Clinical Need for Vascular Grafts 
Cardiovascular disease (CVD) is a significant cause of morbidity and mortality around 
the world with approximately 16.7 million people dying from CVD in 2002 alone.1 
Despite decreased rates of CVD in Canada, CVD still claimed 68,342 lives in 2009, 
which accounted for almost 29 percent of all deaths in Canada.2 The United States of 
America (USA) has also recently observed a decreased rate in CVD; however, it still 
remains the biggest killer in the USA with a reported 599,413 deaths in 2009, accounting 
for almost 25 percent of all deaths.3 
Of CVDs, coronary artery disease (CAD) is the leading cause of death in the world, 
accounting for more than seven million deaths in 2002.1 CAD is a condition whereby the 
narrowing of the coronary arteries prevents sufficient blood flow to the heart. The 
narrowing of the coronary arteries through the deposition of cholesterol, lipids and 
calcium in a process known as atherosclerosis is the primary factor in coronary occlusion, 
as shown in Figure 2.1.4 There are two types of cardiac revascularization procedures 
currently available: percutaneous coronary intervention (PCI) and coronary artery bypass 
graft (CABG) surgery following coronary occlusion.4 
In PCI, a collapsed balloon attached to a balloon catheter is inserted into the narrowed 
blood vessel and is then inflated to compress the plaque against the arterial wall to 
improve or restore blood flow. The balloon is then deflated and withdrawn. A stent may 
also be inserted to stabilize the arterial wall and help maintain patency (opening) of the 
blood vessel.5 As PCI has become more effective and efficient and because PCI is less 
invasive than CABG surgery, it is generally preferred.6 Over the decade of 1998 through 
2008, an age- and population-adjusted increase of 68.8% was observed in the number of 
PCIs performed in Canada. During that same span, there was an increase in 
revascularization procedures of 39%.7 
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Figure 2.1: Schematic of a normal and atherosclerotic artery leading to acute 
myocardial infarction (heart attack).5 Reprinted by permission from Macmillan 
Publishers Ltd: [Nature] (Libby, P. Nature 2002, 420 (6917), 868-874, 
http://www.nature.com/nature/index.html), copyright (2002). 
Although decreases in coronary revascularizations are currently observed in North 
America, the global burden of CAD will reach an estimated 82 million disability-adjusted 
life years (DALYs, or healthy years of life lost) by 2020, up from 47 million DALYs in 
1990.8 The significant increase in DALYs is projected in part due to increased longevity, 
urbanization and lifestyle changes in developing and transitional countries.9 
In cases where the less invasive PCI is deemed inappropriate for long term 
revascularization due to advanced atherosclerosis, the more invasive CABG surgery is 
performed. In these cases, suitable bypass grafts are typically harvested from the patient 
themselves (known as autografts), but may also be obtained from a donor (allografts), a 
different species (xenografts) or obtained artificially.4 
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2.2 Autologous Grafts 
The use of natural vessel grafts, such as the saphenous vein, radial artery and internal 
thoracic artery have all been used as autologous bypass grafts.10 The saphenous vein is 
frequently the conduit of choice due to its technical ease of use in cases of multiple 
grafting procedures or those patients undergoing repeat surgeries.10 Despite the 
popularity of the saphenous vein bypass graft, it has shown limited long-term success 
with patency rates ranging from 57 to 61% at 10 years10 due to intimal and medial 
hyperplasia (excessive cell growth in the tunica intima and media of the arterial wall).11-12 
Hyperplasia typically occurs at the anastomoses (surgical connections of two blood 
vessels) in large part due to the change in haemodynamic environment. At the grafting 
site the vein graft is subject to increased pressures as well as shear and pulsatile forces of 
arterial blood flow. This results in a phenotypic switch of the smooth muscle cells from 
the contractile (vasoactive) to the synthetic phenotype.13  
To improve the mechanical properties of arterial vein grafts and subsequently reduce 
hyperplasia, researchers have focused on reinforcing vein grafts with external support 
devices. Zilla and colleagues have devised a constrictive nitinol (nickel-titanium alloy) 
wire mesh to limit intimal hyperplasia by controlling the dilatation of the vein grafts, 
hence the shear stress, by constricting the diameter of the blood vessel while 
concomitantly reducing the wall stress of the native artery. The authors suggested that the 
reduction in shear stress due to the dilatation of the vein graft would induce intimal 
hyperplasia and that reducing the diameter of the vein graft would maintain the shear 
stress of the native artery. The authors reported that the vein graft that was constricted by 
50% in a baboon model showed significantly suppressed intimal hyperplasia at both 6 
and 12 weeks when compared to the unsupported vein grafts. Additionally, they 
demonstrated that only in the 50% constricted vein grafts was endothelialization 
maintained.14 Although the authors demonstrated some pulse compliance in a subsequent 
knitted nitinol wire mesh study, wire breakage and a lower degree of surface 
endothelialization was observed.15 
Despite the decreased intimal hyperplasia observed with the supported vein grafts, the 
wire mesh supports are not biodegradable and thus risk future complications16 should the 
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wire supports fray, break or undergo radial narrowing from axial distension.14-15 Vijayan 
et al. examined a polyglactin biodegradable external sheath as support for porcine 
saphenous vein grafts to prevent any future risks from permanent stents. The authors 
adopted a loose-fitting macroporous polyglactin stent for bilateral saphenous vein into 
common carotid artery interposition grafting in Large White pigs. At one and six months, 
the stented vein grafts showed decreased neointimal and medial thickening compared to 
unstented controls;16 however, the use of relatively small saphenous veins for 
interposition grafts in large arteries may have created flow conditions not clinically 
observed in bypass graft surgery.14 
The radial artery is typically used as a free graft and has shown patency rates similar to or 
better than the saphenous vein;17-19 however, risk for graft occlusion was higher in small 
target-vessel diameter cases.20 Moreover, elevated levels of vasoconstrictors including 
endothelin-1 and angiotensin II have been reported during and following the use of the 
radial artery in CABG surgery21 necessitating pharmacological intervention.22-23 
The internal thoracic artery (ITA, also known as the internal mammary artery) has 
demonstrated greater long-term patency rates than the saphenous vein and radial artery 
due to its resistance to atherosclerosis13 and intimal hyperplasia,12 and is now considered 
the conduit of choice for coronary artery bypass graft surgery. Despite the increased 
patency rates of ITA grafting, several issues remain. Use of the right ITA is limited due 
to its lack of proximity to major coronary arterial sites, rendering its use non-
standardized.24 Used as a free or composite graft, the right ITA has shown early graft 
occlusion, especially in cases of competitive flow,25 mild to moderate stenosis (narrowing 
of the blood vessel),26 and multiple anastomoses.27 
2.3 Synthetic Prostheses 
Given that in coronary artery bypass surgery, conduit availability, repeat operations and 
graft failure are very real concerns of the autologous graft, synthetic materials as vascular 
grafts have been explored. Poly(ethylene terephthalate) (PET®, Dacron) and expanded 
polytetrafluoroethylene (ePTFE, Gore-Tex®) have demonstrated some degree of success 
as peripheral vascular grafts for larger vessel diameters (in excess of 6 mm) due to high 
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flow rates of blood past the luminal surface.28 In smaller diameter vessels, (3-6 mm), 
early graft occlusion is frequently encountered, resulting from thrombogenicity of the 
synthetic surface and anastomotic hyperplasia.29 Thrombus formation on the surface of a 
biomaterial is dictated by the Vroman effect of protein adsorption upon injury following 
implantation. Multiple factors including blood-material interactions, the extent of cellular 
necrosis and inflammatory response, the loss of basement membrane structures and 
subsequent provisional matrix formation are all contributing factors in the cascade of 
events of wound healing.30 In effort to mitigate this cascade of events, much research has 
been focused on the passivation of the surface of vascular prostheses through the grafting 
of materials to reduce the electrostatic and hydrophobic interactions at the blood-
biomaterial interface, in particular the inhibition of platelet adhesion and activation.31 
Natural and synthetic materials including poly(ethylene glycol) (PEG), dextran, pyrolytic 
carbon, phosphorylcholine, albumin and elastin mimetic protein polymers have been 
investigated to minimize thermodynamically favoured protein adsorption to the vascular 
graft surfaces.31 
2.3.1 Vascular Prostheses Passivation 
Bureau and colleagues have recently examined the graft density of PEG on the surface of 
nonwoven PET fiber structures as non-thrombogenic surfaces. The authors activated the 
surface of the PET with poly(vinyl amine) (PVAm) yielding pendant amine groups which 
were conjugated to carboxylic acid terminated PEG oligomers via N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC.HCl) / N-
hydroxysuccinimide (NHS) chemistry. The authors reported decreased platelet adhesion 
and activation with a 10% PEG solution grafting to the PVAm modified PET fibers when 
compared to knitted Dacron; however, the results were not superior to previously 
investigated carbon-coated ePTFE.32 In a prospective randomized multicenter study, 
Kapfer et al. demonstrated that in an extra-anatomical anterior tibial artery bypass model, 
carbon-impregnated ePTFE prostheses were not significantly better than standard ePTFE 
grafts in terms of graft patency or limb salvage.33 Similarly, Wang et al. also used PVAm 
to develop a surfactant polymer to coat ePTFE vascular grafts to prevent platelet 
adhesion and activation. The authors conjugated both dextran and perfluoroundecanoyl 
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side chains to the PVAm backbone. The fluorocarbon enhanced adhesion to the 
hydrophobic PTFE even under dynamic conditions, while the dextran mimicked the 
polysaccharide-rich glycocalyx, generating a highly hydrated barrier, similar to the PEG-
grafted PET fibers, inhibiting platelet adhesion and activation from both platelet rich 
plasma and whole blood. Despite the promising in vitro results, the data from the 
proposed future study in a porcine model were never reported.34 
The highly hydrated surface of erythrocytes is also responsible for their non-
thrombogenicity. The presence of the polar phosphorylcholine (PC) heads of the lipid 
bilayer of the cell membrane are electrically neutral at physiologic pH while carrying 
both positive and negative charges. The zwitterionic nature of PC resulting in the 
hydrated surface has shown limited protein and cell adhesion in vitro and thus has been 
explored as a non-thrombogenic coating of synthetic prostheses.31 Yoneyama et al. 
demonstrated reduced thrombogenicity in an interpositional carotid rabbit model up to 
five days with a segmented poly(etherurethane) (SPU) / 2-methacryloyloxyethyl 
phosphorylcholine (MPC) polymer blend coating of Dacron prostheses.35 Similarly, 
Chaikof and colleagues deposited a membrane-mimetic film onto the luminal surface of 
gelatin-impregnated ePTFE vascular prostheses and demonstrated reduced platelet 
adhesion after one hour in a baboon femoral arteriovenous shunt model when compared 
to uncoated ePTFE grafts. The authors also observed a reduction in fibrinogen adhesion 
in the membrane-mimetic film coated graft; however, this reduction was not 
significant.31,36 
Instead of preventing platelet adhesion and activation through highly hydrophilic 
surfaces, some researchers have adopted the approach of controlled protein adsorption to 
inhibit coagulation. Albumin induces less platelet adsorption than other plasma proteins 
such as fibrinogen.31 Despite albumin’s rapid adsorption to the surface of a synthetic 
material, more thermodynamically favoured proteins replace albumin on the surface.37 
Given the susceptibility of albumin to be displaced by larger proteins including 
fibrinogen, the promotion of albumin immobilization on the surface of vascular 
prostheses has been investigated. Choi et al. evaluated polylactide coated ePTFE grafts as 
a mediator of protein adsorption. The authors observed a preferential adsorption of 
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albumin over fibrinogen on the surface of the coated ePTFE grafts compared to both 
unmodified and modified ePTFE grafts. The modified grafts were rendered more 
hydrophilic via chemical treatment, yielding an increase in surface energy. Despite the 
preferential adsorption of albumin, the polylactide surfaces induced greater blood cell 
adhesion than both control grafts suggesting a thrombogenic polylactide surface.38 In 
effort to mitigate the thrombogenicity of a secondary material, albumin was immobilized 
to the surface of knitted Dacron grafts through glutaraldehyde crosslinking. In this study, 
Kottke-Marchant et al. observed reduced platelet adhesion and aggregation, as well as 
reduced leukocyte adhesion with the crosslinked albumin-coated knitted Dacron grafts 
when compared to unmodified Dacron. In addition, the release of fibrinopeptide A, an 
indicator of fibrin formation, was also reduced in the albumin-coated knitted Dacron.39 
Although promising in vitro, no difference was observed in clinical outcomes between 
the coated and uncoated grafts in arterial bypass grafts for aortoiliac disease.40-41  
Not unlike albumin, elastin has also demonstrated an inhibition of platelet aggregation;42-
43 however, the mechanism is not fully understood. Despite the initial studies of the 
antagonistic effect of elastin on platelet aggregation, few studies have evaluated the 
extracellular matrix (ECM) protein for passivation of vascular prostheses. Woodhouse et 
al. have tested elastin-like peptides (ELPs) as coatings of vascular graft materials 
including PET (MylarTM), poly(tetrafluoroethylelne/ethylene) copolymer (TefzelTM) and 
a poly(carbonate urethane) (CorethaneTM). The authors passively coated all three test 
materials with a recombinant human elastin peptide and demonstrated a reduction in 
platelet activation in all cases. Moreover, fibrin accretion and thrombus formation on the 
surface of a polyurethane catheter was retarded in a New Zealand white rabbit model.44 
In a follow-up study, Woodhouse and colleagues reported platelet adhesion and 
fibrinogen adsorption on MylarTM coated with three different ELPs. The authors observed 
a reduction in fibrinogen adsorption in all ELP-coated films; however, only the longer 
polypeptide chains exhibited decreased platelet adhesion.45 In a related study, an elastin-
mimetic triblock protein polymer was evaluated by Chaikof and colleagues as a non-
thrombogenic coating of impregnated ePTFE vascular grafts. They too observed 
inhibition of platelet adhesion and fibrin deposition in a baboon arteriovenous shunt 
model.46 
12 
 
 
2.3.2 Bioactive Vascular Prostheses 
As active members of both anti-coagulant and anti-platelet mechanisms, endothelial cells 
are integral in regulating haemostasis.47 Therefore much research has been focused on 
mimicking the anti-thrombogenic features of the endothelial cell surface. Immobilization 
of anti-coagulant molecules thrombomodulin and heparin onto the surface of synthetic 
materials to directly inhibit thrombus formation has been studied. Mitigation of thrombus 
formation can be achieved through a number of coagulation or fibrinolytic pathways as 
illustrated in Figure 2.2. 
To that end, the surfaces of ePTFE prostheses have been modified in numerous ways in 
order to minimize pro-coagulation or anti-fibrinolytic mechanisms or conversely promote 
anti-coagulation and pro-fibrinolytic pathways. Thrombomodulin, an endothelial cell 
surface glycoprotein, strongly binds with thrombin forming a complex that inhibits the 
pro-coagulant properties of thrombin. Thrombomodulin also activates the anticoagulant 
protease protein C, which further hinders thrombus formation.48 Li et al. initially 
demonstrated that a soluble recombinant human thrombomodulin dose dependently 
impeded α-thrombin-induced porcine arterial smooth muscle cell proliferation in vitro.48 
The authors then attempted to graft thrombomodulin to ePTFE vascular prostheses with 
EDC; however, they failed to functionalize the surface of the prosthesis and thus may 
have simply crosslinked thrombomodulin within the graft. Despite this, they did observe 
an increase in bioactivity of thrombomodulin when compared to passively coated ePTFE 
grafts.49 In a follow-up study, the authors demonstrated a reduction in neointimal 
hyperplasia in immobilized recombinant human thrombomodulin-coated ePTFE stent 
grafts.50 
Heparin, a glycosaminoglycan that inhibits both thrombin and activated factors IX, X, XI 
and XII, which are involved in the conversion of prothrombin to thrombin51 has been 
extensively investigated. Along with its anti-coagulation properties, heparin has been 
shown to reduce smooth muscle cell proliferation and thus possesses the capability to 
inhibit intimal hyperplasia.52 Lin et al. demonstrated the reduction in neointimal 
hyperplasia at both the proximal and distal anastomoses on heparin-coated ePTFE grafts 
in a baboon arteriovenous shunt model as shown in Figure 2.3.51 
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Figure 2.2: Schematic illustrating pro- and anti-coagulation, and pro- and anti-
fibrinolytic pathways. Blue arrows denote inhibition.53 
In addition to being a part of the anti-coagulation and anti-platelet mechanisms, 
endothelial cells also maintain haemostasis by providing a blood-compatible lining.54 In 
the absence of an adherent and coherent endothelium along the luminal surface of a 
synthetic graft, late stage thrombosis may still occur despite anti-coagulation therapy. 
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Consequently, research has also focused on improving endothelial cell growth, retention 
and confluency on the luminal surface of synthetic grafts. Due to electrostatic and 
hydrophobic interactions with ePTFE vascular grafts, incomplete endothelialization is 
typically encountered.55 Williams et al. have recently studied the effect of conjugated 
mouse laminin type 1 on endothelialization and neovascularization of ePTFE grafts as 
interpositional aortic grafts in rats. The presence of red cells, leukocytes, fibrin and 
platelets in the control grafts suggested a highly thrombogenic surface, while the laminin 
type 1-conjugated grafts exhibited a complete lining of cells indicative of an intact 
endothelium. The authors also observed neovascularization in the interstices of the 
ePTFE grafts in the laminin-conjugated grafts.56 
 
 
Figure 2.3: Neointimal hyperplasia at proximal (top) and distal (bottom) 
anastomoses. Collagens are blue; elastin is black; others are red. A, Anastomoses of 
untreated expandable ePTFE graft (control). B, Anastomoses of heparin-coated 
ePTFE graft (treated). L, Lumen; N, neointima; G, ePTFE graft material. 
(Verhoeff-Masson stain; original magnification: 40×).51 Reprinted from Lin, P. H.; 
Chen, C.; Bush, R. L.; Yao, Q.; Lumsden, A. B.; Hanson, S. R., Small-caliber 
heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia 
in a baboon model. J. Vasc. Surg. 2004, 39 (6), 1322-1328, copyright (2004), with 
permission from Elsevier. 
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Alternatively, Kibbe and colleagues mechanically coated the luminal nodes and fibrils of 
ePTFE with poly(1,8-octanediol citrate) (POC) and implanted the grafts in a porcine 
carotid model. The authors demonstrated increased endothelial cell growth; however, 
confluency was only reached at 10 days. Moreover, the improved growth rate did not 
limit neoinitimal hyperplasia nor were the authors able to confirm that the 
neoendothelium was functional.57 Hoshi et al. took a further step by covalently 
immobilizing heparin to the shear thinned POC coated ePTFE vascular grafts. The 
authors demonstrated reduced whole blood clotting and platelet adhesion of the heparin 
immobilized POC-ePTFE grafts when compared to non-heparinized POC-ePTFE and 
ePTFE grafts. In addition, the heparin-conjugated grafts supported both endothelial cell 
and blood outgrowth endothelial cell (an endothelial progenitor cell (EPC)) adhesion as 
evidenced by expression of von Willebrand factor (vWf) and vascular endothelial (VE)-
cadherin.58 vWf, synthesized and stored by endothelial cells, is integral in the pro-
coagulation cascade as it aggregates platelets,59 while VE-cadherin is localized at 
intercellular boundaries of confluent endothelial cells and is instrumental in regulating 
endothelial permeability.60 The authors also claimed that smooth muscle cells cultured on 
the heparin-POC-ePTFE grafts showed increased expression of α-actin and decreased cell 
proliferation; however, the smooth muscle α-actin expression was only examined 
qualitatively. The cell proliferation data showed that the heparin-conjugated POC-ePTFE 
grafts resulted in a decreased smooth muscle cell proliferation rate only when compared 
to two-dimensional cell culture on tissue culture polystyrene (TCPS) and not when 
compared to POC-ePTFE grafts.58 Although this data does not suggest that intimal 
hyperplasia may be reduced due to decreased smooth muscle cell growth with the heparin 
immobilized POC-coated ePTFE grafts, Hoshi et al. did demonstrate the combined 
benefit of anti-coagulant therapeutic delivery and improved endothelialization.  
In a study by Lu et al., the authors coated 6 mm diameter ePTFE vascular grafts with an 
anti-CD133 antibody functionalized heparin/collagen multilayer. Poly(ethyleneimine) 
(PEI) was electrostatically bound to the surface of the negatively charged ePTFE graft. 
Alternating immersion in heparin and collagen solutions generated a layer-by-layer self-
assembled mutilayered graft, which was then crosslinked with glutaraldehyde in the 
presence of anti-CD133 to immobilize the antibody to the surface of the vascular graft. 
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The authors chose to immobilize CD133 to the surface of the graft as CD133 is a cell 
surface antigen expressed on EPCs, which induced rapid endothelialization in a seven 
day porcine carotid artery transplantation model. In addition to the in situ 
endothelialization, the authors reported significantly decreased platelet adhesion in the 
heparin/collagen coated ePTFE grafts. Despite the promise of the reported work, future 
studies will need to address two pressing issues – appropriately sized ePTFE grafts (< 6 
mm) and longer in vivo studies to ensure no late stage thrombosis occurs due to a loss of 
functional endothelium.55 
Flameng and colleagues recently coated stem cell homing factor stromal-cell derived 
factor-1α (SDF-1α) on the surface of GelsoftTM (Vascutek Ltd., Inchinnan, Scotland) and 
Polymaille C (Pérouse Laboratories, Ivry le Temple, France), which are both knitted 
polyester vascular grafts pre-coated with collagen. The authors examined SDF-1α (also 
known as CXCL12, C-X-C chemokine ligand 12), as it acts as a chemoattractant for 
hematopoietic stem cells (multipotent cells that can differentiate into all types of blood 
cells), while inducing the recruitment of EPCs. The authors observed an increase in 
endothelialization from 27 ± 4% to 48 ± 4% with the SDF-1α coating compared to 
vascular grafts alone in an ovine model. Concurrently, they also observed a decrease in 
intimal hyperplasia.61 
2.4 Degradable Vascular Grafts 
Although vascular prostheses are used effectively in large diameter vascular bypass graft 
surgery, particularly in the treatment of peripheral artery disease, there still remains no 
small diameter vascular graft with clinically acceptable outcomes. In addition, the 
inability of these biostable vascular prostheses to undergo in vivo remodeling following 
implantation would preclude their use in pediatric cardiac patients who would need grafts 
to grow with them. Despite this lack of growth potential, the research applied to the 
passivation and endothelialization of vascular prostheses could be employed to vascular 
grafts that could undergo remodeling in vivo. For the vascular graft to integrate with the 
host’s tissue, the graft itself must degrade following implantation, but in a manner 
adaptive to the needs of the host, ranging from pediatric to geriatric patients. Engineering 
of degradable vascular grafts currently under investigation include both synthetic and 
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biologically derived scaffolds, typically rendered biomimetic through functionalization 
and then potentially sodded with cells. These avenues of tissue engineering all seek to 
produce grafts promoting vascular cell migration and infiltration, possessing a non-
thrombogenic luminal surface, while providing appropriate viscoelasticity and 
mechanical strength, especially during tissue regeneration. 
2.4.1 Tissue Engineering of Vascular Grafts in Vivo 
One approach in designing tissue-engineered vascular grafts (TEVG) is through the 
implantation of an ‘off-the-shelf’ acellular vascular scaffold. In vivo tissue engineering of 
vascular grafts necessitates the host’s cells to infiltrate and populate a non-thrombogenic 
three-dimensional porous matrix, while concomitantly preventing blood leakage through 
the graft. As stated, the scaffold must also remain compliant to preserve the necessary 
haemodynamic environment, yet provide sufficient burst pressure and suture retention 
strengths. Given the extensive list of prerequisites for a tissue-engineered vascular graft, 
numerous approaches have been explored. 
Walpoth and colleagues recently evaluated a bilayered biodegradable electrospun 
polycaprolatone (PCL) scaffold as a vascular graft. The authors prepared the bilayered 
PCL graft by electrospinning two different concentrations of PCL to obtain a nanofibrous 
luminal surface, and a microfibrous adventitial side, as shown in Figure 2.4.62 The 
microfibrous matrix was designed to allow a dense infiltration of the smooth muscle 
cells, while the nanofibrous structure was designed to allow the endothelial cells to bridge 
the gaps to form a confluent monolayer to prevent blood leakage. In a four week bilateral 
porcine carotid artery model, the authors observed a marginal improvement in graft 
patency – 78% versus 67% for the PCL and ePTFE vascular grafts, respectively. An 
increase in neoendothelialization from 58% to 86% was also observed in the PCL grafts. 
Despite the increase in endothelialization, neointima and thrombus formation were not 
improved with the PCL electrospun vascular grafts.63 In a long-term follow-up study, the 
authors compared the patency of the bilayered PCL vascular graft against the ePTFE 
prosthesis in a Sprague-Dawley rat aorta replacement study. At a median of 16.5 months, 
the rats were euthanized, and the grafts were excised and examined. Graft patency in the 
PCL grafts was 100%, while only 67% of ePTFE grafts remained patent. Although there 
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was a reduction in calcification and a concomitant improvement in cell infiltration and 
graft compliance with the PCL grafts when compared to ePTFE grafts, the PCL graft 
compliance was markedly less than the native aorta.64 
 
Figure 2.4: Vascular graft constructs. Two scaffolds with different porosities were 
electrospun sequentially to form bilayered vascular grafts. The inside-barrier graft 
(A) has a high-porosity layer on the adventitial side (*, C) and a low-porosity layer 
on the luminal side (#, E). The outside-barrier graft (B) was constructed inversely. 
The transition between the two layers was continuous, with no delamination (D).62 
Reprinted from de Valence, S.; Tille, J. C.; Giliberto, J. P.; Mrowczynski, W.; 
Gurny, R.; Walpoth, B. H.; Möller, M., Advantages of bilayered vascular grafts for 
surgical applicability and tissue regeneration. Acta Biomater. 2012, 8 (11), 3914-
3920, copyright (2012), with permission from Elsevier. 
In effort to further improve the interaction of PCL with both endothelial and smooth 
muscle cells, recent work has focused on incorporating tripeptides to direct cell 
behaviour. The tripeptide arginine-glycine-aspartic acid (RGD), the cell adhesive motif of 
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fibronectin has been incorporated into a PCL-functionalized vascular graft. A 
naphthalene-conjugated hexapeptide phenylalanine-phenylalanine-glycine-arginine-
glycine-aspartic acid (FFGRGD) self-assembled on the surface of the hydrophobic PCL 
yielding pendant RGD handles, which had previously demonstrated improved 
hydrophilicity, cell attachment and spreading. In an arteriovenous shunt model in female 
New Zealand White rabbits, Zheng et al. observed reduced platelet adhesion, improved 
patency and smooth muscle cell infiltration and greater endothelialization with the RGD-
functionalized PCL grafts. Although the authors reported improved smooth muscle cell 
infiltration and vasoactivity, this did not result in a thicker smooth muscle tissue, nor was 
endothelialization complete even after a four-week implantation.65 In a similar study, the 
tripeptide cysteine-alanine-glycine (CAG) was electrospun with PCL fibers into a 
vascular graft and implanted in a Sprague-Dawley rat carotid artery model. Kuwabara et 
al. previously noted that the CAG tripeptide improved endothelialization, while it 
retarded smooth muscle cell proliferation. Upon excision at 1, 2 and 4 weeks, the authors 
reported improved endothelialization at all time points and virtually complete 
endothelialization had occurred within two weeks. The presence of vWf was 
demonstrated at one week, while the production of endothelial nitric oxide synthase 
(eNOS) was detected as early as one week demonstrating functional endothelium. The 
authors also demonstrated reduced smooth muscle α-actin expression at 6 weeks in the 
CAG-modified PCL graft suggesting a potential to reduce intimal hyperplasia;66 
however, smooth muscle α-actin is a contractile phenotype marker protein and does not 
give a true representation of smooth muscle cell proliferation. 
Although these studies investigated the ability of PCL-modified vascular grafts to either 
improve patency, endothelialization or smooth muscle cell infiltration, they did not fully 
examine neovascularization in vivo. Matsumura et al. had previously engineered a 
vascular graft consisting of polyglycolide knitted fibers and an L-lactide and ε-
caprolactone copolymer sponge reinforced with glycolide and ε-caprolactone copolymer 
monofilaments, but only recently applied the biodegradable scaffold as a cell-free graft in 
a canine inferior vena cava (IVC) model. Immunohistological studies revealed 
endothelialization (factor VIII-positive) and smooth muscle cell proliferation (smooth 
muscle α-actin) in the tissue-engineered vascular graft (TEVG) at one and 2.5 months 
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with elastic and collagenous fibers also observed at 24 months. The authors reported no 
significant differences in the hydroxyproline, elastin and calcium contents between the 
vascular graft and the native IVC up to 24 months follow-up. Moreover, the elastic 
modulus of the graft reached that of the native IVC at 2.5 months and continued to mirror 
the IVC up to 24 months following implantation.67 In a follow-up study, the authors 
examined their vascular graft in a canine pulmonary artery model. Again, they reported 
no significant differences in hydroxyproline and elastin content between the left 
pulmonary artery and the TEVG; however, significant calcification was observed with 
the TEVG at 12 months. Although the authors noted a lack of stenosis and thrombosis in 
the vasculature of any of the animals, the tubular scaffolds were 8 mm in diameter68 and 
may not replicate the haemodynamics of the small diameter blood vessel. In another 
study examining neovascularization, Wang and colleagues implanted a poly(glycerol 
sebacate) (PGS) vascular graft supported with an outer PCL sheath in the abdominal 
aorta of Lewis rats. The sheath was electrospun around the tubular PGS graft to 
strengthen the graft, allowing it to be sutured in place while preventing blood loss 
through the highly porous PGS network. The authors selected PGS because it is 
elastomeric, permitting effective transduction of mechanical stimulation, while degrading 
rapidly in vivo, hence minimizing the host response to a foreign body. At three months, 
the authors observed significant smooth muscle cell infiltration into the remodeled graft 
wall; however, smooth muscle α-actin expression was localized away from the luminal 
surface as shown in Figure 2.5.69 
The authors also demonstrated significant ECM production at 90 days. Verhoeff’s, 
Masson’s trichrome and safranin O staining revealed the presence of elastin, collagen and 
glycosaminoglycans in the neoartery, nearing the ECM protein content of the native 
aorta, as shown in Figure 2.6.69 The considerable ECM protein content also had a 
significant impact on the mechanical properties. The neoartery was tough yet compliant 
with a burst pressure approaching that of the aorta and greater than that of the saphenous 
vein. Given the promising results, future studies with large animals more representative 
of the human vasculature are proposed. 
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Figure 2.5: Smooth muscle cell infiltration and organization at 14 days. (a) Smooth 
muscle cell distribution (SMαA, green) within the remodeled graft wall. The tissue 
was split longitudinally, half of which is shown. Native aorta is on the right; its 
border with the graft is indicated by the dashed line; scale bar, 500 μm. L, lumen. 
(b) Magnified view of the mid-graft shows distribution of both SMαA–positive 
(green) and SMαA–negative cells. Nuclei counterstained by DAPI (blue); scale bar, 
250 μm. (c) Further magnification of the mid-graft to view the complicated smooth 
muscle cell distribution (SMαA, green); scale bar, 50 μm. (d) Distribution of 
endothelial cells (vWf, red) and smooth muscle cells (SMαA, green) in the graft wall. 
Immunofluorescent images merged with the bright-field image (darkened to not 
overwhelm the fluorescent images). Dark spots (*) in the bright-field image might be 
residual graft material. Scale bar, 100 μm.69 Reprinted by permission from 
Macmillan Publishers Ltd: [Nature Medicine] (Wu, W.; Allen, R. A.; Wang, Y. Nat. 
Med. 2012, 18 (7), 1148-1153, http://www.nature.com/nm/index.html), copyright 
(2012). 
22 
 
 
 
Figure 2.6: ECM organization and quantification at 90 days. (a) Verhoeff’s, 
Masson’s trichrome and safranin O staining show elastin (black), collagen (blue) 
and glycosaminoglycansin (red), respectively. Immunofluorescent staining shows 
distribution of elastin (red), collagen I (green), and collagen III (red). Top: day 90 
explant; bottom: native aorta. Scale bars, 50 μm. (b) Quantification of elastin (n = 4) 
and total collagen (n = 4). Data represent mean ± s.d.69 Reprinted by permission 
from Macmillan Publishers Ltd: [Nature Medicine] (Wu, W.; Allen, R. A.; Wang, 
Y. Nat. Med. 2012, 18 (7), 1148-1153, http://www.nature.com/nm/index.html), 
copyright (2012). 
Another material garnering attention as a vascular biomaterial is the elastomeric 
poly(ester urethane)urea (PEUU) derived from PCL diol, 1,4-diisocyanatobutane and 
putrescine in part due to its mechanical properties, as it has a burst pressure strength and 
suture retention strength approaching that of the internal thoracic artery.70 Further to their 
original study, Vorp, Wagner and colleagues have covalently attached 2-
methacryloyloxyethyl phosphorylcholine (MPC) to the luminal surface of electrospun 
PEUU conduits to impart anti-thrombogenicity. The surface of the PEUU was aminated 
via ammonia plasma treatment and then a phospholipid copolymer of MPC and 
methacrylic acid (PMA) was conjugated via EDC chemistry. The vascular grafts were 
then implanted in the abdominal aorta of rats and examined upon sacrifice at 4, 8, 12 and 
24 weeks. The authors demonstrated a significant reduction in platelet adhesion in the 
PMA-conjugated PEUU grafts, with a corresponding patency rate of 92% compared to 
just 40% in the uncoated controls at eight weeks. In the occluded grafts, 90% were 
attributed to acute thrombosis, while the remaining 10% failed due to intimal hyperplasia. 
The PMA-immobilized PEUU grafts also yielded aligned collagen and elastin fibers, both 
necessary precursors in neovascularization. Moreover, the authors also demonstrated an 
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intact endothelium as evidenced by the continuity in vWf immunostaining between the 
native aorta and the electrospun PEUU graft. The authors also reported significant 
changes to the dynamic compliance and ultimate tensile strength of the functionalized 
PEUU grafts upon excision. An initial increase in the dynamic compliance and 
concomitant decrease in ultimate tensile strength was observed at 4 weeks and believed 
to be the result of acute degradation of the nodes of the electrospun fibers.71 
Although the synthetic grafts may be easier to handle, suture, scale up and sterilize while 
yielding more reproducible properties, some researchers believe that the high modulus 
and tensile strength exhibited by fibroin, a component of spider silk, is equally viable as a 
vascular scaffold material. Catteneo et al. electrospun fibroin into 1.5 mm diameter 
tubular grafts that were implanted in the abdominal aorta of Lewis rats in end-to-end 
anastomoses. Upon explantation at seven days, the constructs were infiltrated with 
smooth muscle cells and lined with endothelial cells as evidenced by the immunostaining 
of smooth muscle α-actin and vWf, respectively. The authors also reported the presence 
of elastin at seven days, and that by volume density, was approximately 50% of native 
vessels. Despite the evidence of complete endothelialization, the graft was only 1.5 cm in 
length.72 In a similar study, Lovett et al. gel spun aqueous fibroin solutions to yield 2 cm 
silk tubular scaffolds and implanted them in the abdominal aorta of Sprague-Dawley rats. 
Silk fibroin grafts remained patent up to four weeks following implantation, while acute 
thrombosis in all PTFE constructs was observed in 24 hours. The recruitment of vascular 
cells from the adjacent native aorta resulted in a medial smooth muscle layer and 
complete endothelialization as confirmed by smooth muscle α-actin and factor VIII 
staining. Further to the in vivo studies, the haemocompatibilty of the silk fibroin grafts 
were also studied in vitro. A reduction in thrombin and fibrinogen adsorption was 
observed compared to PTFE and although an increase in platelet adhesion was seen from 
incubation of platelet-rich plasma on silk fibroin films, the platelets were deemed non-
activated by their non-spreading morphology.73 
In a complementary study, Yagi et al. prepared three kinds of knitted double-raschel silk 
fiber grafts coated with crosslinked silk fibroin again with an internal diameter of 1.5 
mm, but with a length of 7 cm. The silk grafts were also implanted in the abdominal aorta 
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of Sprague-Dawley rats. Upon excision at eight weeks, gross observation of the vascular 
constructs revealed patency of the most elastic and flexible silk fibroin tubular graft 
tested, attributed to a reduction in intimal hyperplasia. Immunohistological studies 
revealed smooth muscle cell infiltration resulting in smooth muscle tissue thickness 
similar to that of the native rat aorta; however, complete endothelialization was not 
achieved, in particular at the midpoint of the vascular graft following eight weeks 
implantation.74 Given that incomplete endothelialization was observed, along with 
growing smooth muscle tissue, longer studies are necessary to ensure intimal hyperplasia 
does not result in occlusion of the vascular grafts. 
Despite some promising results from foreign biomaterials, other researchers believe that 
clinical success will incorporate all fundamental features of the vascular wall. Kumar et 
al. have recently incorporated both fibrillar collagen type 1 and an elastin-like 
polypeptide (ELP) as a vascular graft. Collagen fibrils were prepared from monomeric 
type 1 collagen extracted from rat tail tendon before the ELP was coated on the surface of 
the collagen and rolled to generate a luminal ELP layer on multiple fibrillar collagen 
layers. Initial studies revealed reduced platelet adhesion in the ELP-coated vascular graft 
when compared to the uncoated collagen graft control. Histologically, the two week rat 
aorta interposition study revealed little neointima formation, and continuous vWf 
staining, indicative of an intact endothelium. Despite the promising short-term in vivo 
data, the burst pressure strength and suture retention strength still remain a fraction of 
that of the internal thoracic artery.75 In a similar study by Niklasson and colleagues, the 
authors harvested human aortae and then decellularized the constructs to produce human 
tissue-engineered vessels (hTEV). The decellularized hTEVs exhibited burst strength 
pressures similar to the saphenous vein and twice those obtained from the fibrillar 
collagen obtained from rat tail tendon, yet still inferior to the native ITA. The grafts were 
implanted in an end-to-end anastomoses in the abdominal aorta of female nude mice. 
Upon explantation of the grafts at six weeks, there was evidence of neointima and 
neotissue formation on the decellularized grafts. Although cells did not fully infiltrate the 
decellularized graft, both elastin and smooth muscle cells were prevalent. In addition, 
vWf staining demonstrated the recruitment of endothelial cells to the luminal surface of 
the vascular graft. The authors acknowledge that larger animal studies are needed and 
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that these studies also need to examine the potential for late stage stenosis following 
neotissue or neointima formation.76 
In a more complex approach, McClure et al. have recently prepared vascular grafts 
composed of PCL, elastin (ELAS), collagen (COL) and silk fibroin (SF) in effort to 
prepare a trilayered vascular graft mimicking the extracellular matrix of each individual 
component of the native artery. The subendothelial layer of the tunica intima is 
comprised of collagen type IV and elastin; the tunica media is composed of several dense 
layers of smooth muscle cells in a matrix of collagen types I and III, elastin and 
proteoglycans. The adventitial layer consists of fibroblasts embedded in randomly 
arranged collagen type I. Despite the presence of both collagen type IV and elastin in the 
subendothelial layer, the authors chose to electrospin the intima of the vascular graft from 
a PCL solution, due to recent studies illustrating rapid endothelialization of PCL vascular 
grafts. Because the percentage of ECM proteins of vascular tissue varies, different 
compositions of PCL:ELAS:COL, or PCL:ELAS:SF were co-electrospun prior to 
crosslinking with EDC or genipin to mimic both the tunica media and adventitia.77 
2.4.2 Tissue Engineering of Vascular Grafts in Vitro 
While some researchers have adopted the approach of in vivo tissue engineering, where 
cells are recruited into the biodegradable scaffold from adjacent tissue, others believe that 
seeded cells serve as the ‘building blocks of neotissue.’ Of these in vitro methods, there 
are two unique approaches to enhance tissue regeneration and remodeling: cell sheet self-
assembly and cell sodding of biodegradable scaffolds. Vascular tissue maturation 
typically occurs in a bioreactor under perfusion, where the vascular constructs are 
exposed to the haemodynamic cyclic loading observed in vivo. 
2.4.2.1 Cell Sheet Tissue Engineering 
The first tissue-engineered vascular graft prepared wholly from cultured human cells was 
developed by L’Heureux et al. Vascular smooth muscle cells (SMCs) obtained from 
umbilical veins and fibroblasts from human skin were cultured for 30 days with ascorbic 
acid to produce a cohesive cellular sheet with an associated ECM. The SMC layers were 
first peeled from the culture dish and enclosed around a tubular support to produce 
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concentric sheet layers that mimic the media of the vessel. A secondary sheet of 
fibroblasts was then wrapped around the medial layers to emulate the adventitia. After an 
eight week maturation period in a bioreactor, the perforated tubular mandrel was 
removed and luminal endothelial cell seeding was performed. The authors reported 
expression of vWf and strong inhibition of platelet adhesion in vitro from a coherent 
endothelium. The three-layered organization of the TEVG included both collagen and 
elastin, yielding a burst strength of over 2000 mm Hg, which is similar to that of human 
vessels. In a seven day interpositional femoral artery graft in mongrel dogs, the authors 
reported patency in three of six animals, where occlusion from acute thrombosis resulted 
from non-endothelialized vascular grafts.78 
Recent work using the cell sheet technology has focused on improved neovascularization 
through in vitro pre-vascularization. Okano and colleagues developed a five-layered 
construct where human umbilical vein endothelial cells (HUVECs) were seeded between 
myoblast sheets. Upon four days culture in vitro, capillary-like structures were partially 
formed and then implanted into dorsal subcutaneous tissue of nude rats. At one week 
post-implantation, the capillary-like structures joined the host’s blood vessels creating 
microvessels, which also contained red blood cells.79 In a more exhaustive study, Sekine 
et al. developed three-dimensional (3D) tissue with perfusable blood vessels in vitro. The 
authors isolated cardiac cells from the ventricles of Sprague-Dawley and Lewis neonatal 
rats.80 Cardiac cells were co-cultured with endothelial cells (ECs) and seeded on 
temperature-sensitive culture dishes for ease of cell sheet recovery as published in their 
previous study and shown in Figure 2.7.81 
Upon stacking of the cardiac sheets, they were overlaid on a vascular bed from resected 
femoral tissue containing a connectable artery and vein as shown in Figure 2.8a. Media 
was supplied through the femoral artery (Figure 2.8b) and perfused through the vascular 
bed. The authors demonstrated that in the absence of ECs, no tubular structure was 
observed in the trilayered cell sheet, and that fibroblast growth factor-2 (FGF-2) was 
necessary to ensure media diffusion from the vascular bed to the cell sheet construct. In 
combination, the co-culture of ECs in the cardiac sheets enabled the formation of new 
blood vessels, while the FGF-2 facilitated the connection of these new blood vessels with 
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the vasculature of the underlying femoral tissue. The three-dimensional tissue-engineered 
construct remained viable in vitro via media supplied through the newly formed vessels. 
The functional tissue was then implanted in nude mice where the femoral artery and vein 
of the construct were reconnected to the carotid artery and the jugular vein, respectively. 
A cell sheet construct without a vascular bed and a vascular graft without blood vessel 
anastomoses served as controls. At two weeks, the rats were euthanized and tissue 
viability was significantly greater in the vascular graft with the blood vessel anastomoses. 
Moreover, immunostaining of CD31 and calponin highlighted a uniform distribution of 
blood vessels in the cell sheet construct.80 
 
Figure 2.7: The fabrication of 3D cell-dense tissues by cell sheet engineering. (a) 
Cells are cultured on a temperature-responsive culture dish until reaching 
confluence before recovering the cell sheet. (b) Extremely cell-dense 3D tissue 
constructs can be fabricated by layering recovered cell sheets. Photographs are 
cross-sectional observations of cell sheets by H&E staining.81 Reprinted by 
permission from Macmillan Publishers Ltd: [Nature Protocols] (Haraguchi, Y.; 
Shimizu, T.; Sasagawa, T. et al. Nature Protocols 2012, 7 (5), 850-858, 
http://www.nature.com/nprot/index.html), copyright (2012). 
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Figure 2.8: In vitro engineering of functional 3D tissue with perfusable blood vessels. 
(a) To engineer cell sheet constructs with perfusable blood vessels, EC co-cultured 
cardiac cell sheets are stacked, and then overlaid on a vascular bed in vitro. After 
appropriate perfusion using a bioreactor, the co-cultured ECs formed new blood 
vessels and connected with the blood vessels that originated from the vascular bed. 
Finally, the cell sheet constructs survive via the media supplied through the new 
vessels formed in vitro. (b) The engineered constructs are perfused in a custom-
made bioreactor. The bioreactor is a one-pass system consisting of a delivery pump, 
a custom-made tissue culture chamber, pH transmitter, flow transmitter, pressure 
transmitter, CO2 gas source, process controller and data acquisition system.80 
Copyright © 2013, Rights Managed by Nature Publishing Group. 
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2.4.2.2 Cell Sodding of Biodegradable Scaffolds 
As mentioned, the in vitro maturation of vascular tissue typically occurs in a bioreactor 
under perfusion; however, in cell sodding of biodegradable scaffolds, the vascular 
matrices are also exposed to the haemodynamic cyclic loading observed in vivo. Niklason 
et al. initially demonstrated that SMCs, when cultured dynamically for eight weeks on 
tubular degradable polyglycolic acid (PGA) meshes, yielded densely packed layers of 
SMCs. The engineered vessels exhibited rupture strengths in excess of 2000 mm Hg,82 
exceeding the burst pressure of the saphenous vein.78 Subsequent studies have also 
revealed improved SMC proliferation83 and mechanical properties in dynamic culture 
conditions.84-86 In addition, the studies by Kim and colleagues revealed increased 
collagen84 and elastin deposition under dynamic culture in their collagen coated poly(L-
lactide-co-ε-caprolactone) tubular grafts; however, upon continued dynamic culture, loss 
of seeded HUVECs was observed.83 
Although dynamic culture of SMCs has demonstrated improved cell proliferation, ECM 
production and cell orientation may be influenced by cell source, scaffold and bioreactor 
design. Wang et al. demonstrated increased collagen deposition from adipose stem cell 
derived SMCs in PGA meshes upon pulsatile flow, yet showed no effect on elastin 
synthesis.86 Three week dynamic cultures on elastomeric PGS tubular constructs resulted 
in increased levels of both insoluble collagen and elastin synthesis, which the authors 
attributed to improved mechanical transduction of the cyclic radial distension from the 
bioreactor to the SMCs.87 Kaplan and colleagues observed SMC orientation parallel to 
fluid flow on a silk-based scaffolds,88 while both Lee and Wang and Ratcliffe reported 
SMC orientation perpendicular to fluid flow on synthetic polymer-based scaffolds, 
similar to native vessels.87,89 Despite the conflicting data, realizing that mechanical 
properties mimicking those of native blood vessels can be imparted on to a tubular 
scaffold through the dynamic loading of a perfusion bioreactor, facilitates the 
development of a TEVG. 
Although evidence of improved cell infiltration and orientation into vascular scaffolds 
during in vitro maturation further reinforced the adage that seeded cells served as the 
building blocks of neotissue, this behavior has not fully replicated in vivo. In 2008, Roh 
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et al. developed a small (< 1 mm) diameter vascular graft for use in a mouse model. The 
scaffolds were prepared by rolling non-woven polyester sheets of either PGA or poly(L-
lactic acid) (PLLA) around either 21 or 22 gauge needles and then sealing them with a 
copolymer solution of poly(ε-caprolactone-co-L-lactide) (P(CL/LA)). The scaffolds had 
excellent mechanical properties with burst pressures in excess of the venous burst 
pressures and greater suture retention strength than both venous and arterial blood 
vessels. The intrinsic elasticity was measured as a function of Young’s modulus, and 
despite the vascular scaffolds being stiffer than physiologic vessels, the scaffolds were 
more elastic than ePTFE prosthetic grafts.90 
In a follow-up study, the PGA-P(CL/LA) scaffolds were seeded with human bone 
marrow mononuclear cells (hBM-MNCs) and implanted as IVC interposition grafts in 
immunodeficient mice. The authors investigated the premise that stem cells in the hBM-
MNC population differentiate into vascular SMCs and ECs of the neovessel. All hBM-
MNC seeded vascular grafts remained patent throughout the 24 week study. Upon study 
completion, mature vasculature was also evident, including the presence of a confluent 
endothelium and a sub-endothelium SMC medial layer. Despite the degradation of the 
scaffold and its replacement with collagen fibrils, no elastin was detected in the TEVGs. 
Upon excision of the implants throughout the course of the 24 week study, the authors 
tested the grafts for hBM-MNC surface antigens. After 1 week post-implantation, Roh et 
al. confirmed the absence of human ribonucleic acid (RNA) from the seeded hBM-MNCs 
in the TEVGs using quantitative real time polymerase chain reaction (qPCR). Although 
the hBM-MNCs were not retained or incorporated into the TEVGs as differentiated cells, 
the presence of mouse SMCs and ECs following mouse monocyte recruitment suggested 
that the TEVGs appear to undergo inflammation-induced vascular remodeling. Despite 
the ultimate loss of hBM-MNCs, their secretion of the cytokine CCL2 (C-C motif ligand 
2 and previously known as monocyte chemoattractant protein-1 (MCP-1)) increased 
monocyte recruitment suggesting that the hBM-MNCs were adopting a paracrine 
mechanism in neovessel development.91 Paracrine signaling is a cell-cell communication 
where secreted paracrine factors (signaling molecules) trigger a change in behaviour or 
differentiation of nearby cells. 
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The postulation that seeded cells participate in neovessel formation via paracrine 
signaling was further evaluated. Breuer and his colleagues tested the effect of BM-MNCs 
on the TEVGs implanted in macrophage-depleted mice. The authors demonstrated that 
macrophages (differentiated monocytes) are critical for TEVG patency, as the complete 
inhibition of macrophage infiltration prevented neotissue formation. Conversely, 
excessive macrophage infiltration was observed in the unseeded grafts, which resulted in 
neointimal hyperplasia, and ultimately a stenotic or occluded graft. In fact, early stenosis 
occurred in 80% of unseeded TEVGs, but only 20% of seeded TEVGs in an IVC 
interposition graft. Consequently, patency was improved in the cell-seeded grafts when 
compared to unseeded controls.92 
In spite of hBM-MNC loss upon implantation of the TEVG in immunodeficient mice, the 
patency of all grafts at 24 weeks with a well-developed vasculature including a coherent 
endothelium and SMC medial layer suggested that the neovessel was comprised entirely 
of host cells. To ensure that xenograft transplantation rejection was not responsible for 
the loss of hBM-MNCs in the immunodeficient mice, syngeneic (genetically identical) 
BM-MNCs were also seeded on TEVGs and implanted in mice. Again the authors 
observed almost complete replacement of the BM-MNCs with macrophages, with only 
0.02% of the originally seeded cells still present at 14 days. Moreover the BM-MNCs 
were not a significant source of either the ECs or SMCs of the neovessel. The vascular 
cells forming 93% of proximal neotissue were in fact recruited from the adjacent vessel 
wall.93 
Although seeded cells may not be incorporated into neotissue, extensive research 
demonstrates the improved patency of TEVGs seeded with cells. Ultimately patent 
TEVGs will need to be lined with autologous ECs and supported with a medial layer of 
vasoactive SMCs; however, due to their slow propagation in vitro, focus has shifted to 
more rapidly proliferating stem cells or the incorporation of progenitor cells. Much 
controversy has surrounded the use of embryonic stem cells, but with the ability to 
harvest adult mesenchymal stem cells (MSCs) from BM-MNCs, adipose tissue and 
skeletal muscle tissue, significant research in stem cell-based tissue engineering has 
emerged.94 In addition to the MSCs, the reprogramming of somatic cells to induced 
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pluripotent stem (iPS) cells has further expanded the possible use of stem cells in tissue 
engineering.95 
Cho et al. were the first to examine differentiated BM-MNCs in a TEVG in a canine 
carotid artery model. Both SMαA/smooth muscle myosin heavy chain (SM MHC)-
positive cells and vWf/CD31-positive cells from the mononuclear cell fraction were 
cultured for three weeks in vitro to obtain enough cells for seeding. First, SMαA/SM 
MHC-positive cells were uniformly seeded onto small diameter decellularized canine 
carotid arteries, followed two hours later by the vWf/CD31-positive cells, which were 
seeded onto the luminal surface of the scaffolds and cultured for one week prior to 
implantation in an end-to-end anastomoses of the carotid artery. Explanted grafts showed 
elements of an intact endothelium with well-defined medial and adventitial layers. 
Moreover, the TEVGs remained patent up to eight weeks post-implantation, while 
unseeded grafts occluded within two weeks. The explanted grafts also revealed the 
presence of the fluorescently labeled BM-MNCs up to eight weeks, indicating that some 
of the BM-MNCs actively participated in the vascular tissue regeneration.96 The 
incorporation of the BM-MNCs into the remodeled vascular tissue contradicts the 
observations of Breuer and colleagues; however, the behaviour of mesenchymal stem 
cells is directly related to their perivascular environment97 and may differ between 
humans and dogs. In a follow-up study, the authors seeded the canine BM-MNCs onto a 
poly(lactide-co-ε-caprolactone) scaffold supported by PGA fibers. Excision of the 
TEVGs at eight weeks in a canine abdominal aorta model revealed that the TEVG 
underwent significant remodeling with a structure similar to that of the native aorta as 
shown in Figure 2.9.98 
Notwithstanding the in vivo remodeling following the TEVG implantation, the time 
needed for differentiation of the BM-MNCs would hinder its use as an off-the-shelf 
vascular graft. The seeding of non-differentiated BM-MNCs on to a biodegradable 
vascular scaffold was first reported by Matsumura et al. The BM-MNCs were also seeded 
on a poly(lactide-co-ε-caprolactone) scaffold, but supported with PLLA fibers and then 
implanted in the IVC of beagles. The explanted grafts were analyzed 
immunohistochemically at three hours and again at 2, 4 and 8 weeks post-implantation. 
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Stenosis was not observed in any of the TEVGs while patency was maintained up to two 
years following implantation. Immunohistochemistry revealed that seeded BM-MNCs 
initially expressed endothelial cell lineage markers including CD34, CD31, Flk-1, and 
Tie-2. Following proliferation and differentiation of the BM-MNCs, expression of 
EC markers CD146, factor VIII and CD31, as well as SMC markers SMαA, embryonic 
smooth muscle myosin heavy chain (SMemb), and smooth muscle myosin heavy chain 
isoforms SM1 and SM2 were observed implying the differentiation of the BM-MNCs 
into mature vascular cells in vivo.99 Despite the promising remodeling in vivo, the inner 
diameter of the degradable grafts selected for these studies were 10 and 8 mm, 
respectively, approximately twice the diameter of any healthy male coronary artery.100 
 
Figure 2.9: Histological and immunohistochemical analyses of TEVGs excised eight 
weeks after implantation. (A) H&E staining of retrieved TEVGs showed 
regeneration of vascular tissues (100×). (B) Masson’s trichrome staining indicated 
collagen regeneration (100×). (C) Cells on the luminal sides of explanted TEVGs 
stained positively for vWf, indicating endothelium regeneration (400×). (D) 
Immunohistochemical staining for SMαA (400×) showed regeneration of SM tissue. 
(E) H&E and (F) Masson’s trichrome staining and immunohistochemical staining of 
(G) vWf and (H) SMαA of native abdominal aortas. The scale bars in (A), (B), (E), 
and (F) represent 200 µm. The scale bars in (C), (D), (G) and (H) represent 50 µm.98 
Copyright © 2007 Wiley Periodicals, Inc. 
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More recently Wu et al. compared four types of scaffolds (inner diameter of 5 mm) to 
evaluate their ability to direct BM-MNC differentiation in vitro and promote vascular 
tissue formation. Rat BM-MNCs were seeded on PLGA, PGS, platelet-poor plasma-
coated PGS and plasma-coated PGS supplemented with platelets. The authors examined 
the impact of platelet adhesion on differentiation of bone marrow mononuclear cells as 
platelets have been identified in recruiting circulating EPCs through paracrine release of 
stem cell-derived factor-α and vascular endothelial growth factor. The expression of 
calponin-I and SMαA and deposition of collagen and elastin from cells cultured on PGS 
scaffolds suggested smooth muscle differentiation. Although increased cell proliferation 
was observed with platelet supplementation, and hence ECM secretion, the authors did 
not report the impact of platelets on the differentiation of stem cells into mature 
endothelial cells. vWf immunohistochemistry revealed the presence of the blood 
glycoprotein in platelets,101 but its absence at the luminal surface, as expected in ECs, 
perhaps suggests that the platelets did not actively recruit the EPCs from BM-MNCs, or 
that the BM-MNCs preferentially differentiated into SMCs. 
Although Wu et al. did not report the presence of ECs or their markers, bone marrow 
MSCs, a small portion of the mononuclear cell fraction, have been successfully 
differentiated into ECs in vitro.102-103 The controlled in vitro differentiation of bone 
marrow MSCs to smooth muscle-like and endothelial-like cells can be achieved through 
supplement manipulation of the culture media.104 Decellularized ovine carotid artery 
grafts were seeded with the autologous cells and implanted as interposition grafts. The 
seeded grafts remained patent for up to five months, while the unseeded controls 
occluded within two weeks. The presence of an endothelium and smooth muscle within 
the TEVG was observed at both 2 and 5 months as demonstrated through 
immunohistochemical staining of vWf and SMαA, respectively. MSCs labeled with 
PKH26, a cell membrane bound fluorescent dye, was detected in the luminal side of the 
tunica media at two months, but not at five months, suggesting repopulation of the 
vascular graft.104 Similar observations of improved patency have been reported with bone 
marrow MSC- and EPC-seeded PLLA-PGA scaffolds in a mouse carotid artery model. 
The authors also labeled the bone marrow MSCs with green fluorescent protein (GFP) 
and noted a reduction in GFP expression at 35 days when compared to seven days, 
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further supporting the premise of graft repopulation with host cells.105 Hashi et al. seeded 
bone marrow MSCs onto PLLA scaffolds and implanted them into the common carotid 
artery of rats for 60 days. Well-distributed SMCs within the TEVG indicated strong MSC 
infiltration and differentiation. Neointimal thickening was only observed in the unseeded 
controls. Staining for CD31 revealed not only luminal coverage of the TEVG with 
endothelial cells, but their presence in the outer layer of the graft suggested microvessel 
formation in the surrounding tissue. The authors also reported that explanted grafts at 60 
days showed significant collagen deposition; however, only the MSC-seeded grafts 
exhibited a sub-luminal elastic lamina layer. Finally, the authors also showed that as early 
as seven days, most cells were again recruited from the host due to the absence of human 
antigen nuclear mitotic apparatus staining in the seeded grafts.106 
The accumulating evidence that cells sodded on vascular grafts significantly improve 
patency rates when compared to unseeded grafts, yet fail to integrate in neotissue 
formation, further validates the postulation that seeded cells supplement the host’s innate 
healing process through paracrine signaling. Specifically, Breuer and colleagues believe 
that upon implantation of the bone marrow mononuclear cell-seeded tissue engineering 
graft, the BM-MNCs secrete chemokines such as CCL2, which is known to attract 
circulating monocytes. Following the differentiation of monocytes to macrophages, 
platelet derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) are 
released, promoting infiltration of adjacent ECs and SMCs, which together with the 
macrophages and fibroblasts begin secreting the extracellular matrix. During scaffold 
degradation, ECM remodeling continues with a concomitant exodus of macrophages 
yielding a completely autologous neovessel107-108 as illustrated in Figure 2.10.109 
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Figure 2.10. Proposed mechanism of vascular transformation of hBM-MNC-seeded 
biodegradable scaffolds. Early pulse of CCL2 (MCP-1) secreted from seeded hBM-
MNCs enhances early monocyte recruitment to the scaffold. Infiltrating monocytes 
release multiple angiogenic cytokines, which recruit SMCs and ECs to the scaffold 
predominantly from mature vascular cells in adjacent vessel segments.91 Copyright 
© 2010 National Academy of Sciences.  
2.5 Mediating the Inflammation and Wound Healing 
Response 
The recent change in the tissue engineering paradigm from passivation of the biomaterial 
surface to mediating the host inflammatory response has also been studied by Labow and 
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Santerre. A porous and elastomeric degradable polar/hydrophobic/ionic (D-PHI) 
polyurethane scaffold was ultimately developed to investigate its modulation of the 
inflammatory-wound healing response through its direction of monocyte behaviour. To 
replicate physiological conditions, the translation of biomechanical stimuli to vascular 
SMCs was initially studied. Human coronary artery smooth muscle cells (HCASMCs) 
were seeded on D-PHI scaffolds and subjected to four weeks of cyclic mechanical strain. 
Cell morphology, infiltration and contractile phenotype marker proteins were studied in 
addition to tensile properties. The dynamic culture of SMCs for four weeks resulted in 
greater cell proliferation and infiltration within the scaffold when compared to static 
cultures. Tensile testing also revealed greater elastic modulus and yield strength in the 
four week dynamic cell culture study, implying an increase in ECM deposition. In 
addition to the increase in protein synthesis, the expression of contractile proteins: 
smooth muscle α-actin, calponin, and SM MHC suggested that the HCASMCs still 
maintained their contractile nature throughout the duration of the study.110 
Given that D-PHI polyurethane scaffolds did not result in dedifferentiation of the 
HCASMCs, the authors then investigated the influence of this material on monocyte 
activation and differentiation.111 Monocyte culture was studied, as implantation of the 
biomaterial initially results in adsorption of plasma proteins and then recruitment and 
adhesion of monocytes to the foreign body. Upon adhesion to the surface, monocytes 
differentiate into monocyte-derived macrophages (MDMs) and then secrete cytokines, 
which ultimately guide the inflammation and wound healing mechanisms. The cytokine 
release profile from MDMs that direct effective tissue regeneration is debatable, as anti-
inflammatory cytokines are not necessarily pro-wound healing and vice versa as shown in 
Figure 2.11. Interleukin-1β (IL-1β) is both pro-inflammatory and pro-wound healing, as 
it activates inflammatory cells (lymphocytes and monocytes) and wound healing cells 
(fibroblasts). Conversely IL-10 is known to down-regulate the activity of these cells, 
while concomitantly suppressing further cytokine production.112 The impact of the D-PHI 
polyurethane on MDM cell expression of pro- versus anti-inflammatory cytokines was 
investigated over 72 hours and compared to tissue culture polystyrene (TCPS). Adherent 
monocytes to D-PHI polyurethane films secreted less pro-inflammatory cytokines TNF-α 
and IL-1β at 2, 24 and 72 hours when compared to TCPS. A corresponding increase in 
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the anti-inflammatory cytokine IL-10 from monocytes cultured on D-PHI was observed 
at 72 hours suggesting IL-10 may have down-regulated monocyte activity and or 
cytokine production. Taken together, this data indicates that D-PHI may cause less 
inflammation than TCPS.111 In a follow-up study, the authors compared the effect of D-
PHI architecture on monocyte activation. Up to seven days, monocytes were more 
activated on 2D films, as evidenced by their differentiation to MDMs and subsequent up-
regulation of tumour necrosis factor-α (TNF-α) and unchanging IL-10 levels when 
compared to D-PHI polyurethane scaffolds. 
 
Figure 2.11. Cytokine classification based on their roles in the foreign body reaction. 
Adapted from Brodbeck et al.112 (copyright © 2002 Wiley Periodicals, Inc.) and 
Schutte et al.113 (copyright © 2008 Wiley Periodicals, Inc.) 
Over the same course, the 3D scaffolds exhibited a decreasing secretion of TNF-α and 
significant increase in IL-10 concentration further suggesting a mitigated inflammatory 
response in vivo.114 In a preliminary in vivo study, unseeded D-PHI polyurethane 
scaffolds implanted in a subcutaneous dorsal model in mice exhibited a muted 
inflammatory response up to six weeks. Stable levels of TNF-α over the course of the six 
weeks was observed, while a concomitant increase in IL-10 was observed. Moreover, 
increased levels of IL-13 and CCL2 were detected, while there was a decline in IL-6.115 
39 
 
 
Although CCL2 is classified as pro-inflammatory, as previous stated, CCL2 was 
necessary in neovessel formation in a mouse IVC interposition graft model.116 
Although the D-PHI polyurethane scaffold has demonstrated good mechanical properties 
and a mitigated inflammatory response in vitro and in vivo, the authors only examined the 
inherent inflammatory response of the scaffold. The localized delivery of cytokines from 
the D-PHI polyurethane scaffold could have further augmented the wound healing 
process and subsequent neovessel formation. 
The chemokine CXCL12 (C-X-C motif, ligand 12) was bound to the surface of heparin, 
which was covalently conjugated to an electrospun tubular scaffold comprised of PLA 
and PCL. CXCL12-bound scaffolds resulted in the recruitment of EPCs to the luminal 
surface of the graft, which accelerated endothelialization in male Sprague-Dawley rats. 
Moreover, CXCL12 also resulted in the recruitment of smooth muscle progenitor cells, 
which were differentiated into SMCs, ultimately improving the elastic modulus and 
ultimate tensile strength of the graft.117 The delivery of recombinant human platelet-
derived growth factor-BB (PDGF-BB), which stimulates wound healing has also been 
incorporated into PLGA microspheres embedded in PLA nanofibrous scaffolds. 
Immunohistochemistry revealed greater neovascularization in the PDGF-BB delivered 
scaffolds. Quantitative real-time qPCR demonstrated enhanced gene expression of the 
CXC chemokine members CXCL1, CXCL2 and CXCL5 also in Sprague-Dawley rat 
model. These chemokines are active in angiogenesis, inflammation and wound healing, 
suggesting their implication in the improved angiogenesis in vivo.118 The co-delivery of 
cytokines CCL2 and VEGF from alginate microparticles in a collagen/fibronectin gel 
implanted subcutaneously in mice led to improved functional vessel formation. Despite 
the delivery of the potent monocyte/macrophage chemoattractant CCL2, the authors 
observed neither continuous recruitment of monocytes/macrophages, nor their shift to the 
pro-inflammatory M1 macrophage phenotype.119 The combination of growth factors in 
neovascularization has been examined through the controlled release of VEGF, PDGF 
and transforming growth factor-β1 (TGF-β1) to promote vasculogenesis and 
angiogenesis. Alginate crosslinked scaffolds containing 0.1% alginate-sulfate used to 
bind the growth factors were implanted subcutaneously in rats. The incorporation of 
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alginate-sulfate retarded the release of the growth factors, allowing for a controlled 
release of VEGF, PDGF-BB and TGF-β1based on their equilibrium binding constants. 
Explanted scaffolds revealed significant blood vessel formation at one month with the 
triple growth factor delivery. However, at three months, significant blood vessel 
regression was observed except in the case of the delayed release of VEGF, PDGF-BB 
and TGF-β1 from the alginate-sulfate scaffolds.120 
Although VEGF and PDGF are critical to both vasculogenesis and angiogenesis, 
transforming growth factor-β (TGF-β) is the most recognized mediator of immune 
regulation. TGF-β is a cytokine that initiates inflammation through its recruitment of 
monocytes, neutrophils and lymphocytes, while aiding in the adhesion and activation of 
these leukocytes, yet can inhibit them once activated through the reduction in expression 
of cytokine receptors or increasing expression of IL-1 receptor antagonist (IL-1ra).121 As 
such, TGF-β does not have an intrinsic action, but functions as a switch so that cells have 
the ability to respond appropriately to changes in their environment.122 This ability to 
transmit biological information in vivo has been exploited in tissue regeneration 
following implantation of a TEVG. Further implicating the use of TGF-β1 in vascular 
tissue engineering is that TGF-β1 also regulates SMC proliferation, differentiation and 
up-regulation of contractile phenotype marker proteins,123-125 as illustrated in Figure 
2.12.126 
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Figure 2.12: Overview of the key modulators of SMC phenotype. bFGF, basic 
fibroblast growth factor; PDGF, platelet-derived growth factors; EGF, epidermal 
growth factors; IGF, insulin-like growth factors; LPA, lysophosphatidic acid; TGF-
β1, transforming growth factor-β1; RTK, receptor tyrosine kinase; HSPG, heparan 
sulfate proteoglycan; GPCR, G-protein coupled receptor; TGFβR, TGF-β 
receptor.126 Reprinted with permission. Copyright © 2010, Mary Ann Liebert, Inc. 
2.5.1 Vascular Tissue Engineering with TGF-β1 
Due to the inherent properties of TGF-β1, its incorporation into the design of tissue-
engineered vascular constructs has been explored. Tranquillo and colleagues 
demonstrated that the exogenous addition of TGF-β1 resulted in improved SMC 
proliferation and protein synthesis from neonatal rat aortic smooth muscle cells in fibrin 
gel constructs. Significant collagen was observed at two weeks, while elastin fibers were 
visualized at five weeks. The synthesis of both collagen and elastin enhanced both the 
ultimate tensile strength and the tensile tangent modulus of the fibrin constructs over the 
course of the five week study.127 The increased deposition of extracellular matrix proteins 
from rat SMCs was also previously reported from a TGF-β1-tethered PEG hydrogel.128 
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The conjugation of TGF-β1 has also been studied by Andreadis and colleagues who 
immobilized TGF-β1 in fibrin hydrogels using a Factor XIII domain. A fusion protein 
between TGF-β1 and the α2-plasminogen inhibitor I leader sequence was prepared. The 
α2-plasminogen inhibitor I leader sequence was enzymatically conjugated to fibrin during 
polymerization by factor XIII, effectively immobilizing the TGF-β1 within the hydrogel. 
Following degradation of the fibrin hydrogel, release of the TGF-β1 from the fusion 
protein was induced through the incorporation of a plasmin cleavage site. MSCs were 
embedded in the fibrin hydrogel and after two weeks culture, the fibrin gel contracted to 
5% of its original volume. The contractility of the constructs was measured in response to 
receptor and non-receptor mediated vasoconstrictors with the immobilized TGF-β1 twice 
as contractile as the exogenous addition of native TGF-β1, suggesting the manner of 
TGF-β1 presentation in three-dimensional constructs has a significant impact on the 
ability of SMCs to contract.129 
In a follow-up study, the authors examined the synergistic effect of TGF-β1 
immobilization within fibrin scaffolds and cyclic mechanical stimulation on 
differentiation of human neonatal fibroblasts. No differences were observed in the early 
stage contractile marker protein SMαA; however, the late stage marker SM MHC was 
significantly up-regulated in the pulsed TGF-β1-conjugated fibrin gels, demonstrating a 
synergistic effect. Well-distributed and circumferentially aligned SMCs in the vascular 
wall were also reported. The increase in both the ultimate tensile strength and Young’s 
modulus were attributed to increased collagen synthesis induced through the cyclic 
distension. However, the increase in elastin deposition, unlike collagen, was attributed to 
the conjugated TGF-β1. The prolonged release of the conjugated TGF-β1 may have 
stimulated elastin synthesis through a couple of mechanisms, including the stabilization 
of elastin mRNA or the activation of lysyl oxidase, which activates desmosine in the 
crosslinking of soluble tropoelastin fibers.130 The impact of TGF-β1 on elastin synthesis 
was further studied by Kothapalli et al. The authors demonstrated a moderate increase in 
collagen and matrix elastin synthesis from the exogenous addition of TGF-β1 in rat aortic 
SMCs. A small but significant up-regulation of elastin mRNA was again observed 
supporting the results in the Liang et al. study. To ascertain the mechanism by which the 
elastin was up-regulated, the effect of TGF-β1 on the crosslinking of elastin was also 
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evaluated. Neither tropoelastin nor desmosine levels were affected by exogenous TGF-β1 
addition; however, TGF-β1 had conflicting effects on lysyl oxidase. A modest reduction 
in activity was noted with TGF-β1, yet it resulted in a significant increase in lysyl 
oxidase protein expression. Despite the moderate reduction in overall lysyl oxidase 
activity, the significant increase in lysyl oxidase protein expression may have facilitated 
tropoelastin crosslinking via enhanced catalysis of desmosine.131 
Recently, our group has studied the effect of topography and exogenous TGF-β1 on 
elastogenesis from HCASMCs cultured on a biostable poly(carbonate urethane) (PCU). 
Contrary to the reported results of increased elastogenesis in two-dimensional cultures 
with rat aortic SMCs, no elastin was observed from the HCASMCs seeded on 2D films of 
the PCU although elastin gene expression was detected. Moreover, the addition of TGF-
β1 did not enhance this gene expression in 2D cultures. Three-dimensional studies 
revealed not only an increase in elastin gene expression, but its translation into matrix 
elastin, which was further enhanced by the exogenous addition of TGF-β1. 
Immunoblotting of contractile phenotype marker proteins SMαA and calponin also 
revealed their up-regulation in 2D culture; however, the onset of their up-regulation in 3D 
was delayed, with significance only reached at 14 days.132 The lack of observed elastin in 
2D culture supplemented with TGF-β1contradicts the study by Kothapalli et al., though 
rat aortic SMCs were used in their study, which may not translate to HCASMCs. The use 
of tissue-appropriate autologous vascular cells (or progenitor cells) may offer a better 
representation of their true behaviour in a clinical setting.133 The increased elastogenesis 
in 3D culture, yet delayed onset in the up-regulation of contractile protein expression 
could suggest that TGF-β1 may initially stabilize the elastin mRNA, promoting its 
synthesis prior to enhancing HCASMC differentiation to the vasoactive contractile 
phenotype, both of which are critical in tissue engineering of a vascular graft.132 
2.6 Motivation 
Given that TGF-β1 can modulate the inflammatory response, while concomitantly induce 
extracellular matrix deposition including elastin from HCASMCs, resulting in improved 
contractile protein expression, suggests that a TGF-β1 incorporated vascular graft could 
mediate inflammation, promote wound healing and ultimately long-term patency. The 
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motivation of this study was to develop a functional, biodegradable, porous scaffold that 
could not only support human vascular cell adhesion and proliferation, but also the 
incorporation of TGF-β1 for consideration as a biomimetic scaffold for in vitro vascular 
tissue engineering. 
2.7 Vascular Scaffold Design 
Additional considerations in the development of a vascular scaffold include retaining cell 
function and differentiation upon cell adhesion to the surface of the biomaterial. The 
scaffold should be highly porous with significant pore interconnectivity to allow cell 
infiltration, nutrient and waste diffusion and subsequent vascularization. As the tissue 
construct matures, the scaffold should degrade in a controlled rate mirroring that of ECM 
production.89,134 Obviously, the scaffold and the degradation products thereof, must 
neither elicit a chronic inflammatory response, nor result in dedifferentiation of the 
vascular cells.135 This biocompatibility is a function of the scaffold’s chemical structure, 
morphology and manner of processing. Although the ease of processability is an 
important aspect in scaffold design, toxicity arising from residual monomers, stabilizers, 
initiators, crosslinking agents or solvents can limit scaffold biocompatibility.134 
Furthermore, the scaffold must be readily sterilizable to be used in a clinical setting. 
Control of these factors is critical in designing a successful TEVG. 
The delivery of TGF-β1 from a vascular scaffold could be achieved in a number of ways. 
In the simplest form, the growth factor could be passively adsorbed to the surface of the 
scaffold; however, in the haemodynamic environment, rapid loss of a physically adsorbed 
growth factor would likely occur, limiting its efficacy. Thus, controlled release of TGF-
β1 via an osmotic pressure mechanism136 or through a slowly degrading polymer matrix, 
whether embedded or covalently attached, may offer the most promise in achieving a 
TGF-β1 incorporated vascular scaffold. In the bioconjugation approach, ensuring that the 
biological activity is not compromised during attachment is paramount. As Andreadis and 
colleagues demonstrated, TGF-β1 can be immobilized during fibrin polymerization 
through a fusion TGF-β1 protein,129 but this approach is highly specific, potentially 
limiting its versatility. Secondly, plasma surface treatment can be used to generate 
functional groups on the surface of a synthetic graft, whereby the growth factor could be 
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covalently attached to the surface using conventional peptide synthesis chemistry. 
However the use of plasma surface treatment can result in a rough topography, random 
pore size, non-uniform pore interconnectivity or loss of scaffold morphology.137 Using 
NH3, O2 and H2O species in plasma can penetrate microporous polymer membranes, 
effectively modifying the surface at depths of 50−500 μm,137-139 which could potentially 
affect the bulk properties of the synthetic graft. Alternatively, the conjugation of TGF-β1 
to a biodegradable polymer with pendant functional groups could overcome potential 
issues with the use of plasma surface treatment.  
2.8 Functional Degradable Polymers 
Of all the degradable biomaterials examined as vascular scaffolds and grafts, few contain 
pendant functional groups, with the vast majority of them being natural polymers, 
excluding the synthetic polymers which underwent plasma surface treatment. Despite the 
presence of several different functional handles, bioconjugation to natural polymers is 
problematic due to immunogenicity, batch-to-batch variability and structural complexity. 
The only synthetic polymer with pendant functional groups was the D-PHI polyurethane 
scaffold due to the methacrylic acid monomers co-polymerized during the curing 
process.140 Despite the incorporation of the pendant carboxylic acid groups, to our 
knowledge, the conjugation of a biomolecule to the polymer’s surface was never 
reported. 
A common route to generate functionalizable biodegradable polymers is through the ring 
opening polymerization (ROP) of functional monomers. The ROP of 6-hydroxynon-8-
enoic acid lactone to yield pendant allyl groups141 or cyclic ketones such as 2-oxepane-
1,5-dione, which can be readily reacted with hydrazines to yield pendant hydroxyl or 
amine groups, have been previously reported.142 Although synthetic monomers have been 
used in polyester co-polymerizations, significant research has focused on the 
incorporation of functional α-amino acids yielding a variety of pendant functional groups. 
Amino acids (and poly(amino acid)s) have been used to generate random, block, 
alternating or graft co-polymers, as illustrated in Figure 2.13.143-145 The incorporation of 
functional monomers into polyesters has been thoroughly scrutinized due to their ease of 
syntheses and tunability. Modulation of their molecular weight or co-polymer 
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composition provides a degree of control on their mechanical properties and hydrolytic 
degradation. Despite the versatility in manipulating these properties, vascular scaffolds 
based on the PGA, PLLA or PLGA tend to be stiffer (high elastic modulus)134 than native 
arteries, which has been shown to decrease elastin synthesis in vascular grafts.146 
 
Figure 2.13: Schematic representation of different macromolecular structures of α-
amino acid-containing degradable polymers.143 Reprinted with permission from 
(Sun, H.; Meng, F.; Dias, A. A.; Hendriks, M.; Feijen, J.; Zhong, Z. 
Biomacromolecules 2011, 12 (6), 1937-1955). Copyright (2011) American Chemical 
Society.  
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Although not a polyester, poly(trimethylene carbonate) is another material that has been 
functionalized with allylglycine,147 lysine147 and glutamic acid,148 while separately being 
investigated for use in vascular tissue engineering.85,149-150 Although preliminary results 
of the base polymer are promising, only ring opening polymerization of trimethylene 
carbonate is being investigated; therefore, its functionalization would result in a block co-
polymer based on amino acid incorporation or alternatively, necessitate the incorporation 
of synthetic monomers, which may not offer the same biochemical cues as amino acids 
upon implantation.143 
2.9 Poly(ester amide)s (PEAs) 
Although polyesters offer the ability to tune certain parameters, making them ideal for 
several biomedical applications including sutures,134 bone pins151 and drug delivery 
vehicles, their high elastic modulus134,146 and generation of acidic by-products151 renders 
them poor choices as vascular scaffold materials. Poly(ester amide)s (PEAs), a related 
class of polymers, composed of both ester and amide linkages along the polymer 
backbone, emulate polyesters in that they also offer a degree of control over both the 
mechanical and thermal properties as well as their rates of degradation.152 The PEAs 
studied in this work are derived from an amino acid, a diol and diacid, as shown in Chart 
2.1, and provide a significant degree of control over the polymer’s final properties. 
 
Chart 2.1: Schematic of α-amino acid based poly(ester amide)s. 
Along with the tunability of the PEA properties, incorporation of amide linkages along 
the polymer backbone promote its enzymatic degradation.153-155 The susceptibility of the 
PEA to enzymatic degradation should enhance its surface degradation, limiting the 
possibility of a large accumulation of acidic species in the local tissue. Moreover, the by-
products following degradation of the PEA will include amino acids, which are found 
physiologically, limiting their potential toxicity. Finally, monomers with pendant 
functional groups, including those based on amino acids such as lysine and aspartic acid 
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can be incorporated during the polymerization to provide functional, biodegradable 
polymers. 
The incorporation of functional groups along the backbone of PEAs using α-amino acids 
has been previously reported.156 Jokhadze et al. protected the carboxylic acid group of 
lysine as a benzyl ester, and used the α,ε-amino groups as the diamine in a solution 
polycondensation. After the polymerization, the benzyl ester was selectively cleaved via 
hydrogenolysis, yielding pendant carboxylic acid groups, which they further 
functionalized with 4-amino-TEMPO to mimic nitric oxide to demonstrate the reactivity 
of the side group.157 In a follow-up study, DeFife et al. used the TEMPO-functionalized 
PEA to assess leukocyte adhesion and activation and platelet depletion from whole blood. 
While the TEMPO-functionalized PEA neither depleted leukocytes nor platelets from 
blood, it also muted the inflammatory response through a down-regulation of pro-
inflammatory cytokines IL-6 and IL-1β from monocytes. A concomitant up-regulation in 
the anti-inflammatory cytokine IL-1ra, a natural inhibitor of IL-1β, which competitively 
binds the IL-1 receptor, was also observed.158 Guan et al. conducted a similar study to 
that of Jokhadze et al. where again a benzyl ester was hydrogenated to yield the pendant 
carboxylic acid; however, in their study, Guan et al. used dimethylolpropionic acid 
(DMPA) to yield the PEA based on glycine with the functional handle. This study was 
the first to report a functional interfacial polycondensation of poly(ester amide)s.159  
Chu and colleagues have gone a step further and incorporated both D,L-allylglycine and 
L-arginine as the functional amino acid into a solution polymerized PEA. The 
introduction of the double bond allowed the authors to introduce pendant amine, 
carboxylic acid and sulfonate groups through the reaction of the double bond with 
functional thiol molecules. Moreover, the double bond could also be used in photo or 
thermal crosslinking potentially yielding a PEA elastomer.160 The incorporation of the L-
arginine was devised so that the cationic PEAs could then be fabricated into 
nanoparticles, used as protein delivery vehicles or to improve cell attachment. Release of 
bovine serum albumin (BSA) from arginine-based PEA nanoparticles demonstrated a 
burst effect with over 30% of the model compound being released into phosphate 
buffered saline (PBS) within two days with little BSA being released over the following 
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eight days. The authors demonstrated bovine aortic endothelial cell attachment and 
proliferation on the surface of the arginine-based PEA up to four days culture. The 
authors also reported a reduction in inflammatory response due to a decrease in TNF-α 
release from mouse J774 macrophages when compared to PCL controls; however, no 
statistical analyses were conducted.161 
Not only have the α-amino acids been varied to generate different PEAs, so too have the 
diols and diacids. Unsaturated 2-butene-1,4-diol and fumaric acid has been incorporated 
into PEAs to generate a double bond along the polymer backbone162 and subsequently 
reacted with thiols,163-164 amines164 or PEG diacrylate to generate hydrogels.165 Newly 
synthesized epoxy-based PEAs using cis- and trans-epoxysuccinic acids have been 
reported and subsequently functionalized with both electrophilic and nucleophilic model 
compounds. Both chemical (1,6-diaminohexane) and free radical (benzoyl peroxide) 
crosslinking following the reaction of the oxirane with either an acrylate or methacrylate 
group were also reported.166 
2.10 Objectives 
Even though functional poly(ester amide)s have been examined in the biomedical field as 
drug delivery vehicles,167 non-viral gene delivery vehicles,168-170 stimuli-responsive 
degradable polymers171 and as coatings on stents,158 to our knowledge, biomimetic 
poly(ester amide)s as vascular scaffolds have not been investigated. Despite the use of 
these functional PEAs in the biomedical field, one challenge that has limited the use of 
PEAs in vascular tissue engineering is the relatively low molecular weights of the 
polymers achieved through solution polycondensation.172-174 The polycondensation 
between two reactive monomers at the interface of an aqueous and organic layer is an 
attractive alternative to polycondensation done in solution, as it is faster and less 
influenced by impurities since they tend to remain in the bulk phase, resulting in high 
molecular weight polymers.175 In an interfacial polymerization, selection of the 
monomers is paramount, necessitating the use of a hydrophobic acid chloride to prevent 
premature hydrolysis. Given the hydrophobic nature and elastomeric attributes of sebacic 
acid in vascular scaffolds,146,176 sebacoyl chloride was selected as the acid chloride in this 
study. 
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Although both solution153,157,160,162-163,169,174,177-179 and interfacial180-191 polymerizations of 
PEAs with sebacoyl chloride have been well documented including the functional 
interfacial polycondensation that generated pendant carboxylic acid groups,159 prior to 
this study there were no published accounts comparing the two polymerization 
techniques. In addition, the functional interfacial polycondensation of PEAs yielding a 
pendant amine group for future conjugation had not been previously reported.  
The ultimate goal of this study was to synthesize a biodegradable, porous, functional 
poly(ester amide) scaffold that would facilitate the conjugation of bioactive TGF-β1 to 
evaluate its potential use for in vitro vascular tissue engineering. Specifically, targeted 
objectives included: 
• Synthesize a family of poly(ester amide)s based on natural α-amino acids, 
aliphatic diols and sebacoyl chloride via both solution and interfacial 
polycondensation: 
o L-alanine and L-phenylalanine to impart suitable mechanical and thermal 
properties; L-lysine and L-aspartic acid to introduce amine and carboxylic 
acid functional handles for TGF-β1 conjugation 
o 1,4-butanediol, 1,8-octanediol and sebacoyl chloride to impart elasticity 
and hydrophobicity to improve processability in organic solvents 
• Evaluation of human coronary artery smooth muscle cell attachment, 
morphology, focal adhesion and proliferation on synthesized PEAs on two-
dimensional films 
• Electrospinning of PEAs to generate a three-dimensional scaffold and investigate 
HCASMC attachment, morphology and infiltration 
• Investigation of poly(ester amide) chemical structure, topography and exogenous 
addition of TGF-β1 on HCASMC phenotype expression via Western blot analysis 
• Conjugation of bioactive TGF-β1 to the surface of a functional PEA 
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The evaluation of these PEAs also included aspects such as ease of synthesis and cost. 
Given that new polymers were synthesized, detailed characterization of the PEAs is also 
reported. 
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Chapter 3  
3 Strategies in Functional Poly(ester amide) Syntheses to 
Study Human Coronary Smooth Muscle Cell 
Interactions*
The chapter initially compares two polymerization approaches for the syntheses of α-
amino acid based poly(ester amide)s (PEAs). The subsequent effect of these PEAs on 
human coronary artery smooth muscle cell attachment, morphology, viability and 
propensity to form focal adhesions was also examined. 
 
3.1 Abstract 
The design of new generation cardiovascular biomaterials focuses on biomimetic 
properties that are capable of eliciting specific cellular responses and directing new tissue 
formation. Synthetic poly(ester amide)s (PEAs) containing α-amino acid residues have 
the potential to elicit favourable cellular responses. Furthermore, they are biodegradable 
owing to the incorporation of naturally occurring amino acids. In this study, a family of 
PEAs was synthesized from selected α-amino acids using both solution and interfacial 
polymerization approaches to optimize their properties for vascular tissue engineering 
applications. By careful selection of the monomers and the polymerization approach, 
high molecular weight PEAs with low glass transition temperatures were obtained. 
Human coronary artery smooth muscle cells (HCASMCs) cultured directly on bare PEA 
films attached and spread well up to 7 days of culture. Moreover, cell viability was 
significantly enhanced on all non-functional PEAs compared with tissue culture 
polystyrene controls. The trifluoroacetic acid salt of the lysine-containing functional 
PEAs was found to retard cell growth, but still supported cell viability up to 5 days of 
culture. Immunostaining of HCASMCs revealed strong vinculin expression suggesting 
that the HCASMCs initiated cellular processes for focal adhesion contacts with all PEA 
                                                 
* A version of this chapter has been published. Reprinted (adapted) with permission from (Knight, D.K.; 
Gillies, E.R.; Mequanint, K. Biomacromolecules 2011, 12, 2475-2487). Copyright (2011) American 
Chemical Society. 
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surfaces. Conversely, smooth muscle α-actin expression was not abundant on the PEA 
surfaces suggesting a proliferative smooth muscle cell phenotype. Altogether, our results 
indicate that these PEAs are promising materials for vascular tissue engineering 
scaffolds. 
Keywords: vascular tissue engineering, poly(ester amide)s, interfacial polycondensation, 
human coronary artery smooth muscle cells, vinculin, smooth muscle α-actin. 
3.2 Introduction 
Vascular tissue engineering has emerged as a viable strategy for the design of 
biologically and mechanically responsive vascular constructs for therapeutic uses and 
pharmacologic studies.1-2 With the exception of a few cases,1,3 biodegradable scaffolding 
biomaterials are required for engineering three-dimensional vascular tissues.4 In this 
regard, both naturally occurring (such as collagen) and synthetic biodegradable or 
biostable biomaterials have been extensively studied.5-6 Because naturally occurring 
materials afford limited control over their final properties, many vascular tissue 
engineering studies in the past were conducted using poly(lactic acid) (PLA), 
poly(glycolic acid) (PGA), or copolymers of PLA and PGA.7 Despite encouraging 
results, these biomaterials produce acidic products during degradation that can induce 
undesired phenotype modulation in seeded vascular smooth muscle cells (VSMCs).8-9 
Poly(trimethylene carbonate) which degrades into non-acidic byproducts has been 
considered for vascular tissue engineering,10-11 but its effect on cultured VSMCs is not 
fully understood. Biomaterials to be used in vascular tissue engineering must therefore be 
able to regulate vascular cell phenotype, in addition to cell adhesion, proliferation and 
migration. Despite considerable progress towards the synthesis of new generation 
biodegradable biomaterials for vascular tissue engineering, regulation of HCASMC 
phenotype remains a challenge. Thus, we propose the use of biodegradable α-amino acid-
based poly(ester amide)s as an alternative biomaterial which may regulate HCASMC 
growth and phenotype. 
Poly(ester amide)s (PEAs) are a class of synthetic polymers bearing both ester and amide 
repeat units. As these repeat units along the polymer chain can be introduced using a 
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variety of materials and methods, the name PEA is generic rather than specific. Due to 
the susceptibility of PEAs to both hydrolytic and enzymatic degradation, a wide range of 
PEAs with varying degradation rates are reported in the literature12-18 and reviewed 
elsewhere.19-20 Although the ester linkages afford cleavage via hydrolysis, the 
hydrophobicity of the PEAs will promote enzyme adsorption, thus enhancing its surface 
erosion,21 which may limit a large accumulation of degradation products in the local 
tissue.22 The chemical compositions of the amino acid-based PEAs are analogous to 
peptides and proteins. The selection of monomers based on α-amino acids with side 
chains offer pendant functional groups14,23-26 for which cell signaling molecules can be 
conjugated, potentially accelerating favourable cell-material interactions. Finally, the by-
products following degradation of these PEAs will include amino acids, which are found 
physiologically, limiting their potential systemic toxicity.27 
Although the syntheses and characterization of PEAs derived from dicarboxylic acids, 
diols and α-amino acids have been reported,12-18 studies on their potential use as 
biomaterials are only a recent endeavor. For example, Liu and coworkers reported the use 
of arginine-based PEAs as a non-viral gene delivery vehicle with a high binding capacity 
toward plasmid DNA.28 PEAs have also been examined for the sustained release of 
antibiotics and paclitaxel.29-30 Li and Chu studied the release profile of a nitroxyl radical 
model compound, 4-amino-2,2,6,6-tetramethylpiperidine-1-oxy (4-amino-TEMPO) 
loaded into PEA fibers based on L-phenylalanine,31 while others reported the conjugation 
of 4-amino-TEMPO to a carboxylic acid functionalized PEA as an anti-inflammatory 
stent coating.25 Furthermore, Reinhart-King and coworkers synthesized PEAs from L-
phenylalanine and L-lysine in an attempt to investigate the effect of polymer charge 
(neutral, negative or positive) on cellular response.32 Although there is no clear evidence 
that endothelial cells formed a monolayer (due to the lack of specific immunostaining 
such as VE-cadherin or α-catenin), their study suggested that endothelial cell attachment, 
spreading, and growth were favoured on positive and neutral PEA substrates when 
seeded at high density. However, in this latter study, the examination of vascular 
endothelial cells on the surface of the PEA would suggest that the material is being 
considered as a synthetic vascular graft. Because these PEAs are readily biodegradable,14 
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the in vivo integrity of the grafts in the presence of hemodynamic forces could potentially 
limit such application. 
Despite the aforementioned studies highlighting the use of PEAs as biomaterials, there 
are limited studies conducted on their potential use as in vitro vascular tissue engineering 
scaffolds. Recently our group has synthesized both non-functional and functional PEAs 
from α-amino acids.23-24,33 In these studies, most of the PEAs synthesized had either too 
low a molecular weight, which were not considered useful biomaterials or were too brittle 
with high glass transition temperatures which equally could not be considered as vascular 
scaffold materials. Increasing the molecular weight increases polymeric chain 
entanglements, allowing long range segmental motion of the chains, while reducing the 
rate of viscous deformation.34 This enhanced viscoelasticity is needed in vascular tissue 
engineering as it mimics the natural extracellular matrix (collagen and elastin) so that 
seeded cells can adapt to their microenvironment.35 Collectively, published data suggest 
that the molecular weight of PEAs may not impart the viscoelasticity required of a 
vascular tissue engineering scaffold material, thus warranting further optimization of the 
synthetic approach. Therefore the objectives of the present study were: (i) to investigate 
the effect of the polymerization method on the molecular weight of the PEAs, (ii) to 
investigate human coronary artery smooth muscle cell (HCASMC) adhesion, spreading 
and viability on the synthesized PEAs. The rationale for using HCASMCs is based on our 
long-term objective of fabricating a human vascular tissue model with clinical relevance. 
3.3 Experimental 
3.3.1 Materials 
Di-p-toluenesulfonic acid salt monomers 1 and 2 were prepared as previously reported 
(Scheme 3.1).23,36 Di-p-toluenesulfonic acid salt monomer 3 was a new monomer 
prepared by the same procedure as monomers 1 and 2 (Scheme 3.1).21 Di-p-nitrophenyl 
sebacate (4) was also prepared as previously reported (Chart 3.1).21 Bis-N-ε-t-BOC-L-
lysine ester (5) was prepared as previously reported by our group (Chart 3.1).24 Solvents 
were purchased from Caledon Labs (Georgetown, ON). All other chemicals were 
purchased from Sigma Aldrich (Milwaukee, WI). Unless noted otherwise, all chemicals 
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were used as received. Anhydrous tetrahydrofuran (THF) was obtained from a solvent 
purification system. N,N-dimethylacetamide (DMA) and triethylamine (NEt3) were 
distilled from calcium hydride (CaH2) and dichloromethane (CH2Cl2, DCM) was distilled 
from P2O5. Flash chromatography was performed using silica gel 60 with a particle size 
range of 0.063-0.200 mm (EMD Chemicals Inc. Gibbstown, NJ). Dialysis was performed 
against N,N-dimethylformamide (DMF) with Spectra/Por 6 dialysis tubing (Spectrum 
Laboratories, Inc., Rancho Dominguez, CA), molecular weight cutoff of 25 kDa. 
3.3.2 Methods 
1H (400 MHz) and 13C (100 MHz) nuclear magnetic resonance (NMR) spectra were 
obtained on a Varian Inova 400 spectrometer (Varian Canada Inc., Mississauga, ON). 
Chemical shifts are reported in parts per million (ppm) and are calibrated against residual 
solvent signals of chloroform (CDCl3, δ 7.27 ppm, 77.00 ppm) or dimethyl sulfoxide 
(DMSO, δ 2.50 ppm). All coupling constants (J) are reported in Hertz (Hz). Fourier 
transform infrared (FTIR) spectra were obtained using a Bruker Tensor 27 (Bruker 
Corporation, Milton, ON) from KBr disks or as films from DCM on NaCl plates. 
Absorption frequencies of the functional groups are reported in wavenumbers (cm-1) and 
assigned as published by Pavia et al.37 Low-resolution mass spectrometry was achieved 
using a Finnigan MAT 8400 mass spectrometer (Thermo Fisher Scientific Inc., Waltham, 
MA) with a mass range (m/z) up to 8,400. High-resolution mass spectrometry was 
achieved using a Micromass LCT (electrospray time-of-flight (ES+)) mass spectrometer 
(Waters Corporation, Milford, MA) with a mass range (m/z) up to 10,000. Gel 
permeation chromatography data were obtained using a Waters 2695 Separations Module 
equipped with a Waters 2414 Refractive Index Detector (Waters Limited, Mississauga, 
ON) and two PLgel 5 µm mixed-D (300 mm × 7.5 mm) columns connected in series 
(Varian Canada Inc., Mississauga, ON). Samples (5 mg/mL) dissolved in the eluent, 
which comprised of 10 mM LiBr and 1 % (v/v) NEt3 in DMF at 85°C were injected (100 
µL) at a flow rate of 1 mL/min and calibrated against polystyrene standards. Molecular 
weights are reported in grams/mole (g/mol). Thermogravimetric analyses were performed 
on a SDT Q600 (TA Instruments – Waters LLC, New Castle, DE) under dry nitrogen at a 
heating rate of 20°C/min up to 600°C. Differential scanning calorimetry was performed 
73 
 
 
on a DSC Q20 (TA Instruments – Waters LLC, New Castle, DE) at a heating rate of 
10°C/min from -50 to 200°C. All samples prepared ranged from 2 to 5 mg, and glass 
transition temperatures (Tgs) were obtained from the second heating cycle. 
3.3.3 PEA Nomenclature 
The polymers are labeled by the number of methylene groups contributed by the diacid, 
the three letter amino acid designation, the number of methylene groups in the diol and 
finally by the method of preparation – solution (Sol) or interfacial (Int) polycondensation 
– for example 8-Ala-8-Sol. Lys(BOC) represents the incorporation of the lysine monomer 
5 as a co-monomer at a mole ratio of 10% relative to the di-p-toluenesulfonic acid salt 
monomer 1, 2, or 3 - for example 8-Ala-8-Lys(BOC)-4-Sol. The 4 represents the number 
of methylene groups in the butanediol moiety of 5. 
3.3.4 Syntheses of Monomers 
3.3.4.1 Di-p-Toluenesulfonic Acid Salt Monomer, 1 
Syntheses of all di-p-toluenesulfonic acid salt monomers were modified from Guo et al.36 
A suspension of L-alanine (5.0 g, 56 mmol, 2.2 equiv.), p-toluenesulfonic acid•H2O (11 g, 
61 mmol, 2.4 equiv.) in toluene (100 mL) was refluxed at 140°C with stirring in a flask 
equipped with a Dean-Stark trap for 2 h to remove the residual water. To this solution, 
1,8-octanediol (3.7 g, 26 mmol, 1.0 equiv.) was added and heated at reflux for 48 h. The 
resulting material was filtered and recrystallized from isopropanol (30 mL) twice 
following its filtration in hot isopropanol, to provide monomer 1. Yield: 75%. 
1H NMR (400 MHz, DMSO-d6): δ 8.26 (br s, 6H, -NH3+ TsO-), 7.48 (d, 4H, J = 8.2, Ar-
H meta to CH3), 7.12 (d, 4H., J = 7.8, Ar-H ortho to CH3), 4.20-4.08 (m, 6H, -C(O)O-
CH2-, -CαH), 2.29 (s, 6H, Ar-CH3), 1.64-1.57 (m, 4H, -C(O)O-CH2-CH2-), 1.38 (d, 6H, J 
= 7.2, -CαH-CH3), 1.35-1.25 (m, 8H, -C(O)O-CH2-CH2-(CH2)4-). 13C NMR (100 MHz, 
DMSO-d6): δ 170.0, 145.2, 138.0, 128.2, 125.5, 65.6, 48.0, 28.5, 27.9, 25.1, 20.8, 15.8. 
FTIR (KBr pellet, cm-1): 3062 (N-H stretch, primary amine salt; C-H stretch, aromatic), 
2929 (C-H stretch, aliphatic), 2854 (C-H stretch, aliphatic), 1751 (C=O stretch, ester), 
1602 (C-N stretch, primary amine salt; C=C stretch, aromatic), 1534 (C-N stretch, 
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primary amine salt), 1498 (C=C stretch, aromatic), 1400 (CH3 bend, aliphatic), 1332 
(CH2 wag, aliphatic), 1246 (S=O stretch, SO3 salt), 1155 (C-O stretch, ester). HRMS 
(m/z): calc for C14H29N2O4+, 289.2127; found 289.2130, [M+H]+. 
3.3.4.2 Di-p-Toluenesulfonic Acid Salt Monomer, 2 
A suspension of L-phenylalanine (10 g, 61 mmol, 2.2 equiv.), p-toluenesulfonic acid•H2O 
(11 g, 66 mmol, 2.4 equiv.) in toluene (100 mL) was refluxed at 140°C with stirring in a 
flask equipped with a Dean-Stark trap for 2 h to remove the residual water. To this 
solution, 1,4-butanediol (2.5 mL, 28 mmol, 1.0 equiv.) was added and heated at reflux for 
48 h. The product was filtered and recrystallized twice from water (300 mL) following its 
hot filtration, to provide monomer 2. Yield: 55%. 
1H NMR (400 MHz, DMSO-d6): δ 8.41 (br s, 6H, -NH3+ TsO-), 7.50-7.47 (m, 4H, Ar-H 
meta to CH3), 7.36-7.21 (m, 10H, Ph), 7.13-7.10 (m, 4H, Ar-H ortho to CH3), 4.30 (dd, 
2H, J1 = 7.7, J2 = 6.2, -CαH), 4.00-3.97 (m, 4H, -C(O)O-CH2-), 3.17-2.99 (m, 4H, -CαH-
CH2-Ph), 2.29 (s, 6H, Ar-CH3), 1.39-1.28 (m, 4H, -C(O)O-CH2-CH2-). 13C NMR (100 
MHz, DMSO-d6): δ 169.0, 145.2, 138.0, 134.6, 129.3, 128.6, 128.2, 127.3, 125.5, 64.9, 
53.3, 36.2, 24.1, 20.8. FTIR (KBr pellet, cm-1): 3103 (N-H stretch, primary amine salt), 
3023 (C-H stretch, aromatic), 2935 (C-H stretch, aliphatic), 1737 (C=O stretch, ester), 
1523 (C-N stretch, primary amine salt), 1499 (C=C stretch, aromatic), 1456 (CH2 wag, 
aliphatic), 1239 (S=O stretch, SO3 salt), 1196 (C-O stretch, ester). HRMS (m/z): calc for 
C22H29N2O4+, 385.2127; found 385.2120, [M+H]+. 
3.3.4.3 Di-p-Toluenesulfonic Acid Salt Monomer, 3 
A suspension of L-phenylalanine (10 g, 61 mmol, 2.2 equiv.), p-toluenesulfonic acid•H2O 
(11 g, 61 mmol, 2.4 equiv.) in toluene (100 mL) was refluxed at 140°C with stirring in a 
flask equipped with a Dean-Stark trap for 2 h to remove the residual water. To this 
solution, 1,8-octanediol (4.0 g, 28 mmol, 1.0 equiv.) was added and heated at reflux for 
48 h. The resulting product was filtered and recrystallized from water (2 L) to provide 
monomer 3. Yield: 77%. 
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1H NMR (400 MHz, DMSO-d6): δ 8.40 (br s, 6H, -NH3+ TsO-), 7.48 (d, 4H, J = 8.2, Ar-
H meta to CH3) 7.36-7.22 (m, 10H, Ph), 7.11 (d, 4H, J = 7.6, Ar-H ortho to CH3) 4.30 
(dd, 2H, J1 = 7.6, J2 = 6.3, -CαH), 4.05-4.02 (m, 4H, -C(O)O-CH2-), 3.17-2.99 (m, 4H, -
CαH-CH2-Ph), 2.29 (s, 6H, Ar-CH3), 1.48-1.38 (m, 4H, -C(O)O-CH2-CH2-) 1.20-1.07 (m, 
8H, -C(O)O-CH2-CH2-(CH2)4-). 13C NMR (100 MHz, DMSO-d6): δ 169.1, 145.3, 137.9, 
134.6, 129.3, 128.5, 128.1, 127.2, 125.5, 65.5, 53.3, 36.2, 28.4, 27.7, 25.0, 20.8. FTIR 
(KBr pellet, cm-1): 3181 (N-H stretch, primary amine salt), 3030 (C-H stretch, aromatic), 
2920 (C-H stretch, aliphatic), 2856 (C-H stretch, aliphatic), 1733 (C=O stretch, ester), 
1601 (C-N stretch, primary amine salt; C=C stretch, aromatic), 1525 (C-N stretch, 
primary amine salt), 1496 (C=C stretch, aromatic), 1459 (CH2 wag, aliphatic), 1233 (S=O 
stretch, SO3 salt), 1167 (C-O stretch, ester). HRMS (m/z): calc for C26H37N2O4+, 
441.2753; found 441.2755, [M+H]+. 
3.3.4.4 Synthesis of Di-p-Nitrophenyl Sebacate Monomer, 4 
The synthesis of di-p-nitrophenyl sebacate was adapted from Katsarava et al.21 A solution 
of p-nitrophenol (8.3 g, 60 mmol, 2.0 equiv.) and triethylamine (8.4 mL, 60 mmol, 2.0 
equiv.) in dry THF (100 mL) was cooled to below 0°C using a dry ice/acetone bath. 
Sebacoyl chloride (6.4 mL, 30 mmol, 1.0 equiv.) in dry THF (50 mL) was added 
dropwise over a period of 30 min. The reaction mixture was then allowed to reach room 
temperature and stirred overnight. The resulting solution was concentrated under rotary 
evaporation and then precipitated in cold water (150 mL) yielding monomer 4, which was 
recrystallized from ethyl acetate (250 mL) following its hot filtration. Yield: 92%. 
1H NMR (400 MHz, DMSO-d6): δ 8.31-8.27 (m, 4H, Ar-H), 7.45-7.41 (m, 4H, Ar-H), 
2.64 (t, 4H, J = 7.4, -O(CO)-CH2-), 1.70-1.62 (m, 4H, -O(CO)-CH2-CH2-), 1.43-1.30 (m, 
8H, -O(CO)-CH2-CH2-(CH2)4-). 13C NMR (100 MHz, DMSO-d6): δ 171.2, 155.4, 144.9, 
125.2, 123.1, 33.4, 28.5, 28.3, 24.1. FTIR (KBr pellet, cm-1): 3118 (C-H stretch, 
aromatic), 3088 (C-H stretch, aromatic), 2937 (C-H stretch, aliphatic), 2847 (C-H stretch, 
aliphatic), 1754 (C=O stretch, ester), 1620 (C=C stretch, aromatic), 1593 (C-H stretch, 
aromatic, para-substituted), 1536 (N=O stretch, Ar-NO2), 1489 (C-H stretch, aromatic, 
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para-substituted), 1346 (N=O stretch, Ar-NO2), 1201 (CH2 wag, aliphatic), 1129 (C-O 
stretch, ester). HRMS (m/z): calc for C22H25N2O8+, 445.1611; found 445.1596, [M+H]+. 
3.3.4.5 Synthesis of Bis-N-α-Carboxybenzyl (CBZ)-N-ε-tert-
Butyloxycarbonyl (BOC)-L-Lysine Diester Monomer, 5 
Synthesis of bis-N-α-CBZ-N-ε-t-BOC-L-lysine diester was prepared as previously 
reported.24 N-α-CBZ-N-ε-t-BOC-L-lysine (2.0 g, 5.2 mmol, 3.1 equiv.) was dissolved in 5 
mL of anhydrous dichloromethane. To this solution was added 1,4-butanediol (0.15 mL, 
1.7 mmol, 1.0 equiv.), N,N’-dicyclohexylcarbodiimide (DCC) (1.1 g, 5.3 mmol, 3.1 
equiv.), 4-(dimethylamino)pyridine (DMAP) (0.049 g, 0.40 mmol, 0.24 equiv.), and 4-
(dimethylamino)pyridinium 4-toluenesulfonate (DPTS) (0.10 g, 0.36 mmol, 0.21 equiv.). 
The resulting solution was stirred under a nitrogen atmosphere at 25°C and was 
monitored by thin layer chromatography (70:30 ethyl acetate:hexanes) until completion 
(approximately 1.5 h). The reaction mixture was then filtered to the remove 
dicyclohexylurea (DCU) byproduct and the solvent was removed under reduced pressure. 
The product was purified by column chromatography using 50:50 ethyl acetate:hexanes 
as an eluent to yield 5 as a viscous oil. Yield: 89%. 
1H NMR (400 MHz, CDCl3): δ 7.36-7.26 (m, 10H, Ph), 5.79-5.50 (m, 2H, O-C(O)-NH-), 
5.08 (m, 4H, Ph-CH2-O-C(O)-), 4.79-4.61 (m, 2H, -NH-BOC), 4.37-4.26 (m, 2H, -CαH), 
4.22-4.01 (m, 4H, -C(O)O-CH2-), 3.13-2.94 (m, 4H, -CH2-NH-BOC), 1.88-1.54 (m, 8H, -
CαH-CH2-, -CH2-CH2-NH-BOC), 1.54-1.27 (m, 26H, -C(O)O-CH2-CH2-, -CαH-CH2-
CH2-, BOC CH3). 13C NMR (100 MHz, CDCl3): δ 172.4, 156.0, 156.0, 136.2, 128.4, 
128.1, 128.0, 67.0, 66.9, 64.6, 53.7, 39.9, 31.9, 29.5, 28.3, 25.0, 22.3. 
3.3.4.6 Synthesis of Bis-N-ε-tert-BOC-L-Lysine Diester Monomer, 6 
The hydrogenation of bis-N-α-CBZ-N-ε-t-BOC-L-lysine diester with Pd/C catalyst (35 
mg, 10 wt%) was achieved as reported.24 Pd/C was added to a solution of protected 
monomer 5 (340 mg, 0.42 mmol, 1.0 equiv.) in ethanol (5 mL). The resulting solution 
was stirred under a hydrogen atmosphere and monitored with thin layer chromatography 
(70:30 ethyl acetate:hexanes) until completion (at approximately 2 h). The reaction 
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mixture was filtered through celite and the solvent was removed in vacuo providing 
monomer 6. Yield: 77%. 
1H NMR (400 MHz, CDCl3): δ 4.64 (br m, 2H, -NH-BOC), 4.20-4.09 (m, 4H, -C(O)O-
CH2-), 3.43 (dd, 2H, J = 7.0 and 5.5, -CαH), 3.12 (m, 4H, -CH2-NH-BOC), 1.80-1.31 (m, 
38H, -C(O)O-CH2-CH2, NH2-CαH-, -CαH-CH2-CH2-CH2-, BOC CH3). 13C NMR (100 
MHz, CDCl3): δ 175.9, 155.9, 78.9, 64.2, 54.3, 40.2, 34.5, 29.7, 28.3, 25.2, 22.8. 
3.3.5 General Procedure for Solution Polymerization of the Non-
Functional Poly(ester amide)s 
Solution polycondensation of the non-functional poly(ester amide)s was performed as 
previously reported (Scheme 3.2).21 The di-p-nitrophenyl sebacate monomer 4 (1.0 
equiv.) and the di-p-toluenesulfonic acid salt monomer (1.0 equiv.) were combined in a 
round bottom flask, evacuated and purged with nitrogen. Distilled DMA (4.0 mL) was 
added to these monomers and the resulting mixture was heated to 60°C. Triethylamine 
(1.0 mL, 7.3 mmol, 2.2 equiv.) was then added dropwise to the solution and the 
temperature was raised to 70°C. The reaction mixture was maintained at this temperature 
for 48 h. The solution was then precipitated in cold ethyl acetate (125 mL) and collected. 
Residual impurities were first removed by washing with ethyl acetate followed by its 
Soxhlet extraction with ethyl acetate for 48 h to provide pure polymer. 
3.3.5.1 8-Ala-8-Sol 
This polymer was prepared by the general procedure described above, from monomers 1, 
4. Yield: 1.2 g, 67%. 1H NMR (400 MHz, CDCl3): δ 6.17 (d, 2H, J = 7.4, -NH-CO-), 
4.59 (m, 2H, -CαH), 4.18-4.08 (m, 4H, -C(O)O-CH2-), 2.23-2.17 (m, 4H, -NH-C(O)-
CH2-), 1.69-1.58 (m, 8H, -C(O)O-CH2-CH2-, -NH-C(O)-CH2-CH2-), 1.42-1.27 (m, 22H, 
-CαH-CH3, -C(O)O-CH2-CH2-(CH2)4-, -NH-C(O)-CH2-CH2-(CH2)4-). 13C NMR (100 
MHz, CDCl3): δ 173.3 (-C(O)O-), 172.6 (-NH-CO-), 65.4 (-C(O)O-CH2-), 47.8 (-CαH), 
36.3 (-NH-CO-CH2-, 29.0 (-C(O)O-CH2-CH2-), 28.4 (-C(O)O-CH2-CH2-(CH2)4-), 25.6 (-
NH-CO-CH2-CH2-), 25.4 (–NH-CO-CH2-CH2-(CH2)4-), 18.5 (-CαH-CH3). FTIR (KBr 
pellet, cm-1): 3311 (N-H stretch, amide), 3085 (Fermi resonance overtone of the 1560 cm-
1 band), 2930 (C-H stretch, aliphatic), 2854 (C-H stretch, aliphatic), 1736 (C=O stretch, 
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ester), 1655 (C=O stretch, amide I), 1560 (N-H bend, C-N-stretch, amide II), 1459 (CH2 
wag, aliphatic), 1219 (C-O stretch, ester). GPC: Mn = 36,600, Mw = 51,400, PDI = 1.41. 
DSC: Tg = 13.5°C. 
3.3.5.2 8-Phe-4-Sol 
This polymer was prepared by the general procedure described above, from monomers 2 
and 4. Yield: 2.4 g, 85%. Spectral data agreed with those previously reported.18 GPC: Mn 
= 53,500, Mw = 103000, PDI = 1.93. DSC: Tg = 38.5°C. 
3.3.5.3 8-Phe-8-Sol 
This polymer was prepared by the general procedure described above, from monomers 3 
and 4. Yield: 0.71 g, 61%. 1H NMR (400 MHz, CDCl3): δ 7.31-7.08 (m, 10H, Ph), 5.96 
(d, 2H, J = 7.6, -NH-CO-), 4.89 (m, 2H, -CαH), 4.16-4.04 (m, 4H, -C(O)O-CH2-), 3.18-
3.05 (m, 4H, -CαH-CH2-Ph), 2.20-2.13 (m, 4H, -NH-C(O)-CH2-), 1.67-1.51 (m, 8H, -
C(O)O-CH2-CH2-, -NH-C(O)-CH2-CH2-), 1.35-1.20 (m, 16H, -C(O)O-CH2-CH2-(CH2)4-, 
-NH-C(O)-CH2-CH2-(CH2)4-). 13C NMR (100 MHz, CDCl3): δ 172.5 (-C(O)O-), 171.8 (-
NH-CO-), 135.9 (Ar-C), 129.2 (Ar-C), 128.4 (Ar-C), 127.0 (Ar-C), 65.5 (-C(O)O-CH2-), 
52.9 (-CαH), 38.0 (-CαH-CH2-Ph), 36.4 (-NH-C(O)-CH2-), 29.0 (-C(O)O-CH2-CH2-), 
28.3 (-C(O)O-CH2-CH2-(CH2)4-), 25.7 (-NH-C(O)-CH2-CH2-), 25.4 (-NH-C(O)-CH2-
CH2-(CH2)4-). FTIR (KBr pellet, cm-1): 3305 (N-H stretch, amide), 3065 (C-H stretch, 
aromatic), 3030 (C-H stretch, aromatic), 2928 (C-H stretch, aliphatic), 2853 (C-H stretch, 
aliphatic), 1736 (C=O stretch, ester), 1649 (C=O stretch, amide I), 1543 (N-H bend, C-N 
stretch, amide II), 1498 (C=C stretch, aromatic), 1455 (CH2 wag, aliphatic), 1181 (C-O 
stretch, ester). GPC: Mn = 44400, Mw = 63300, PDI = 1.43. DSC: Tg = 25.7°C. 
3.3.6 General Procedure for Interfacial Polymerization of the Non-
Functional Poly(ester amide)s 
Sebacoyl chloride (5.0 mmol, 1.0 equiv.) was dissolved in anhydrous dichloromethane 
(30 mL), and this solution was added dropwise over 30 min to an aqueous solution (30 
mL) containing di-p-toluenesulfonic acid salt monomer 1, 2 or 3 (5.0 mmol, 1.0 equiv.) 
and sodium carbonate (10 mmol, 2.0 equiv.) and allowed to react for 12 h (Scheme 2). 
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Upon completion of the reaction, the solvent was removed in vacuo. The polymer was 
then washed with excess water prior to purification via Soxhlet extraction with ethyl 
acetate for 48 h and dried in vacuo. 
3.3.6.1 8-Ala-8-Int 
This polymer was prepared by the general procedure described above using monomer 1 
and sebacoyl chloride. Yield: 1.6 g, 68%. Spectral data agreed with those reported above 
for 8-Ala-8-Sol. GPC: Mn = 45,100, Mw = 62,500, PDI = 1.38. DSC: Tg = 13.5°C. 
3.3.6.2 8-Phe-4-Int 
This polymer was prepared by the general procedure described above using monomer 2 
and sebacoyl chloride. Yield: 2.1 g, 78%. Spectral data agreed with those previously 
reported.18 GPC: Mn = 63,600, Mw = 168,000, PDI = 2.64. DSC: Tg = 38.8°C. 
3.3.6.3 8-Phe-8-Int 
This polymer was prepared by the general procedure described above using monomer 3 
and sebacoyl chloride. Yield: 1.8 g, 60%. Spectral data agreed with those reported above 
for 8-Phe-8-Sol. GPC: Mn = 65,600, Mw = 89,100, PDI = 1.36. DSC: Tg = 24.2°C. 
3.3.7 General Procedure for Solution Polymerization of the 
Functional Poly(ester amide)s 
The solution polymerized functional PEAs were synthesized similarly to the base 
poly(ester amide)s. Di-p-nitrophenyl sebacate monomer 4 (2.6 mmol, 1.0 equiv.), the di-
p-toluenesulfonic acid salt monomer 1, 2 or 3 (2.4 mmol, 0.9 equiv.) and bis-N-ε-t-BOC-
L-lysine diester monomer, 6 (0.26 mmol, 0.1 equiv.) were combined in a round bottom 
flask, evacuated and purged with nitrogen. Distilled DMA (5.0 mL) was added to these 
monomers and the resulting mixture was heated to 60°C. Distilled triethylamine (5.7 
mmol, 2.2 equiv.) was then added dropwise to the solution and the temperature was 
raised to 70°C. The reaction mixture was maintained at this temperature for 48 h. The 
solution was then precipitated in cold ethyl acetate (100 mL) and collected. The crude 
product was dissolved in DMF and dialyzed for at least 8 h twice. The purified PEA was 
concentrated on the rotary evaporator, precipitated in water (5 mL) and lyophilized for 24 
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h. Finally, the polymer was precipitated in cold ethyl acetate (50 mL) from chloroform (5 
mL), collected and dried in vacuo. 
3.3.7.1 8-Ala-8-Lys(BOC)-4-Sol 
This polymer was prepared by the general procedure described above using monomers 1, 
4 and 6. Yield: 0.43 g, 34%. 1H NMR (400 MHz, CDCl3): δ 6.39-6.11 (br m, 2H, -C(O)-
NH-CαH-(CH2)4-NH-BOC, -C(O)-NH-CαH-CH3), 4.78 (br m, 0.2H, -NH-BOC), 4.65-
4.52 (m, 2H, -CαH-CH3, -CαH-(CH2)4-NH-BOC), 4.23-4.08 (m, 4H, -C(O)O-CH2-), 3.15-
3.05 (m, 0.4H, -CH2-NH-BOC), 2.36-2.11 (m, 4H, -NH-C(O)-CH2-), 1.90-1.70 (br m, 
0.8H, -CαH-CH2-CH2-CH2-CH2-NH-BOC), 1.70-1.54 (m, 8H, -C(O)O-CH2-CH2-, -NH-
C(O)-CH2-CH2-), 1.44 (br s, 1.8H, BOC CH3), 1.40 (d, 5.4H, J = 7.0, -CαH-CH3), 1.38-
1.27 (m, 15.6H, -NH-C(O)-CH2-CH2-(CH2)4-, -C(O)O-CH2-CH2-(CH2)4-, -CαH-CH2-
CH2-CH2-CH2-NH-BOC). FTIR (KBr pellet, cm-1): 3307 (N-H stretch, amide), 3069 
(Fermi resonance overtone of the 1560 cm-1 band), 2931 (C-H stretch, aliphatic), 2856 
(C-H stretch, aliphatic), 1743 (C=O stretch, ester), 1649 (C=O stretch, amide I), 1543 (N-
H bend, C-N-stretch, amide II), 1457 (CH2 wag, aliphatic). GPC: Mn = 19,000, Mw = 
28,700, PDI = 1.51. DSC: Tg = 15.1°C. 
3.3.7.2 8-Phe-4-Lys(BOC)-4-Sol 
This polymer was prepared by the general procedure described above using monomers 2, 
4 and 6. Yield: 0.79 g, 52%. 1H NMR (400 MHz, CDCl3): δ 7.33-7.08 (m, 9H, Ph), 6.28 
(br m, 0.2H, -C(O)-NH-CαH-(CH2)4-NH-BOC), 6.01 (d, 1.8H, J = 7.8, C(O)-NH-CαH-
CH2-Ph), 4.92-4.83 (m, 1.8H, -NH-CαH-CH2-Ph), 4.74 (br m, 0.2H, -NH-BOC), 4.57 (br 
m, 0.2H, -NH-CαH-(CH2)4-NH-BOC), 4.21-3.98 (m, 4H, -C(O)O-CH2-), 3.18-3.04 (m, 
4H, CαH-CH2-Ph, CαH-CH2-CH2-CH2-CH2-NH-BOC), 2.25-2.09 (m, 4H, -NH-C(O)-
CH2-), 1.90-1.68 (m, 0.8H, -CαH-CH2-CH2-CH2-CH2-NH-BOC), 1.68-1.47 (m, 8H, -
C(O)O-CH2-CH2-, -NH-C(O)-CH2-CH2-), 1.44 (br s, 1.8H, BOC CH3), 1.40-1.15 (m, 
8.4H, -CαH-CH2-CH2-CH2-CH2-NH-BOC, -NH-C(O)-CH2-CH2-(CH2)4-). FTIR (KBr 
pellet, cm-1): 3309 (N-H stretch, amide), 3064 (C-H stretch, aromatic), 3030 (C-H stretch, 
aromatic), 2928 (C-H stretch, aliphatic), 2854 (C-H stretch, aliphatic), 1745 (C=O 
81 
 
 
stretch, ester), 1647 (C=O stretch, amide I), 1542 (N-H bend, C-N stretch, amide II), 
1496 (C=C stretch, aromatic), 1455 (CH2, wagging vibration) 1176 (C-O stretch, ester). 
GPC: Mn = 48,800, Mw = 73,900, PDI = 1.52. DSC: Tg = 37.6°C. 
3.3.7.3 8-Phe-8-Lys(BOC)-4-Sol 
This polymer was prepared by the general procedure described above using monomers 3, 
4 and 6. Yield: 0.76 g, 41%. 1H NMR (400 MHz, CDCl3): δ 7.32-7.08 (m, 9H, Ph), 6.27 
(br m, 0.2H, -C(O)-NH-CαH-(CH2)4-NH-BOC), 5.95 (d, 1.8H, J = 7.8, -C(O)-NH-CαH-
CH2-Ph), 4.89 (m, 1.8H, -CαH-CH2-Ph), 4.75 (br m, 0.2H, -NH-BOC), 4.57 (br m, 0.2H, 
-CαH-(CH2)4-NH-BOC), 4.16-4.04 (m, 4H, -C(O)O-CH2-), 3.18-3.05 (m, 4H, -CαH-CH2-
Ph, -CH2-NH-BOC), 2.36-2.09 (m, 4H, -NH-C(O)-CH2-), 1.90-1.70 (m, 0.8H, -CαH-
CH2-CH2-CH2-CH2-NH-BOC), 1.70-1.47 (m, 8H, -C(O)O-CH2-CH2, -NH-C(O)-CH2-
CH2-), 1.44 (br s, 1.8H, BOC CH3), 1.38-1.18 (m, 15.6H, -CαH-CH2-CH2-CH2-CH2-NH-
BOC, -C(O)O-CH2-CH2-(CH2)4-, NH-C(O)-CH2-CH2-(CH2)4-). FTIR (KBr pellet, cm-1): 
3302 (N-H stretch, amide), 3065 (C-H stretch, aromatic), 3030 (C-H stretch, aromatic), 
2929 (C-H stretch, aliphatic), 2853 (C-H stretch, aliphatic), 1738 (C=O stretch, ester), 
1649 (C=O stretch, amide I), 1543 (N-H bend, C-N stretch, amide II), 1498 (C=C stretch, 
aromatic), 1455 (CH2, wagging vibration) 1178 (C-O stretch, ester). GPC: Mn = 38,100, 
Mw = 49,800, PDI = 1.31. DSC: Tg = 23.4°C. 
3.3.8 General Procedure for Interfacial Polymerization of the 
Functional Poly(ester amide)s 
The di-p-toluenesulfonic acid salt monomer 1, 2 or 3 (1.9 mmol, 0.9 equiv.) and sodium 
carbonate (4.3 mmol, 2.0 equiv.) were dissolved in distilled water (30 mL). Bis-N-ε-t-
BOC-L-lysine diester monomer 6 (0.21 mmol, 0.1 equiv.) was dissolved in 
dichloromethane (15 mL) and added to the aqueous phase and allowed to mix for 30 min. 
Sebacoyl chloride (2.1 mmol, 1.0 equiv.) diluted in anhydrous dichloromethane (15 mL), 
was added dropwise over 30 min to the biphasic solution and was allowed to react for 24 
h. Upon completion of the reaction, solvent was removed in vacuo. The functional PEA 
was dissolved in DMF permitting filtration of the insoluble salts. The filtrate was then 
dialyzed against DMF for at least 8 h twice. The purified PEA was concentrated on the 
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rotary evaporator, precipitated in water (5 mL) and lyophilized for 24 h. Finally, the 
polymer was precipitated in cold ethyl acetate (50 mL) from chloroform (5 mL), 
collected and dried in vacuo. 
3.3.8.1 8-Ala-8-Lys(BOC)-4-Int 
This polymer was prepared by the general procedure described above using monomers 1, 
6 and sebacoyl chloride. Yield: 0.40 g, 40%. Spectral data agreed with those reported 
above for 8-Ala-8-Lys(BOC)-4-Sol. GPC: Mn = 29,500, Mw = 47,600, PDI = 1.62. DSC: 
Tg = 14.5°C. 
3.3.8.2 8-Phe-4-Lys(BOC)-4-Int 
This polymer was prepared by the general procedure described above using monomers 2, 
6 and sebacoyl chloride. Yield: 0.84 g, 69%. Spectral data agreed with those reported 
above for 8-Phe-4-Lys(BOC)-4-Sol. GPC: Mn = 48800, Mw = 73900, PDI = 1.52. DSC: 
Tg = 37.6°C. 
3.3.8.3 8-Phe-8-Lys(BOC)-4-Int 
This polymer was prepared by the general procedure described above using monomers 3, 
6 and sebacoyl chloride. Yield: 0.84 g, 57%. Spectral data agreed with those reported 
above for 8-Ala-8-Lys(BOC)-4-Sol. GPC: Mn = 21,200, Mw = 45,700, PDI = 2.16. DSC: 
Tg = 22.9°C. 
3.3.9 General Deprotection Procedure 
Each BOC-protected functional PEA (100 mg) was dissolved in 1:1 trifluoroacetic acid 
(TFA):CH2Cl2 (2 mL) mixture and reacted for 2 h. The solvents were subsequently 
removed in vacuo, and then the product was precipitated in cold ethyl ether (50 mL) from 
dichloromethane (5 mL). The precipitate was collected and again dried in vacuo, yielding 
the functional PEA with pendant amine groups as their TFA salts. 
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3.3.9.1 8-Ala-8-Lys(TFA)-4  
Yield: 75%. 1H NMR (400 MHz, DMSO-d6): δ 8.15 (d, 2H, J = 7.0 -C(O)-NH-CαH-CH3, 
-C(O)-NH-CαH-(CH2)4-NH3+TFA-), 7.65 (br m, 0.6H, -NH3+TFA-), 4.42-4.34 (m, 0.2H, -
CαH-(CH2)4-NH3+TFA-), 4.20 (m, 1.8H, -CαH-CH3), 4.10-3.92 (m, 4H, -C(O)O-CH2-), 
2.81-2.71 (br m, 0.4H, -CαH-CH2-CH2-CH2-CH2-NH3+TFA-), 2.21-1.96 (m, 4H, -CH2-
C(O)-NH-CαH-(CH2)4-NH3+TFA-, -CH2-C(O)-NH-CαH-CH3), 1.68-1.59 (m, 0.8H, -CαH-
CH2-CH2-CH2-CH2-NH3+TFA-), 1.59-1.38 (m, 8H, -C(O)O-CH2-CH2-, -NH-C(O)-CH2-
CH2-), 1.38-1.12 (m, 21H, -C(O)O-CH2-CH2-(CH2)4-, -NH-C(O)-CH2-CH2-(CH2)4-, -
CαH-CH2-CH2-CH2-CH2-NH3+TFA-, -CαH-CH3). FTIR (KBr pellet, cm-1): 3315 (N-H 
stretch, amide), 3076 (Fermi resonance overtone of the 1560 cm-1 band), 2931 (C-H 
stretch, aliphatic), 2856 (C-H stretch, aliphatic), 1742 (C=O stretch, ester), 1648 (C=O 
stretch, amide I), 1543 (N-H bend, C-N-stretch, amide II), 1458 (CH2 wag, aliphatic). 
GPC: Mn = 17,000, Mw = 30,000, PDI = 1.76. DSC: Tg = 15.4°C. 
3.3.9.2 8-Phe-4-Lys(TFA)-4 
Yield: 65%. 1H NMR (400 MHz, DMSO-d6): δ 8.23 (d, 1.8H, J = 8.2, -C(O)-NH-CαH-
CH2-Ph), 8.14 (d, 0.2H, J = 5.5, -C(O)-NH-CαH-(CH2)4-NH3+TFA-), 7.63 (br m, 0.6H, -
NH3+TFA-), 7.33-7.12 (m, 9H, Ph), 4.51-4.39 (m, 1.8H, -CαH-CH2-Ph), 4.19 (br m, 0.2H, 
-CαH-(CH2)4-NH3+TFA-), 4.09-3.88 (m, 4H, -C(O)O-CH2-), 3.06-2.81 (m, 3.6H, -CαH-
CH2-Ph), 2.75 (br m, 0.4H, -CαH-CH2-CH2-CH2-CH2-NH3+TFA-), 2.21-2.07 (m 0.8H, -
CαH-CH2-CH2-CH2-CH2-NH3+TFA-, -CH2-C(O)-NH-CαH-(CH2)4-NH3+TFA-), 2.03 (t, 
3.6H, J = 7.0, -CH2-C(O)-NH-CαH-CH2-Ph), 1.60 (br m, 0.4H, -CαH-CH2-CH2-CH2-
CH2-NH3+TFA-), 1.56-1.28 (m, 8H, -C(O)O-CH2-CH2-, -NH-C(O)-CH2-CH2-), 1.28-1.00 
(m, 8.4H, -CαH-CH2-CH2-CH2-CH2-NH3+TFA-, -NH-C(O)-CH2-CH2-(CH2)4-). FTIR 
(KBr pellet, cm-1): 3317 (N-H stretch, amide), 3064 (C-H stretch, aromatic), 3030 (C-H 
stretch, aromatic), 2928 (C-H stretch, aliphatic), 2855 (C-H stretch, aliphatic), 1736 
(C=O stretch, ester), 1655 (C=O stretch, amide I), 1543 (N-H bend, C-N stretch, amide 
II), 1496 (C=C stretch, aromatic), 1458 (CH2, wagging vibration) 1176 (C-O stretch, 
ester). GPC: Mn = 27,600, Mw = 63,500, PDI = 2.30. DSC: Tg = 43.5°C. 
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3.3.9.3 8-Phe-8-Lys(TFA)-4 
Yield: 62%. 1H NMR (400 MHz, DMSO-d6): δ 8.27-8.10 (m, 2H, -C(O)-NH-CαH-CH2-
Ph, -C(O)-NH-CαH-(CH2)4-NH3+TFA-), 8.00 (br m, 0.6H, -NH3+TFA-), 7.29-7.13 (m, 
9H, Ph), 4.44 (m, 1.8H, -CαH-CH2-Ph), 4.17 (br m, 0.2H, -CαH-(CH2)4-NH3+TFA-), 4.07-
3.89 (m, 4H, -C(O)O-CH2-), 3.05-2.81 (m, 3.6H, -CαH-CH2-Ph), 2.74 (br m, 0.4H, -CαH-
CH2-CH2-CH2-CH2-NH3+TFA-), 2.28-2.13 (m 0.8H, -CαH-CH2-CH2-CH2-CH2-
NH3+TFA-, -CH2-C(O)-NH-CαH-(CH2)4-NH3+TFA-), 2.13-1.93 (m, 4H, -CH2-C(O)-NH-
CαH-CH2-CH2-CH2-CH2-NH3+TFA-, -CH2-C(O)-NH-CαH-CH2-Ph), 1.59 (br m, 0.4H, -
CαH-CH2-CH2-CH2-CH2-NH3+TFA-), 1.56-1.29 (m, 8H, -C(O)O-CH2-CH2-, -NH-C(O)-
CH2-CH2-), 1.29-1.00 (m, 15.6H, -CαH-CH2-CH2-CH2-CH2-NH3+TFA-, -C(O)O-CH2-
CH2-(CH2)4-, -NH-C(O)-CH2-CH2-(CH2)4-). FTIR (KBr pellet, cm-1): 3308 (N-H stretch, 
amide), 3064 (C-H stretch, aromatic), 3030 (C-H stretch, aromatic), 2929 (C-H stretch, 
aliphatic), 2854 (C-H stretch, aliphatic), 1741 (C=O stretch, ester), 1648 (C=O stretch, 
amide I), 1543 (N-H bend, C-N stretch, amide II), 1497 (C=C stretch, aromatic), 1455 
(CH2, wagging vibration) 1179 (C-O stretch, ester). GPC: Mn = 41,600, Mw =70,500, PDI 
= 1.70. DSC: Tg = 24.5°C. 
3.3.10 Cell Culture and Immunofluorescence Microscopy 
Polymer films were obtained by twice dip-coating 12 mm diameter glass coverslips into 
1% (wt) solutions of the PEAs in DMF and were dried at 60°C under reduced pressure 
overnight. One glass coverslip was placed in each well of a 24-well culture plate. The 
films were immersed in 70% ethanol for 30 min and then exposed to UV irradiation for 1 
h, prior to conditioning overnight in Hank’s Balanced Salt Solution (HBSS, 0.5 mL; 
Invitrogen Canada Inc., Burlington, ON). Natural, human fibronectin (2 µg/cm2; Santa 
Cruz Biotechnology Inc., Santa Cruz, CA) in HBSS was adsorbed to glass coverslips for 
1 h and the resulting surfaces served as positive controls. The human coronary artery 
smooth muscle cells (HCASMCs; Lonza Walkersville Inc., Walkersville, MD) were 
seeded directly on the surface of the PEA films in 24-well culture plates and were 
cultured for 1 and 7 days before fixation and immunostaining. All experiments were 
conducted in triplicate. 
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Human coronary artery smooth muscle cells were grown in smooth muscle cell basal 
medium (SmBM; Lonza Walkersville Inc., Walkersville, MD) supplemented with smooth 
muscle growth medium-2 (SmGM-2 SingleQuots; Lonza Walkersville Inc., Walkersville, 
MD) and used between passages 5 and 9. Cultures were maintained at 37°C in a 
humidified incubator containing 5% CO2. 
For immunostaining studies, cells were washed with pre-warmed PBS immediately prior 
to fixing at ambient temperature for 10 min in 4% formaldehyde solution (1 mL; EMD 
Chemicals, Gibbstown, NJ) in divalent cation-free PBS. Following 3 washes in PBS, 
HCASMCs were permeabilized with 0.1% Triton X-100 (0.5 mL; VWR International, 
Mississauga, ON) in PBS for 5 min and again washed 3 times with PBS. The HCASMCs 
were incubated with 1% bovine serum albumin (BSA) in PBS (0.5 mL; Sigma-Aldrich, 
Oakville, ON) for 30 min at ambient temperature prior to their incubation with either 
monoclonal anti-vinculin (SPM227, 1:50 dilution; Abcam, Cambridge, MA) for 1 h or 
monoclonal anti-α-actin (clone 1A4, 1:50 dilution; Santa Cruz Biotechnology, Inc., Santa 
Cruz, CA). Following 3 washes in PBS, the HCASMCs were then incubated in the dark 
for 1 h at ambient temperature with Alexa Fluor® 488-conjugated goat anti-mouse IgG 
(1:300 dilution; Invitrogen Canada Inc., Burlington, ON). Following 3 washes in PBS, 
the HCASMCs were further incubated in the dark at ambient temperature with Alexa 
Fluor® 568-conjugated phalloidin (1:50 dilution; Invitrogen Canada Inc., Burlington, 
ON) for 20 min in a 1% BSA/PBS solution followed by another 3 washes with PBS. The 
HCASMCs were then counterstained with 4’-6-diamidino-2-phenylindole 
dihydrochloride (DAPI, 300 nM in PBS, 0.5 mL; Invitrogen Canada Inc., Burlington, 
ON) for 5 min to label the nuclei and again washed 3 times with PBS. Coverslips were 
mounted on microscope slides with SHURMountTM – Toluene Based Liquid Mounting 
Media (Triangle Biomedical Sciences, Inc., Durham, NC). Samples were analyzed with a 
Zeiss LSM 5 Duo confocal microscope with 9 laser lines and appropriate filters (Carl 
Zeiss Canada Ltd., Toronto, ON). 
3.3.11 Cell Toxicity and Proliferation Studies Using MTT Assays 
Colorimetric assays of the metabolic activity of viable cells were used to quantify cell 
toxicity and proliferation and were performed using 3-(4,5-dimethylthiazol-2-yl)-2,5-
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diphenyltetrazolium bromide (MTT) (Vybrant® MTT Cell Proliferation Assay Kit, 
Invitrogen Canada Inc., Burlington, ON, Canada). At predetermined time points, fresh 
culture media was added (100 µL) followed by MTT (10 μL, Component A) and 
incubated for 4 h. MTT salts are reduced to water insoluble formazan salts by 
metabolically active cells. Sodium dodecyl sulfate (SDS, 100 µL, Component B) was 
then added and thoroughly mixed and incubated for a further 18 h to solubilize the 
formazan, which was quantified using a BioTek EL307C multiplate reader (BioTek 
Instruments, Inc., Winooski, VT) at 570 nm (maximum absorbance). 
3.3.12 Statistical analysis 
MTT assay data are given as the mean ± standard deviation for three independent 
experiments conducted in triplicate. Differences between two groups were compared 
using a student’s unpaired t test with GraphPad Prism 4, where values of p < 0.01 were 
considered statistically significant. 
3.4 Results and Discussion 
3.4.1 Monomer Syntheses 
The rationale for synthesizing a family of poly(ester amide)s based on the hydrophobic α-
amino acids L-alanine and L-phenylalanine was to impart suitable thermal and mechanical 
properties. PEAs based on these α-amino acids are semi-crystalline,38 which may result in 
improved mechanical properties.34 Alanine-based PEAs also exhibit high degradation 
temperatures, which would facilitate their processing in the melt.39 Moreover, the 
hydrophobic nature of L-alanine (Ala) and L-phenylalanine (Phe) in combination with 
long aliphatic diols would further enhance the processability of these PEAs due to their 
improved solubility in organic solvents such as chloroform.38 Four different monomers 
would potentially be available from the selection of α-amino acids – L-alanine and L-
phenylalanine, and diols – 1,4-butanediol and 1,8-octanediol. Characterization of di-p-
toluenesulfonic acid salts of bis-L-alanine and -L-phenyalanine esters (monomers 1 and 2) 
are included within this report and agree with previously reported studies.23,36 The bis-L-
alanine ester derived from 1,4-butanediol was very low yielding and subsequently, its 
polycondensation was not pursued. The previously unreported acid catalyzed 
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condensation of L-phenylalanine and 1,8-octanediol was successfully performed to 
provide monomer 3. Di-p-nitrophenyl sebacate monomer 4 and the bis-N-ε-t-BOC-L-
lysine diester monomer 6 were synthesized in good yields as previously reported (Chart 
3.1).21,24 
x
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Toluene, 140oC, 48 h
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Scheme 3.1: Syntheses of di-p-toluenesulfonic acid salt monomers 1-3. 
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Chart 3.1: Structures of monomers di-p-nitrophenyl sebacate 4 and the bis-N-ε-t-
BOC-L-lysine diester 6. 
3.4.2 Comparison of Solution and Interfacial Polycondensation of 
Non-Functionalized Poly(ester amide)s 
Although solution polymerization to prepare PEAs has been carried out,21 interfacial 
polymerization is generally attractive since it is faster, less influenced by impurities, and 
yield higher molecular weights than solution polycondensation reactions.40 Despite these 
benefits, the hydrolysis of the diacid chloride could lead to early termination of the 
interfacial polymerization.40 This hydrolysis can be minimized through the selection of a 
hydrophobic diacid chloride, preventing its undesirable interaction with water, ensuring 
its reaction only upon encountering an amine group. In this study, the selection of the 
hydrophobic sebacoyl chloride enabled the syntheses of PEAs from both 
polycondensation approaches, permitting a direct comparative study to examine the effect 
of polymerization technique on the properties of the PEAs for vascular tissue engineering 
applications. 
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As shown in Scheme 3.2(A), the solution polymerizations were performed by combining 
di-p-toluenesulfonic acid salt monomer 1, 2 or 3 with 4 in N,N-dimethylacetamide 
(DMA) and reacting at 70°C for 48 h. The interfacial polymerizations, shown in Scheme 
2(B), were performed by adding a solution of sebacoyl chloride in CH2Cl2 to a solution of 
the di-p-toluenesulfonic acid salt monomer 1, 2 or 3 in an aqueous Na2CO3 solution and 
allowing the reaction mixture to stir for 12 h. The structure of each non-functionalized 
PEA pair was confirmed through its 1H and 13C NMR and FTIR spectra. The 
effectiveness of both the solution and interfacial polycondensation approaches in 
generating highly pure PEAs can be observed through the identical spectral output of 8-
Ala-8, 8-Phe-4 and 8-Phe-8 from both approaches (Figure 3.1, Figure 3.2 and Figure 3.3). 
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Scheme 3.2: Comparison of the interfacial and solution polymerization approaches. 
Upon successful elucidation of the chemical structure of each PEA pair, the thermal 
properties were examined. Differential scanning calorimetry (DSC) and 
thermogravimetric analyses (TGA) were conducted on the PEAs to evaluate their glass 
transition and decomposition temperatures and are shown in (Table 3.1). As illustrated, 
the glass transition temperature of 8-Ala-8 is around 13°C, while those PEAs containing 
L-phenylalanine with its bulkier side chain have higher Tgs as expected. The length of the 
diol also has a significant impact on the glass transition temperature, as the Tg increased 
from 25°C in the 8-Phe-8 case to around 39°C when 1,4-butanediol was incorporated, 
which is consistent with published data.14 Although the Tg in the 8-Phe-4 case is slightly 
above physiologic conditions, a lower glass transition temperature is anticipated due to 
the plasticizing effect of culture media. In vascular tissue engineering, a scaffold which 
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deforms under physiologically-relevant forces is better suited to mimic the natural ECM 
composition,41 thus a polymer with a glass transition temperature below or near that of 
physiologic conditions is preferred. Furthermore, given the low Tgs, three-dimensional 
(3D) scaffolds fabricated from the current PEAs are likely to be more pliable, allowing 
cells to interact favorably. In fact, 3D scaffold pliability has been reported to mimic 
physiologic focal adhesion contacts when compared with rigid substrata.42-44 In addition 
to having suitable glass transition temperatures, all PEAs had a decomposition 
temperature exceeding 300°C, indicating that these materials could be easily processed in 
the melt without degradation. To demonstrate that such processing is feasible, the 
molecular weight of 8-Phe-4 before and after melt pressing was measured. The results 
indicate that the molecular weight did not change due to melt pressing. 
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Figure 3.1: Overlayed 1H NMR spectra of 8-Ala-8 synthesized from solution and 
interfacial polycondensations. 
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Figure 3.2: Overlayed 1H NMR spectra of 8-Phe-4 synthesized from solution and 
interfacial polycondensations. 
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Figure 3.3: Overlayed 1H NMR spectra of 8-Phe-8 synthesized from solution and 
interfacial polycondensations. 
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Table 3.1: Comparision of solution and interfacial polycondensation of non-
functionalized PEAs. 
PEA Yield (%) Mn (g/mol) Mw (g/mol) PDI Tg (°C) Td (°C) 
8-Ala-8-Sol 67 36,600 51,400 1.40 13.5 336 
8-Ala-8-Int 68 45,100 62,500 1.39 11.8 311 
8-Phe-4-Sol 85 53,500 103,000 1.93 38.5 334 
8-Phe-4-Int 78 63,600 168,000 2.64 38.8 320 
8-Phe-8-Sol 61 44,400 63,300 1.43 25.7 343 
8-Phe-8-Int 60 71,800 111,000 1.55 24.5 336 
For each non-functional PEA pair examined, the interfacial polymerization approach 
produced polymers with higher molecular weights. In interfacial polymerization, any 
impurities from the di-p-toluenesulfonic acid salt monomer syntheses remained in the 
bulk aqueous phase, ensuring the effective polymer chain propagation at the interface.36 
From a synthetic vantage point, 8-Phe-4 offers the highest molecular weight and yield; 
however, the polydispersity index (PDI) is higher than either of the other two PEAs. 
Furthermore, the PDI of 8-Phe-4-Int is over 2.6, which is considerably higher than its 
solution polymerized counterpart. The high PDI observed may in part be due to the 
comparatively high weight average molecular weight broadening the distribution of 
polymer chains. Since solution polymerization was carried out for 48 h at 60°C, 
thermolysis may have occurred which, in turn, could reduce the molecular weights of the 
polymers. In order to rule out this possibility, the molecular weight of 8-Phe-4-Sol was 
determined after 24 h of polymerization and found to be 36,300 Da. The molecular 
weight after 48 h of polymerization was 53,500 Da indicating that thermolysis did not 
occur. 
3.4.3 Comparison of Solution and Interfacial Polycondensation of 
Functionalized Poly(ester amide)s 
The solution polycondensation of the functional PEAs containing L-lysine was previously 
reported in our group23-24 and the same procedure was used here to prepare the functional 
PEAs: 8-Ala-8-Lys(BOC)-4-Sol, 8-Phe-4-Lys(BOC)-4-Sol, and 8-Phe-8-Lys(BOC)-4-
Sol. To date, no study has been conducted to assess the incorporation of pendant amine 
groups in an interfacial polycondensation of PEAs. Therefore, we investigated the effect 
of the polymerization method on the synthesis of functional PEAs. The challenge in this 
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approach was that unlike the di-p-toluenesulfonic acid salt monomers, the protected 
lysine monomer 6 was not readily water soluble, preventing its dissolution in the aqueous 
phase. Furthermore, the addition of the BOC-protected lysine monomer into the organic 
phase with the sebacoyl chloride would have resulted in polymerization of these two 
monomers. Consequently, the di-p-toluenesulfonic acid salt monomer was dissolved in 
water, while monomer 6 was dissolved in dichloromethane and mixed for 30 min 
resulting in a biphasic mixture. Following the addition of sebacoyl chloride, the reaction 
was allowed to proceed for 24 h, which yielded functional PEAs of higher molecular 
weight than at shorter reaction times. The base stable BOC protecting group could be 
readily removed by treatment of the polymers with 1:1 trifluoroacetic acid (TFA):CH2Cl2 
to provide the polymers 8-Ala-8-Lys(TFA)-4-Int, 8-Phe-4-Lys(TFA)-4-Int, and 8-Phe-8-
Lys(TFA)-4-Int. 
The structures of the protected and deprotected functional PEAs were again confirmed 
with 1H NMR and FTIR spectroscopy, while 13C NMR spectroscopy was not a 
sufficiently sensitive technique to clearly detect the relatively low abundance of lysine 
moieties in the high molecular weight polymers. Representative 1H NMR spectra of 8-
Ala-8-Lys(BOC)-4 and the corresponding deprotected polymer 8-Ala-8-Lys(TFA)-4 are 
shown in Figure 3.4(A) and (B) respectively. Overlayed NMR spectra of the protected 
and deprotected functional 8-Phe-4- and 8-Phe-8-based PEAs are shown in Figure 3.5(A) 
and (B) and Figure 3.6(A) and (B). By comparison with the spectrum of 8-Phe-4 (Figure 
3.2), all the major peaks associated with the PEA backbone are also observed in the 
functional PEAs. However, additional peaks associated with the lysine monomer are 
clearly observed. For example, the peak at 6.74 ppm (labeled as 20) can be attributed to 
the proton on the nitrogen atom adjacent to the BOC group. The relative integration of 
these peaks and those of the PEA backbone were used to assess the incorporation of the 
lysine monomer and the results are given in Table 3.2. The solution and interfacial 
methods led to very similar lysine incorporations. Following the cleavage of the BOC 
group, the presence of the broad peak in the 1H NMR spectrum at 7.65 ppm arises due to 
the protons of the protonated amine salt (labeled as 28). 
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Figure 3.4: Overlayed 1H NMR spectra of 8-Ala-8-based functional PEAs. Note that 
the unlabeled peaks above correspond to the peaks labeled in Figure 3.1. 
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Figure 3.5: Overlayed 1H NMR spectra of 8-Phe-4-based functional PEAs. Note that 
the unlabeled peaks above correspond to the peaks labeled in Figure 3.2. 
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Figure 3.6: Overlayed 1H NMR spectra of 8-Phe-8-based functional PEAs. Note that 
the unlabeled peaks above correspond to the peaks labeled in Figure 3.3. 
As with the non-functional PEAs, the thermal properties of the functional PEAs were 
investigated. Thermogravimetric analyses were conducted to determine whether the 
incorporation of the lysine had an impact on the thermal decomposition of the PEAs. 
Representative thermographs are shown in Figure 3.7, Figure 3.8 and Figure 3.9. The 
introduction of the BOC-protected lysine monomer in 8-Phe-4 for example, results in 
decomposition around 250°C (Figure 3.8), which may be attributed to the thermal 
cleavage of the BOC group.24 In the deprotected case, thermal degradation occurs closer 
to 220°C. In comparing these two cases, the weight loss is approximately the same 
indicating that this loss could in fact be due to the TFA salt. Thus the incorporation of the 
lysine monomer has little impact on the thermal degradation of the PEA backbone. 
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Figure 3.7: Overlayed TGA thermographs of 8-Ala-8-based functional PEAs. 
 
Figure 3.8: Overlayed TGA thermographs of 8-Phe-4-based functional PEAs. 
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Figure 3.9: Overlayed TGA thermographs of 8-Phe-8-based functional PEAs. 
As observed with the thermogravimetric analyses, the glass transition temperatures of the 
functional PEAs were also influenced by the incorporation of the protected and 
deprotected lysine residues, as shown in Figure 3.10, Figure 3.11 and Figure 3.12. Again, 
using 8-Phe-4 as an example, the glass transition temperature decreased from 39 to 38°C 
with 10 mol% BOC-protected lysine incorporated, indicating the additional free volume 
created by the functional handle mitigated the bulkiness of the BOC group. Upon 
cleavage of the BOC group, yielding the TFA salt, the Tg increased to 44°C, suggesting 
potential intra- and intermolecular hydrogen bonding further inhibiting rotation of the 
functional handles. 
97 
 
 
 
Figure 3.10: Overlayed DSC traces of 8-Ala-8-based functional PEAs. 
 
Figure 3.11: Overlayed DSC traces of 8-Phe-4-based functional PEAs. 
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Figure 3.12: Overlayed DSC traces of 8-Phe-8-based functional PEAs. 
In addition to having an effect on the thermal properties of the PEAs, the incorporation of 
lysine also impacted the molecular weights of the functional PEAs. As shown in Figure 
3.13, Figure 3.14 and Figure 3.15 and tabulated in Table 3.2, the molecular weights of the 
functional PEAs are lower than their corresponding non-functional PEAs, which may be 
attributed to the fact that the BOC-protected lysine monomer did not react as readily as 
the other monomers. However, the molecular weights of those PEAs synthesized from an 
interfacial polycondensation were again all higher than their solution counterparts, as 
observed in the non-functional PEAs. Also observed from Table 3.2 is that upon cleavage 
of the BOC protecting group with TFA, there is a reduction in the molecular weight of 
the functional PEAs, presumably from cleavage of the PEA backbone. In our studies, a 
reduction in Mw between 23% and 48% was observed. Molecular weight reduction in 
functional PEAs following protecting group removal has been previously reported.26,45 In 
Deng et al.,26 when a comparable L-lysine content to our study was incorporated into the 
PEAs, the authors observed over a 70% reduction in molecular weight following 
deprotection of the carboxybenzyl (CBZ) groups, yielding molecular weights under 20 
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kDa. These authors also observed greater cleavage with increasing L-lysine content. More 
recently, other approaches including the use of unsaturated PEA backbones46 or allyl 
glycine14 monomers followed by thiol-ene chemistry have been used to introduce pendant 
functional handles to PEAs. While these approaches circumvent the need for protection 
and deprotection of functional amino acids, the coupling of organic thiols results in loss 
of biomimicry of the PEA. Also, the high cost of the allylglycine monomer would make 
this approach costly to scale up. By careful selection of the monomers and employing 
interfacial polymerization, the present study provides a means to prepare both non-
functional and functional PEAs of high purities and molecular weights, with low glass 
transition temperatures and thermal processability. All of these properties are desirable in 
a vascular biomaterial. 
Table 3.2: Comparison of solution and interfacial polycondensation of 
functionalized PEAs. 
PEA† Yield 
(%) 
Subst. 
(%) 
Mn 
(g/mol) 
Mw 
(g/mol) PDI Tg (°C) Td (°C) 
8-Ala-8-Lys(BOC)-4-Sol 34 11 19,000 28,700 1.51 15.1 231 
8-Ala-8-Lys(BOC)-4-Int 40 12 29,500 47,600 1.61 15.8 252 
8-Ala-8-Lys(TFA)-4-Int 75 10 17,000 30,000 1.76 15.4 182 
8-Phe-4-Lys(BOC)-4-Sol 52 13 48,800 73,900 1.51 39.8 247 
8-Phe-4-Lys(BOC)-4-Int 57 13 73,400 122,000 1.66 37.9 252 
8-Phe-4-Lys(TFA)-4-Int 65 13 27,600 63,500 2.30 43.5 219 
8-Phe-8-Lys(BOC)-4-Sol 41 10 38,100 49,800 1.31 23.4 277 
8-Phe-8-Lys(BOC)-4-Int 57 11 52,400 91,200 1.74 24.2 295 
8-Phe-8-Lys(TFA)-4-Int 62 13 41,600 70,500 1.70 24.5 215 
† As the interfacial method proved to be more effective in providing higher molecular 
weights, only those PEAs prepared interfacially were deprotected and characterized. 
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Figure 3.13: Overlapped GPC chromatographs of 8-Ala-8-based functional PEAs. 
 
Figure 3.14: Overlapped GPC chromatographs of 8-Phe-4-based functional PEAs. 
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Figure 3.15: Overlapped GPC chromatographs of 8-Phe-8-based functional PEAs. 
3.4.4 Vascular Smooth Muscle Cell Attachment and Proliferation 
To fully assess these PEAs as potential materials for vascular tissue engineering, their 
interactions with human coronary artery smooth muscle cells (HCASMCs) were studied. 
Firstly, insight into which PEA would best support HCASMC attachment and spreading 
was sought from the cellular interactions with the bare non-functional PEAs. Because 
interfacial polycondensation resulted in higher molecular weight for both the non-
functional and functional PEAs required of vascular tissue engineering applications, only 
data from those PEAs produced from an interfacial polymerization were included in the 
remaining study. Initially, a time-course analysis of HCASMC attachment and spreading 
was studied using phase contrast microscopy up to one week of culture to assess whether 
the bare PEAs could support HCASMCs (Figure 3.16). Cell spreading was observed on 
all PEAs and were similar to that of fibronectin (FN)-treated surfaces at 24 hours (panels 
I and M). Given that HCASMCs were sparsely seeded (2,000 cells/cm2), these images 
illustrate that HCASMC attachment and spreading is directly on the surface of PEAs 
rather than on the surface of another cell. Furthermore, the surfaces were not treated with 
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extracellular matrix (ECM) protein indicating acceptable HCASMC interactions with the 
PEAs themselves. HCASMCs remained well spread up to 7 days of culture. The phase 
contrast micrographs for the functional PEAs, namely 8-Phe-4-Lys(TFA)-4-Int and 8-
Phe-4-Lys(TFA)-4-Int appeared to be somewhat diffuse due to the rough surface texture 
of these PEAs, but individual spread cells are clearly visible. 
 
Figure 3.16: Time-course phase contrast micrographs of HCASMCs seeded at 2,000 
cells/cm2 at 24 hours and 7 days on glass coverslips (A, E), FN-coated coverslips (I, 
M), non-functional PEAs: 8-Ala-8-Int (B, F), 8-Phe-4-Int (C, G) and 8-Phe-8-Int (D, 
H). The phase contrast micrographs of the corresponding lysine-functionalized 
PEAs: 8-Ala-8-Lys(TFA)-4-Int, 8-Phe-4-Lys(TFA)-4-Int and 8-Phe-8-Lys(TFA)-4-
Int are shown in panels (J, N), (K, O), and (L, P) at 24 hours and 7 days 
respectively. HCASMCs were uniformly spread on all PEA surfaces. Scale bar = 
200 µm. 
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The cell attachment and spreading data observed in the phase contrast images of 
HCASMC were confirmed by quantifying cell viability. The optical density results of the 
MTT assay on the PEAs are provided in Figure 3.17. For the non-functionalized PEAs 
(Figure 3.17A), cellular growth and survival on each PEA film was significantly greater 
at each time point than on the tissue culture polystyrene (TCPS), which served as the 
control. Given that TCPS is a well established cell culture substrate, it is interesting to 
note that the bare PEAs showed increased cell viability even at 1 day of culture. 
Moreover, there was no delayed toxicity as cell viability continued to increase up to 5 
days of culture, suggesting the potential use of these PEAs for long-term cell cultures 
needed in vascular tissue engineering strategies. In fact, a statistically significant (p < 
0.01) increase in cell viability was observed between day 3 and day 5 cultures on both 8-
Phe-4-Int and 8-Phe-8-Int indicating these PEAs also support HCASMC proliferation.  
 
Figure 3.17: HCASMC viability as determined by MTT assay. Cells were seeded at 
20,000 cells/cm2 on TCPS (control) and non-functional (A) and functionalized (B) 
PEAs and measured following 1, 3 and 5 days of culture. Data are expressed as 
mean ± standard deviation for three independent experiments conducted in 
triplicate. Statistical significance, denoted by *, is observed between all non-
functional PEAs and TCPS at each day (p < 0.01). 
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Cell viability was also carried out for the corresponding lysine-functionalized PEAs. As 
the data in Figure 3.17B indicate, at day 1, cell viability on PEAs based on phenylalanine 
(8-Phe-4-Lys(TFA)-4-Int and 8-Phe-8-Lys(TFA)-4-Int) was significantly higher than 
both the TCPS and the alanine-based PEA (p < 0.001). This result is consistent with the 
non-functional counterparts (Figure 3.17A). For both day 3 and 5 cultures, 8-Ala-8-
Lys(TFA)-4-Int was significantly lower than the phenylalanine-based functional PEAs. 
At day 5, cell proliferation on all functional PEAs was significantly lower than TCPS 
indicating that for HCASMCs seeded on functionalized PEAs, metabolic events do not 
seem to lead to robust cell growth. Statistical analysis (p < 0.01) of cell viability on each 
functional PEA as a function of culture time, however, showed significant cell growth 
suggesting that cells were growing on the functional PEAs, but that the rate is lower than 
on TCPS. Given that the functionalized PEAs were positively charged, we anticipated 
comparable cell viability results to TCPS which is also positively charged. This, 
however, was not the case presumably due to the effect of the TFA salt, which has been 
reported to retard cell growth and viability.47 Collectively, these results are promising as 
they suggest that the current PEAs can support HCASMC attachment, spreading and 
proliferation without modification with cell adhesive proteins. Although the current cell 
work is focused on understanding the interactions of the HCASMCs, our long-term goal 
is to utilize the functionalized PEAs for conjugating biomolecules that regulate cell 
growth, differentiation, and signaling pathways which may ultimately determine the 
success of engineered vascular tissues. Previous work in our group has shown that the 
pendant amine groups of PEAs containing lysine can be conjugated to molecules using 
standard reagents.23-24 
Although HCASMC viability data on degradable PEAs is not available in the literature, 
bovine aortic endothelial cell (BAEC) and fibroblast growth on different PEAs was 
recently reported.32,48 The data, however, showed that BAEC growth was slower than the 
control32 whereas in the other study, it was similar to the control material used.48 In 
another study, enhanced cell viability of gelatin-coated PEAs was also reported,26 but 
unlike our study, cells were not exposed directly to the PEA surface making direct 
comparison difficult. 
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Our data (Figure 3.16 and Figure 3.17) showed that without surface modification, 
HCASMC attachment and proliferation on the PEAs was encouraging. In order to gain 
information on the cytoskeletal organization, staining for filamentous actin (F-actin), 
vinculin and smooth muscle α-actin cell marker protein expression was examined. F-actin 
serves as the building block necessary for cell motility,49 thus its qualitative intercellular 
abundance and organization on all PEAs was examined. As shown in Figure 3.18, 
HCASMCs adhered to the current PEAs with abundant F-actin expression regardless of 
the PEA chemical composition. At 24 h culture, all cells seeded on PEAs had spread 
similar to the FN-coated coverslip positive control (Figure 3.18 I). However, at day 7, 
cells on the positive control surface appeared to be better aligned (Figure 3.18 M) while 
the cells on the functionalized PEAs remained randomly oriented. 
The adhesion of cells to a biomaterial is the first event in tissue engineering. Subsequent 
cellular events such as differentiation and ECM secretion depend on this critical event. 
Cells seeded on materials that cannot present specific ligand to integrins adhere by non-
specific adhesive forces. Vinculin is a cytoskeletal protein associated with cell-cell and 
cell-matrix adhesions by anchoring F-actin to the membrane. To gain information on the 
level of focal contacts, we labeled cells with antibodies to vinculin. The results shown in 
Figure 3.19 (A-D; I-L) suggest that cells started to form focal attachment sites (shown by 
the arrowhead as the red tip in the periphery of the cells). 
In addition to cell attachment, spreading and viability, vascular tissue engineering 
requires that cells be given a more specific level of instruction so that tissue fabrication is 
successful. In this regard, regulation of vascular smooth muscle cell (VSMC) phenotype 
is important. VSMCs are not terminally differentiated and are able to modulate their 
phenotype in response to changing environmental cues. During tissue generation and 
maturation, a synthetic VSMC phenotype is beneficial for cellular proliferation and ECM 
secretion, which is achieved through the rapid up-regulation of genes required for 
proliferation including matrix metalloproteinases and l-caldesmon, while suppressing the 
expression of genes that define the contractile phenotype.41 Conversely, in a contractile 
phenotype, VSMCs have a relatively low proliferative activity and produce only small 
amounts of ECM proteins while robustly expressing contractile cytoskeletal marker 
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proteins such as smooth muscle α-actin (SMαA) and contract in response to electrical, 
chemical and mechanical stimuli.50 To obtain preliminary information on the state 
HCASMC differentiation, we stained 7 day cultures for SMαA. The immunofluorescence 
images illustrates that the expression of SMα-actin on all PEAs was not abundant (Figure 
3.19 E-H; M-P) suggesting a proliferative-type smooth muscle cell phenotype. Taken 
together, these data suggest the current PEAs support HCASMC attachment, spreading, 
proliferation, vinculin expression and a proliferative-type smooth muscle cell phenotype 
that warrants further investigation of these functional PEAs for vascular tissue 
engineering applications. 
 
Figure 3.18: Confocal microscopy images of HCASMCs seeded at 2,000 cells/cm2 at 
24 hours and 7 days on non-functional (B-D, F-H) and lysine-functionalized (J-L, N-
P) PEAs and labeled for F-actin (green) and nuclei (blue). At longer culture times, 
cells on the FN-coated control appeared to be better aligned (M); whereas, on the 
functionalized PEAs, cells were randomly oriented. Scale bar = 50 μm. 
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Figure 3.19: Immunofluorescence microscopy images of HCASMCs after 24 hours 
and 7 days culture on non-functional and lysine-containing functional PEAs. 
HCASMCs were stained for F-actin (green), vinculin (A-D and I-L; shown by the 
arrowhead; red), smooth muscle α-actin (E-H and M-P; red) and nuclei (blue). Scale 
bar = 50 μm. 
3.5 Conclusions 
A series biodegradable of PEAs was synthesized from the α-amino acids L-alanine, L-
phenylalanine and L-lysine. To prepare high molecular weight PEAs that can be used for 
vascular tissue engineering applications, both solution and interfacial polymerization 
methods were investigated. All PEAs prepared by interfacial polycondensation gave 
higher molecular weights compared with their solution polymerization counterparts. The 
synthesized PEAs had glass transition temperatures ranging from 10 to 40°C, indicating 
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their pliability under physiologic conditions. HCASMC attachment and spreading was 
observed on all PEAs up to 7 days of culture, while cell viability was significantly higher 
on all non-functional PEAs than TCPS. The trifluoroacetic acid salt of the lysine-
containing functional PEAs supported HCASMC, but retarded cell growth when 
compared to TCPS. Immunostaining of cells illustrated strong vinculin expression on all 
surfaces; however, smooth muscle α-actin expression was not abundant suggesting a 
proliferative smooth muscle cell phenotype. Collectively, this study shows that all PEAs 
are good candidates as vascular biomaterials as they support HCASMC attachment, 
spreading and proliferation. Specifically, 8-Phe-4-Lys(TFA)-4-Int and 8-Phe-8-
Lys(TFA)-4-Int are more attractive since the pendant functional groups enable the 
conjugation of molecules that regulate cell growth, differentiation, and signaling 
pathways. Future work will focus on both mechanical properties and detailed cellular 
responses to 3D scaffolds of these functional PEAs. 
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Chapter 4  
4 Focal Contact Formation of Vascular Smooth Muscle 
Cells on Langmuir-Blodgett and Solvent Cast Films of 
Biodegradable Poly(ester amide)s†
This chapter examines the adhesion of human coronary artery smooth muscle cells on 
two-dimensional PEA films. Ultrathin films prepared by Langmuir-Blodgett technology 
were prepared on waveguides, which enabled the observation of close and focal contacts 
between the smooth muscle cells and the PEA surface using waveguide evanescent field 
fluorescence (WEFF) microscopy. The data was then compared to conventional 
immunostaining of focal adhesions. 
 
4.1 Abstract 
The ability of biomaterials to support the adhesion of cells is a necessary condition for 
their use in scaffold-guided tissue engineering. Waveguide evanescent field fluorescence 
(WEFF) microscopy is a relatively new microscopic technique that allows the number of 
cell adhesions to a waveguide surface be measured by imaging the interfacial contact 
region between the cells and their substratum. In this work, the adhesion of human 
coronary artery smooth muscle cells (HCASMCs) to ultrathin films (20 nm) of poly(ester 
amide)s (PEAs) prepared by Langmuir-Blodgett (LB) technology on waveguides was 
investigated and compared with conventional vinculin immunostaining on solvent cast 
PEA films. Cell culture was conducted both in the presence and absence of serum to 
evaluate the effect of non-specific protein adsorption that mediates cell adhesion. WEFF 
microscopy analyses revealed that the cationic PEA enhanced the number of attachment 
sites compared with the control waveguides regardless of the culture medium. Although 
differences in cell adhesions between different PEAs were suggested by the results, no 
statistically significant differences were found. Similar results were observed with 
                                                 
† A version of this chapter has been published. Reprinted (adapted) with permission from (Knight, D.K.; 
Stutchbury, R.; Imruck, D.; Halfpap, C.; Lin, S.; Langbein, U.; Gillies, E.R.; Mittler, S.; Mequanint, K. 
ACS Applied Materials & Interfaces 2012, 4, 1303-1312). Copyright (2012) American Chemical Society. 
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presently and previously reported vinculin immunostaining studies, further validating the 
use of WEFF microscopy to quantify cell adhesions. Moreover, the focal adhesions of the 
HCASMCs to the PEA surfaces indicate these PEAs can promote integrin signaling, 
which is vital in cell survival, migration and proliferation and ultimately in scaffold-
guided vascular tissue engineering. 
Key words: Waveguide evanescent field fluorescence (WEFF) microscopy, Langmuir-
Blodgett (LB) films, poly(ester amide)s (PEAs), human coronary artery smooth muscle 
cells (HCASMCs), vinculin immunostaining, focal adhesions. 
4.2 Introduction 
With the aim to successfully engineer scaffold-guided tissues, there is an ever-increasing 
interest in the interactions of cells with both synthetic and natural biomaterials.1-2 When 
cells are seeded onto a biomaterial, both non-specific and receptor-mediated cell 
interactions between various molecules on the cell membrane and chemical groups on the 
biomaterial determine the fate of cell adhesion, spreading, proliferation and 
differentiation.3 In view of this, the study of the contact regions between a cell and its 
substratum is of considerable interest as its investigation provides useful information 
about the cytocompatibility of the substratum and the affinity of cells towards that 
particular surface. While information concerning these interactions is often inferred from 
enzyme-linked immunosorbent assays (ELISA) and immunostaining of focal adhesion 
molecules,4 different microscopic techniques such as total internal reflection fluorescence 
(TIRF),5-6 surface plasmon resonance microscopy (SPRM),7 interference reflection 
microscopy (IRM)8 and fluorescence interference-contrast (FLIC) microscopy9 have also 
been used. 
Recently, waveguide evanescent field fluorescence (WEFF) microscopy was developed 
with the capability to image cell-substratum contact regions with certain advantages.10-15 
In WEFF microscopy, waveguides are implemented as microscopy substrates. The 
generation of an evanescent field of up to ~70 nm in depth from the waveguide surface 
enables the excitation of fluorescent dyes located in the cells within this range only. Due 
to evanescent field decay beyond ~70 nm, the remainder of the cell is not illuminated and 
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thus does not contribute to the image. It has been established that WEFF and TIRF 
microscopy can deliver comparable information.13 However, the key advantages of 
WEFF microscopy are that biomaterials can be easily coated on to the surface of the 
waveguide and that the user can freely choose the field of view and the magnification 
during an experiment.12,14 As WEFF microscopy restricts the distance above the 
waveguide to ~70 nm, it necessitates the fabrication of ultrathin films of the material 
being tested for cell adhesion. 
The objectives of the present work were two-fold: (i) to prepare Langmuir-Blodgett (LB) 
films from three different poly(ester amide)s (PEAs) on waveguide substrates and, (ii) to 
describe the use of WEFF microscopy for investigating human coronary artery smooth 
muscle cell (HCASMC) adhesions on LB PEA films to compare it with a conventional 
immunostaining approach. The class of biodegradable PEAs used in this study is of 
significant interest for the development of a wide range of biomedical applications as the 
incorporation of naturally occurring α-amino acids enables the syntheses of functional 
biomimetic materials. Recently, our group has been investigating the potential of PEAs to 
serve as vascular tissue engineering scaffolds.16-17 The favourable interaction of 
HCASMCs with these materials will be a necessary condition in enabling the attachment, 
proliferation, and differentiation of cultured cells. While a number of classes of PEAs 
have been previously reported,18-20 the particular PEAs of interest in this work are 
composed of α-amino acids, diols and dicarboxylic acids. As their backbones contain 
both ester and amide linkages they can undergo both hydrolytic and enzymatic 
degradation where suitable monomer selection can provide non-toxic metabolic 
intermediates upon degradation. Another attractive feature of these PEAs is that their 
biological and mechanical properties can be readily tuned by the crystallinity, 
hydrophobicity and chemical functionality of their constituent monomers.21 In the current 
study, Langmuir-Blodgett (LB) technology was used to prepare ultrathin films of three 
different PEAs on waveguide substrates and the average number of cell adhesions (focal 
and close contacts) formed by HCASMCs were determined as a function of the polymer 
structure and cell culture conditions. The data obtained from WEFF microscopy are 
compared with quantitative data obtained by immunostaining for vinculin, which is a 
116 
 
 
focal adhesion component localized to adhesive plaques. The attachment, spreading and 
morphology of HCASMCs on PEA films were also evaluated. 
4.3 Experimental 
4.3.1 Waveguide Evanescent Field Fluorescence (WEFF) 
Microscopy 
The WEFF microscope which is described elsewhere14 consists of an inverted 
microscope (Carl Zeiss, Oberkochen, Germany), where the specimen was placed on top 
of the waveguide. A HeNe laser (λ = 543 nm) was coupled into a waveguide mode by a 
grating located on the waveguide. In order to block the undesired excitation wavelength, 
a long pass filter with a cut-off wavelength of λcut-off = 560 nm was fitted between the 
objective and the camera. The camera was connected to the computer on which the 
images were processed with Image-Pro 6 software. Bright field microscopy images of the 
sample were captured with the same field of view as the WEFF microscopy images to 
enable counting of cells. 
4.3.2 Waveguide Fabrication 
Step-index waveguides were fabricated from SG11 glass slides (Schott, Grünenplan, 
Germany). The glass slides were first sonicated in a 2 % Hellmanex® solution (Hellma, 
Müllheim, Germany) in deionized (DI) water for 15 min and then rinsed followed by a 
further sonication with DI water. The rinse and sonication steps were repeated with 
anhydrous ethanol. Following this cleaning procedure, the glass slides were placed in 
molten AgNO3 (EMD Chemicals, Gibbstown, NJ) in a tube furnace (Yokogawa Meters 
and Instruments Corporation, Tokyo, Japan). This enabled ion exchange to occur at the 
interface of the glass slide and molten salt. After ion exchange, the glass slides were 
removed from the melt, cooled with nitrogen gas under ambient conditions, thoroughly 
rinsed and sonicated for 30 min in Milli-Q water.13 A waveguide mode coupling grating 
was fabricated by a holographic laser set-up in photoresist.22 Multimode waveguides with 
thicknesses of 500-600 nm and gratings with periodicities (Λ) in the order of 530-550 nm 
and 600-650 nm were achieved. 
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4.3.3 Preparation of Ultrathin Langmuir-Blodgett (LB) Poly(ester 
amide) (PEA) Films for Cell Culture 
The syntheses and characterization of the PEAs are described elsewhere.17 PEAs 
(Scheme 4.1) were dissolved in chloroform at a concentration of 1.0 mg/mL. The 
solutions were sonicated to promote dissolution and then filtered through a 0.2 µm 
syringe filter. The LB film preparation parameters were identical for all PEAs - LB 
trough: KSV 3000 (KSV Nima, Espoo, Finland); spread volume: 200 µL; compression 
rate: 5 mm/min; film lift speed: 2 mm/min; and surface pressure (∏) at deposition: 2 
mN/m. The substrates used for film transfer were the waveguides, which were first 
cleaned with 70% ethanol followed by a rinse with milliQ water. The waveguides were 
mounted in the water phase of the trough before spreading the polymer solution. The 
polymer solution was then carefully spread onto the milliQ water subphase with a 
Hamilton microliter syringe. After solvent evaporation, the barriers were moved to 
achieve a surface pressure of 2 mN/m. The LB transfer took place with the waveguide 
substrate oriented perpendicular to the barrier direction, to allow for stretching of the 
aggregates. 
4.3.4 LB Film Characterization 
LB films prepared from PEAs were viewed under dark-field light microscopy 
(Axioskope-2 MAT, Carl Zeiss, Oberkochen, Germany) to examine the homogeneity of 
the films before cell seeding and culturing. Film thicknesses were determined by 
interference between light reflecting from the surface and light traveling through the film 
using variable angle spectroscopic ellipsometer (M2000V, J.A. Woollam, Lincoln, NE). 
For comparative purposes film thicknesses were also measured by Dektak 3 surface 
profilometer and Atomic Force Microscopy (AFM) (both from Veeco Instruments, Santa 
Barbara, CA). 
4.3.5 Cell Culture 
Primary HCASMCs were purchased from Lonza Walkersville, Inc. (Walkersville, MD) 
and used between passages 5 and 9. HCASMCs cultured in serum were grown in smooth 
muscle cell basal medium (SmBM, Lonza Walkersville, Inc., Walkersville, MD) 
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supplemented with smooth muscle cell growth medium-2 (SmGM-2, SingleQuots; Lonza 
Walkersville Inc., Walkersville, MD). HCASMCs cultured in the absence of serum were 
grown in BioWhittaker PC-1TM base medium (Lonza Walkersville, Inc., Walkersville, 
MD) supplemented with PC-1TM sterile supplement (Lonza Walkersville Inc., 
Walkersville, MD) and L-glutamine (2 mM, Invitrogen Canada Inc., Burlington, ON). All 
cultures were maintained at 37°C in a humidified incubator containing 5% CO2. Culture 
media was replaced at day 1 and every other day thereafter. 
4.3.6 Cell Culture for WEFF Microscopic Analysis 
Waveguides were immersed in 70% ethanol for 30 min and were allowed to dry for 30 
min under germicidal UV light. HCASMCs were then seeded directly onto the surface of 
the PEA LB films or control waveguides at a density of 10,000 cells/waveguide and 
cultured up to 80% confluency (typically for 3 or 4 days). The cells were fixed at ambient 
temperature for 10 min in 4% formaldehyde (0.5 mL; EMD Chemicals, Gibbstown, NJ) 
in phosphate-buffered saline (PBS), followed by 2 washes in PBS. The cell membrane 
labeling solution was prepared by adding 5 µL of the lipophilic dye solution – 1,1'-
dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate in ethanol (Vybrant® DiI 
cell-labeling solution, Invitrogen Canada Inc., Burlington, ON) to 1 mL of normal growth 
medium. The labeling solution (100 μL) was added and gently agitated to cover the cell-
seeded waveguides and then incubated at 37°C for 20 min. The staining medium was 
then drained off and replaced with fresh media and incubated for a further 10 min. The 
cells were washed three times with normal growth medium prior to microscopic analysis.  
4.3.7 Fluorescence Microscopy 
Polymer films were obtained by twice dip-coating 12 mm diameter glass coverslips into 
1% (wt) solutions of the PEAs in DMF and were dried at 60°C under reduced pressure 
overnight. One glass coverslip was placed in each well of a 24-well culture plate. The 
films were sterilized with 70% ethanol for 30 min and then exposed to germicidal UV for 
1 h, prior to conditioning overnight in Hank’s Balanced Salt Solution (HBSS, 0.5 mL; 
Invitrogen Canada Inc., Burlington, ON). For examining HCASMC morphology, the 
HCASMCs were seeded directly on the surface of the dip-coated PEA films at a density 
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of 15,000 cells/cm2 and cultured in the presence of serum for 24 h prior to fixation and 
staining as described below. For vinculin immunostaining studies, natural, human 
fibronectin (FN, 2 µg/cm2; Santa Cruz Biotechnology Inc., Santa Cruz, CA) in HBSS was 
adsorbed to glass coverslips for 1 h and the resulting surfaces served as positive controls. 
All cells were seeded directly on the surface of the PEA or FN coated coverslips at a 
density of 2,000 cells/cm2 and cultured in the presence or absence of serum for 24 h 
(serum) or 4 days (serum-free). Cells were washed with pre-warmed PBS before fixation 
with a 4% formaldehyde solution (1 mL; EMD Chemicals, Gibbstown, NJ) in divalent 
cation-free PBS at ambient temperature for 10 min. Following 3 washes in PBS, 
HCASMCs were permeabilized with 0.1% Triton X-100 (0.5 mL; VWR International, 
Mississauga, ON) in PBS for 5 min and again washed 3 times with PBS. The HCASMCs 
were incubated with 1% bovine serum albumin (BSA) in PBS (0.5 mL; Sigma-Aldrich, 
Oakville, ON) for 30 min at ambient temperature prior to their incubation with 
monoclonal anti-vinculin (SPM227, 1:50 dilution; Abcam, Cambridge, MA) for 1 h. 
Following 3 washes in PBS, the HCASMCs were then incubated in the dark for 1 h at 
ambient temperature with Alexa Fluor® 488-conjugated goat anti-mouse IgG (1:300 
dilution; Invitrogen Canada Inc., Burlington, ON). Following 3 washes in PBS, the 
HCASMCs were further incubated in the dark at ambient temperature with Alexa Fluor® 
568-conjugated phalloidin (1:50 dilution; Invitrogen Canada Inc., Burlington, ON) for 20 
min in a 1% BSA/PBS solution followed by another 3 washes with PBS. The HCASMCs 
were then counterstained with 4’-6-diamidino-2-phenylindole dihydrochloride (DAPI, 
300 nM in PBS, 0.5 mL; Invitrogen Canada Inc., Burlington, ON) for 10 min to label the 
nuclei and again washed 3 times with PBS. The coverslips were mounted on microscope 
slides with ProLong® Gold antifade reagent (Invitrogen Canada Inc., Burlington, ON), 
dried overnight at room temperature in the dark, prior to sealing with nail enamel. 
Samples were analyzed with a Zeiss LSM 5 Duo confocal microscope with 9 laser lines 
and appropriate filters (Carl Zeiss, Oberkochen, Germany). 
4.3.8 Statistical Analyses 
The statistical data are given as the mean ± standard error for experiments conducted at 
least in triplicate. Differences between two groups were compared using a two-tailed 
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unpaired student’s t-test with GraphPad Prism 4, where values of p < 0.05 were 
considered statistically significant. 
4.4  Results and Discussion 
While a diverse array of PEAs have been previously reported by our group16-17,21,23 and 
others24-28 and recently reviewed,29 The PEAs depicted in Scheme 4.1 were selected for 
this investigation. This was in part due to their solubility in chloroform, a solvent 
compatible with LB technology; whereas, many previously synthesized PEAs are only 
soluble in water-miscible solvents such as N,N-dimethylformamide (DMF).30 In addition, 
these PEAs are currently under investigation in our group as viable materials for the 
development of tissue engineering scaffolds. The PEAs all contain sebacic acid and L-
phenylalanine. 8-Phe-4-Sol contains 1,4-butanediol, while 8-Phe-8-Int contains 1,8-
octanediol and is therefore slightly more hydrophobic. In 8-Phe-8-Lys(TFA)-4-Int, 10 
mol% of the L-phenylalanine was randomly substituted with L-lysine. This PEA was of 
interest because the cationic amines of the lysine moieties could be used to promote cell 
adhesion31 or to conjugate biomolecules that regulate cell growth, differentiation and 
other signaling pathways.32 
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Scheme 4.1: Chemical structures of the selected PEAs. 
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The molecular weight data of the specific batches of PEAs used in this study are provided 
in Table 4.1. 
Table 4.1: Molecular weight and polydispersity indices of the selected PEAs. 
PEA 
Number Average 
Molecular Weight 
(Mn, g/mol) 
Weight Average 
Molecular Weight 
(Mw, g/mol) 
Polydispersity 
Index 
8-Phe-4-Sol 53,500 103,000 1.92 
8-Phe-8-Int 65,600 89,100 1.36 
8-Phe-8-Lys(TFA)-4-Int 20,700 44,700 2.15 
Given that the evanescent field decays beyond 70 nm, the polymer film thickness needed 
to be less than 20 nm to observe cell adhesion to the various PEA surfaces. This film 
thickness could not be achieved by solvent casting. Alternatively, spin coating was 
attempted, but also proved unsuccessful because the gratings on the waveguides were 
undesirably covered by the PEA films. The above difficulties were addressed by using 
LB technology to obtain ultrathin PEA films (Table 4.2). Polymers are used in LB 
technology despite their long chains, inherent polydispersity, high viscosity, and strong 
intra- and intermolecular interactions. For example, intra- and intermolecular hydrogen 
bonding of the amide groups of these PEAs could potentially lead to aggregate 
formation.33 As aggregates deposited onto the waveguide at low pressure can result in the 
formation of a non-closed and non-uniform film, each PEA solution was transferred to 
the waveguide perpendicular to the barrier direction. This technique facilitated stretching 
of the aggregates minimizing inhomogeneities in the PEA film transfer, which otherwise 
could result in uncoated areas on the waveguide. Despite this approach to minimize 
inhomogeneities in preparing LB films of the PEAs, those prepared from DMF resulted 
in aggregation and inhomogeneous distribution over the substrate as evidenced by the 
clustering of bright spots in Figure 4.1B. This is attributed to DMF’s slow evaporation 
and miscibility with the subphase. However, PEA LB films obtained from a chloroform 
solution were more evenly distributed on the subphase and the films formed more 
homogeneously as the scattering spot distribution shows (Figure 4.1C). Unlike typical LB 
monolayers, when the PEAs were compressed by the barriers they did not collapse, even 
when the barriers were near complete closure. This is evident in the isotherm as depicted 
for 8-Phe-4-Sol in Figure 4.1D, which has no steep decline or peak corresponding to a 
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collapse of the solid phase at small mean molecular areas. Similar isotherms were 
obtained with 8-Phe-8-Int and 8-Phe-8-Lys(TFA)-4-Int as seen in Figure 4.1(E) and (F). 
Further compression led to an undesirable thick smear between the barriers of the LB 
trough resulting from stacked PEA chains. Consistent with the present study, such 
stacked and non-collapsing films at increased compression (corresponding to small mean 
molecular areas) were also reported for collagen.34 
 
Figure 4.1: Dark-field microscopy images of a bare waveguide (A), LB film of 8-
Phe-4-Sol obtained using DMF (B), LB film of 8-Phe-4-Sol obtained using 
chloroform (C). Surface pressure isotherms for 8-Phe-4-Sol (D), 8-Phe-8-Int (E) and 
8-Phe-8-Lys(TFA)-4-Int (F) from a solution in chloroform (D). Scale bar applicable 
to A, B and C represents 200 µm. 
Not surprisingly, these PEA LB films did not perform like classic LB films. Aggregates 
were visible on the subphase which may have been the result of strong intra- and 
intermolecular interactions (Figure 4.1B and C). These aggregates were floating into and 
upon each other, and the increase in the surface pressure during compression of the 
barriers was caused by an increase in packing density of the aggregates. An increase in 
the thickness of the film must be accompanied by this pressure increase. Therefore, when 
preparing LB films with these PEAs, the layer formed on the subphase is not a 
monolayer, but most likely a multilayer (Table 4.2).  
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Table 4.2. Film thicknesses of 8-Phe-4-Sol from different LB film preparation 
conditions. 
LB Film Preparation Conditions Film Thickness Roughness 
Spread 
volume 
(μL) 
Concentration 
(mg/mL) 
Surface 
Pressure 
(∏, mN/m) 
Ellipsometry 
(nm) 
Dektak 
(nm) 
AFM 
(nm) AFM (nm) 
300 1.0 5 14.4-14.6 16.9-17.9 - - 
300 1.0 10 15.8-16.0 11.0-12.0 - - 
300 0.5 10 13.0-16.0 - 12.0-14.0 0.28-0.45 
200 1.0 10 20.0-21.0 - 13.0-15.0 0.40-0.45 
Previously non-classic LB behavior with aggregate formation was observed for collagen 
due to strong intermolecular interactions. Since the spacer diol chain between the 
adjacent amide bonds is short for 8-Phe-4-Sol (Scheme 4.1) compared with 8-Phe-8-Int 
and 8-Phe-8-Lys(TFA)-4-Int, the formation of a multilayer rather than a monolayer is 
likely for 8-Phe-4-Sol. This increased density of amide bonds due to the short chain diol 
chain could yield more hydrogen bonding and an increase in film viscosity. In contrast, 8-
Phe-8-Int and 8-Phe-8-Lys(TFA)-4-Int have a longer diol chain and therefore have fewer 
possibilities for intra- and intermolecular hydrogen bonding resulting in less viscous 
films. In addition to this longer diol chain, 8-Phe-8-Lys(TFA)-4-Int has an L-lysine side 
chain that allows free rotation, resulting in weaker intermolecular bonding. As presented 
in Table 4.2, film thicknesses of LB films of 8-Phe-4-Sol were less than 20 nm when the 
spread volume was maintained at 300 µL. A surface pressure change from 5 mN/m to 10 
mN/m and a PEA concentration change from 0.5 mg/mL to 1 mg/mL did not have any 
appreciable effect on the film thicknesses. Although film thickness data varied between 
ellipsometry and AFM measurements for a spread volume of 200 µL, it appeared that a 
higher film thickness resulted from a lower spread volume, at least on the basis of the 
ellipsometry data. 
To examine and quantify HCASMC adhesion to these PEAs, two approaches were 
adopted – WEFF microscopy to observe cell adhesion to the substratum and vinculin 
immunostaining to illustrate possible integrin-mediated HCASMC focal adhesion. For 
WEFF microscopy analyses, cells were grown on LB films until 80% confluent (typically 
3-4 days). The LB technology for film formation was necessary because the total 
thickness of the PEA film and the cell membrane should not exceed the penetration depth 
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of the evanescent field of the manufactured waveguides, which decays within roughly 70 
nm. By staining the cell membranes with the fluorescent dye, DiI, the areas of the cells 
that are closest to the surface of the waveguide, are the most strongly excited and 
fluorescent, while those areas outside the evanescent field do not fluoresce. In 
illuminating only this interfacial area, the number of attachment sites per HCASMC 
could then be determined by counting the bright spots appearing in the WEFF 
microscopy images using ImageJ software (National Institutes of Health, Bethesda, MD) 
and dividing it by the number of cells present. Figure 4.2 shows representative images of 
HCASMCs cultured on the control waveguide and PEA LB films taken with bright field 
and WEFF microscopy. In the bright field images (left), individual cells are well-spread. 
The white spots in the corresponding WEFF images (right) show the sites of cell 
attachment to the PEA LB films. The number of cells on the control waveguide (Figure 
4.2A and B) appeared to be lower than those on the PEA LB films suggesting that the 
PEAs provided a better environment for HCASMC attachment and spreading. The WEFF 
image of the control waveguide (Figure 4.2B) does not exhibit any epi-fluorescence 
because of the absence of the PEA film. The PEA films located in the area of the highest 
evanescent fields of the waveguide are the primary source of scattered excitation photons 
(compare with Figure 4.1C). These scattered photons can reach all areas of the cell, 
including those outside the evanescent field and excite fluorescence photons. While the 
WEFF images of the PEA-coated waveguides illustrate predominantly the evanescent 
information and hence the contact points of the cell, (Figure 4.2D, F, H), it could also 
show a nebulous background outlining the cell body due to this epi-fluorescence. Epi-
fluorescence which is also a common observation in TIRF can be removed from WEFF 
images by choosing smaller integration times, but the cell outline information will be 
lacking.13  
An analysis of the number of adhesions that the HCASMCs formed on both the control 
waveguide and PEA LB films was first conducted in the presence of serum in the culture 
media. As shown in Figure 4.3, few cell adhesion sites on the control waveguide were 
observed. Although the waveguide was not expected to be an ideal substrate for cell 
culture, the adsorption of proteins on a surface is often considered the first step towards 
the adhesion of cells on that surface.3 In particular, the serum used in cell culture contains 
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many cell adhesive proteins including fibronectin and vitronectin, which may promote 
the formation of differential focal adhesions.31 Therefore, the role of protein adsorption in 
the establishment of adhesions of HCASMCs on the waveguides was also evaluated by 
culturing cells in the absence of serum. On the control waveguides, this resulted in an 
average of 0.9 attachment sites per cell. This result was not statistically significant (p > 
0.05) from the serum-containing (S+) media study of 2.1 attachment sites per cell 
indicating protein adsorption did not play a significant role in HCASMC adhesion to the 
control waveguides. Moreover, the number of attachment sites in both S+ and S- control 
waveguides appeared to be lower than those obtained from immunostaining studies 
reported in the literature (at least 5-10 focal adhesions per cell) for various cell types on 
different materials.35-38 In generating a waveguide on the surface of a glass slide, low 
polarizability ions (sodium) are exchanged for high polarizability ions (silver) to enhance 
the refractive index on the surface. Given that the waveguide surfaces are silver ion-
exchanged, reduced attachment sites are attributed to residual silver ions which are 
known to reduce cell adhesion.39 However, the presence of the LB PEA films may have 
masked the detrimental effects of the residual silver ions on cell adhesion. In addition to 
focal adhesions, there is a potential for cells to also form non-focal contacts such as close 
contacts.38 Although close contacts typically range from 20 to 50 nm from the 
substratum, the ventral cell membrane of the HCASMCs may remain equidistant from 
the surface, as previously reported with retinal pigment epithelial cells,40 inhibiting 
effective isolation and segregation of individual close contacts, arbitrarily 
underestimating the number of cell attachment sites. We did not distinguish between 
focal contacts and close contacts as the distances of the individual contacts were not 
investigated in this study. 
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Figure 4.2: Bright field and corresponding WEFF microscopy images of HCASMCs 
seeded on the control waveguide (A and B) and LB films of 8-Phe-4-Sol (C and D), 
8-Phe-8-Int (E and F) and 8-Phe-8-Lys(TFA)-4-Int (G and H). HCASMCs were 
cultured until 80% confluent, fixed and stained using DiI prior to imaging. Scale 
bars represent 200 µm. 
Not only did the presence of serum not influence the number of attachment sites in the 
control waveguide, this behavior was also seen in all three PEA LB films as no statistical 
significance was observed among them (p > 0.05, Figure 4.3). In the S+ culture, 8-Phe-4-
Sol exhibited 15.3 ± 6 adhesions per cell, which was high but not significantly different 
from the control waveguide. 8-Phe-8-Int exhibited 27.2 ± 9 adhesions per cell suggesting 
that the increased hydrophobicity imparted by the longer chain diol created a more 
favourable environment for cell attachment, potentially due to increased protein 
adsorption. However, due to the relatively high standard error associated with the 
measurements, these results were not statistically different. 8-Phe-8-Lys(TFA)-4-Int 
containing the lysine moiety exhibited a similar number (28.7 ± 8) of cell adhesions to 8-
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Phe-8-Int, the same polymer lacking the incorporation of the lysine residues. While the 
presence of cationic lysine residues was expected to result in increased cell adhesion 
based on previous reports,31,41 the WEFF microscopy results suggest that the number of 
lysine moieties incorporated into these polymers may not have been sufficient to 
significantly increase the number of cell adhesion sites. However, the number of adhesion 
sites of the HCASMCs on 8-Phe-8-Lys(TFA)-4-Int in both S- and S+ culture was 
significantly higher than the control waveguides (p < 0.05). This result may indicate the 
cationic nature of the lysine residues of 8-Phe-8-Lys(TFA)-4-Int is engaged in non-
specific electrostatic binding with the negatively charged glycocalyx layer on the cell 
surface in the absence of serum. In S+ culture, the cationic amine groups of 8-Phe-8-
Lys(TFA)-4-Int may also bind electrostatically with cell adhesive proteins such as 
fibronectin or vitronectin, which carry net negative charges at physiologic conditions as 
their isoelectric points are 5.6-6.1 and 4.8-5.0 respectively, thereby also enhancing cell 
adhesion.31,42 Ultimately, the number of attachment sites observed in the comparative 
serum study, suggests that for all substrata, protein adsorption did not play a major role in 
the establishment of cell adhesions. 
 
Figure 4.3: Average number of attachment sites per cell on control waveguides and 
on PEA LB films cultured in serum-containing (S+) or serum-free (S-) media. * 
denotes statistical significance (p < 0.05). 
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After evaluating the potential use of WEFF microscopy for determining the number of 
cell attachment sites on PEA LB films, we compared the data with vinculin 
immunostaining, which is a well-established method for quantifying focal adhesions. To 
achieve this, HCASMCs were cultured on solvent cast PEAs films. Initially, a time-
course analysis was conducted using phase contrast microscopy to ensure HCASMC 
attachment and spreading on the solvent cast PEA films, prior to their immunostaining 
(Figure 4.4). In order to emulate the expected cell density on the waveguides after 3 or 4 
days culture, cells were seeded at 15,000 cells/cm2 on the solvent cast PEA films. Four 
hours after seeding, most cells adhered to the surface (including the glass coverslip 
control), but remained spherical in shape with little evidence of spreading (Figure 4.4A, 
D, G, J). However, after 8 hours, cell spreading was observed on all materials as judged 
by the flat morphology and larger contact areas occupied by individual cells (Figure 
4.4B, E, H, K). Given that the surfaces were not coated with cell adhesive proteins, the 
observed spreading is likely attributed to the surface adsorption of serum proteins from 
the culture media. To confirm this, we cultured cells in the absence of serum and 
evaluated cell spreading. The data (Figure 4.5 and Figure 4.6) suggest that cell 
attachment and spreading on the PEAs is retarded when compared with those cultured in 
the presence of serum as cell spreading only became evident at 24 hours of culture, 
presumably due to cell-secreted adhesive proteins. Although this was not entirely 
unexpected, it suggests that these PEAs can support attachment of HCASMCs even in the 
absence of serum. Complete HCASMC spreading and their cell-cell contact formation is 
seen following 24 hours of S+ culture as presented by the confocal microscopy images 
(Figure 4.4C, F, I, L). It is noted that favourable cell-substratum adhesion is required for 
subsequent cellular responses such as proliferation and differentiation. 
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Figure 4.4: Phase contrast and confocal microscopy images of HCASMCs cultured 
on PEA films. Cells were seeded at 15,000 cells/cm2 and cultured for up to 24 hours 
in serum-containing (S+) media. Phase contrast images were taken at 4 and 8 hours; 
whereas, the confocal microscopy images were taken after 24 hours of culture. 
HCASMC F-actin (green) and nuclei (blue) are shown in the confocal images (C, F, 
I, L). Phase contrast scale bar represents 200 μm, while confocal microscopy image 
scale bars represent 50 µm. Glass coverslips served as controls. 
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Figure 4.5: Phase contrast microscopy images of HCASMCs cultured on PEA films. 
Cells were seeded at 2,000 cells/cm2 and cultured for up to 24 hours in serum-
containing (S+) media. Scale bar represents 200 μm. Glass coverslips served as 
controls. 
Given that HCASMCs were well-spread on all PEA films after 24 hours, we then 
examined whether these cells could form focal contacts also known as focal adhesions 
(FAs), which are specialized sites of adhesion between the cell and the substrate. In 
addition to anchoring cells, focal adhesion proteins are involved in integrin signaling that 
activates various intracellular signaling pathways that direct cell viability, proliferation 
and differentiation. Although there are many proteins involved in FAs, vinculin is the 
most studied and well understood actin-binding protein;4,43 therefore, we immunostained 
for vinculin and quantified the number of HCASMC focal contacts. 
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Figure 4.6: Phase contrast microscopy images of HCASMCs cultured on PEA films. 
Cells were seeded at 2,000 cells/cm2 and cultured for up to 24 hours in serum-free 
(S-) media. Scale bar represents 200 μm. Glass coverslips served as controls. 
As shown in Figure 4.7, HCASMCs expressed vinculin in both S- and S+ culture media. 
However, the vinculin appeared to be concentrated at the cell periphery for the S- 
cultures with the exception of the fibronectin-coated control cultures (Figure 4.7A, E, I, 
M). The rationale for using fibronectin was due to its cell adhesive RGD peptide motif, 
which served as a positive control. In the presence of serum, the vinculin was distributed 
uniformly throughout the cell body (Figure 4.7C, G, K, O). For the fibronectin-treated 
positive control cultures, the distribution of vinculin seems to be independent of serum 
(Figure 4.7Q, S). Because vinculin is localized on the cytoplasmic face of integrin-
mediated cell–extracellular matrix junctions,43 HCASMCs cultured on these fibronectin 
coated controls appear to be making more focal contact areas than on the PEA surfaces. 
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Figure 4.7: Confocal microscopy images of vinculin immunostained HCASMCs on 
glass coverslips (A-D), PEA films (E-P) and FN-coated coverslips (Q-T) in the 
absence or presence of serum. Black and white images show vinculin 
immunostaining only, while fluorescence labeling of HCASMC F-actin (green), 
vinculin (red) and nuclei (blue) are all shown in the composite images. Scale bar 
represents 50 um. 
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In order to gain further insight into these cultures, the number of FAs per cell and per unit 
area of cell on the PEA films were determined (Figure 4.8A, B), where the number of 
focal contacts and cell area were both calculated using ImageJ software. In the S+ 
cultures, there was a significant increase in FAs in the fibronectin-coated control cultures 
compared with both 8-Phe-4-Sol and 8-Phe-8-Int, but not 8-Phe-8-Lys(TFA)-4-Int likely 
due to the scatter in data that introduced a relatively large error in this case. This scatter 
in the data is in part attributed to those cells fixed in the process of migration as they tend 
to form extensive close contacts,44 which under-express vinculin.40 This data, however, is 
consistent with the immunostaining findings, where HCASMCs formed more FAs with 
the fibronectin-coated controls (Figure 4.7S, T). Although the fibronectin-coated control 
in the S+ culture exhibited an increased number of focal adhesions, there was no 
statistical significance in the number of FAs per cell on all other materials tested 
regardless of culture conditions (p > 0.05). Similarly the number of focal adhesions per 
unit area on all the materials cultured in serum is significantly lower than the fibronectin 
coated controls (p < 0.05). However, fibronectin had no significant effect on the number 
of focal adhesions per unit area in the absence of serum (p > 0.05). In comparison to the 
WEFF data presented in Figure 4.3 where 8-Phe-8-Lys(TFA)-4-Int showed a statistically 
significant increase in the number of attachment sites per cell, the immunostaining data 
(Figure 4.8) did not show significance between the control and 8-Phe-8-Lys(TFA)-4-Int. 
This difference is attributed to the two different control surfaces used in the respective 
experiments. For reasons mentioned earlier, the WEFF control experiments were done on 
silver ion-exchanged glass slides needed to form a waveguide; whereas, the 
immunostaining experiments were conducted using conventional cell culture glass 
coverslips. 
Overall, an average of 35–64 FAs per HCASMC cultured on PEA films calculated from 
vinculin immunostaining are consistent with the WEFF microscopy data. Although the 
WEFF microscopy data shown in Figure 4.3 (average attachment sites of 15–29 per cell) 
are slightly lower than the vinculin immunostaining data shown in Figure 4.8 (average 
focal adhesions of 35–64 per cell), there is no statistical significance among any of the 
PEAs tested in either serum-containing or serum-free culture media (p > 0.05), which 
may be the result of adhesive proteins present in the serum-free media facilitating cell 
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adhesion. In addition, these results compare favorably with literature data.45-48 For 
example, for fibroblasts, an average of 20–30 FAs per cell is reported;35-36 whereas, for 
myoblasts an average of 70 FAs per cell is reported.37,49 It also appears that FAs per cell 
is dependent on the culture substrates used where stiff surfaces had higher FAs per cell 
than flexible substrates. For example, fibroblasts cultured on graphene and carbon 
nanotubes had more than 100 FAs per cell;50 whereas, the same cells cultured on a 
standard culture dish had 20 FAs per cell while lung fibroblasts seeded on silicone rubber 
had 5 FAs per cell.45 Finally, a decrease in the FAs per cell from 20–5 is reported for HT-
1080 cells cultured in 3D surfaces.47 In view of these reported values, our data on solvent 
cast PEA films are within the expected range. Furthermore, given that HCASMCs were 
making focal adhesions on these PEAs, it suggests these materials can promote integrin 
signaling, which is critical to cell migration and differentiation. 
Figure 4.8: Number of focal adhesions per HCASMC (A) and per unit area (µm2) 
(B) on the PEA films in serum-containing (S+) and serum-free (S-) media. The * 
denotes statistical significance (p < 0.05). 
4.5 Conclusions 
In this study, we investigated the adhesion of HCASMCs to PEA films using WEFF 
microscopy and compared it with a conventional vinculin immunostaining technique. The 
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WEFF microscopy work required the preparation of ultrathin films of the PEAs on 
waveguide surfaces by LB technology, an aspect that was challenging due to the 
hydrogen bonding capabilities of the PEAs resulting in their propensity to aggregate. 
Despite this challenge, 20 nm thick PEA films were successfully prepared. The WEFF 
results indicated that all PEAs deposited on the waveguides enhanced HCASMC 
adhesion compared with the uncoated control waveguides. However, due to the relatively 
high standard error in the WEFF data, only the cationic PEA was significantly higher 
than the control waveguide. The quantification of vinculin immunostaining supported the 
WEFF microscopy data, as there was no statistical difference in the number of focal 
adhesions per cell or per unit area among the PEAs tested regardless of culture 
conditions. Only the fibronectin-coated controls in serum-containing media exhibited a 
significantly higher number of focal adhesions per cell and per unit area. The presence of 
these focal adhesions implies that all these PEAs promote integrin-mediated signaling, a 
crucial step in cell migration and proliferation. Taken together, our results demonstrate 
the promise of PEA surfaces for the attachment of HCASMCs and suggest that a diverse 
range of PEAs can potentially be used for vascular tissue engineering applications. 
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Chapter 5  
5 Synthesis and Evaluation of a Biomimetic Aspartic Acid-
Derived Poly(ester amide) for Vascular Tissue 
Engineering 
This chapter examines the syntheses of functional PEAs containing L-aspartic acid to 
generate pendant carboxylic acid groups. The subsequent effect of these PEAs on 
HCASMC attachment, morphology, viability and focal adhesion formation was also 
examined. A base and functional PEA were electrospun into a three-dimensional fibrous 
scaffold and their subsequent impact on HCASMC morphology, infiltration and 
phenotype marker protein expression was analyzed. Finally, transforming growth factor-
β1 was successfully conjugated to the surface of the functional PEA demonstrating the 
ability to attach signaling molecules that can direct cell function. 
5.1 Abstract 
Functionalization of polymeric biomaterials permits the conjugation of cell signaling 
molecules capable of directing cell function. Poly(ester amide)s (PEAs) containing 
pendant carboxylic acid groups were successfully synthesized by incorporating L-aspartic 
acid into the PEA backbone through an interfacial polycondensation approach. Human 
coronary artery smooth muscle cell (HCASMC) attachment, spreading and proliferation 
was observed on two-dimensional PEA films. Vinculin expression at the cell periphery 
suggested the HCASMCs formed focal adhesions on the functional PEAs, while the 
absence of smooth muscle α-actin expression implied the cells adopted a proliferative 
phenotype. The PEAs were further electrospun to yield nano-scale three-dimensional 
scaffolds with average fiber diameters ranging from 130–294 nm. Immunoblotting 
studies revealed an increase in smooth muscle α-actin and calponin expression from 
HCASMCs cultured on 3D scaffolds when compared to 2D films. X-ray photoelectron 
spectroscopy and immunofluorescence demonstrated the conjugation of transforming 
growth factor-β1 (TGF-β1) to the surface of the functional PEA through the pendant 
carboxylic acid groups. Taken together, this study demonstrates that the aspartic acid 
containing PEAs are viable biomaterials for vascular tissue engineering.  
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Keywords: vascular tissue engineering, L-aspartic acid, functional poly(ester amide), 
conjugation, electrospinning, fibers, human coronary artery smooth muscle cells, 
vinculin, smooth muscle α-actin, calponin, TGF-β1. 
5.2 Introduction 
Successful tissue engineering strategies rely on the design of appropriate biomaterials 
that mimic the natural extracellular matrix. Cells seeded on a degradable 3D scaffold can 
either be implanted directly to a host or matured in a bioreactor prior to implantation. As 
part of the biomaterials toolbox, the use of functionalized materials that can modulate cell 
function is attractive.1-2 Degradable, functional polymers that permit the immobilization 
of growth factors or other signaling molecules may facilitate the development of new 
biomimetic biomaterials. Functional polymers with well-defined surface chemistry can be 
achieved through the introduction of tri-functional monomers during polymerization. 
Although synthetic monomers have been used in these co-polymerizations, significant 
research has focused on the incorporation of functional α-amino acids, yielding a variety 
of pendant functional groups.3 The co-polymerization of functional α-amino acids 
provides polymers with the combined properties of synthetic polymers and naturally 
occurring polypeptides. Poly(ester amide)s (PEAs), a class of biodegradable polymers 
consisting of ester and amide linkages along the polymer backbone, can be synthesized 
from naturally occurring α-amino acids.4-5 PEAs derived from α-amino acids have been 
investigated for drug delivery,6-7 non-viral gene delivery,8 stimuli-induced degradation,9 
coatings for drug-eluting stents10 and vascular tissue engineering.11-15 
The most appropriate amino acid choices for introducing functional handles for 
subsequent conjugation of biomolecules are L-lysine, L-glutamic acid and L-aspartic acid. 
The incorporation of L-lysine into functional PEAs has been previously reported, to 
which model compounds N-acetyl L-valine and 2-[2-(2-methoxyethoxy)ethoxy]acetic 
acid were conjugated,16 while also promoting vascular smooth muscle cell attachment, 
proliferation and focal adhesion formation.12-13 The introduction of L-aspartic acid into 
the PEA is complementary and will present a negative charge to cells owing to the 
pendant carboxylate at neutral pH, in comparison to the cationically charged pendant 
amine groups in the L-lysine functional PEA. However, data on the synthesis of suitable 
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L-aspartic acid containing PEA biomaterials is limited. For instance, water-soluble 
polydepsipeptides incorporating aspartic acid were synthesised by ring opening 
polymerization of cyclodepsipeptides and tin 2-ethylhexanoate catalyst at elevated 
temperatures, which produced low molecular weight polymers with little practical 
utility.17 More recently, Li and co-workers have synthesized hyperbranched PEAs from 
α-amino acids including L-aspartic acid at elevated temperatures in the presence of 
catalyst after converting the functional groups to a methyl ester limiting the availability 
of the pendant functionality.18 The incorporation of L-aspartic acid into PEAs comprising 
amino acids, dicarboxylic acids and diols through a homogeneous polycondensation has 
also been previously reported.19 However, the solution polymerization approach provided 
relatively low molecular weight polymers not suitable for biomaterials. It should be 
reiterated that polymeric biomaterials designed for tissue engineering applications must 
have sufficiently high molecular weight to be processed into films and scaffolds to have 
the necessary initial mechanical and dimensional stability for use in a cell culture 
environment. 
Although there are several strategies to fabricate or regenerate vascular tissues, scaffold-
guided tissue engineering remains the most frequently encountered approach.20 Thus far, 
PEAs containing α-amino acids have been demonstrated to support vascular smooth 
muscle cells (VSMC) attachment,14-15 proliferation and focal adhesions.12-13 In vascular 
tissue engineering, transforming growth factor β1 (TGF-β1) is a target biomolecule as it 
has been reported to modulate smooth muscle cell proliferation, differentiation and up-
regulation of the quiescent contractile phenotype.21-23 The ability to deliver TGF-β1 
easily and locally from a biodegradable PEA scaffold could aid in vascular tissue 
regeneration. The immobilization of TGF-β1 within a degradable scaffold may also 
promote prolonged signaling beneficial in elastogenesis and adoption of quiescent 
smooth muscle cells following controlled release of the cytokine. As the functional PEAs 
containing L-aspartic acid are anticipated to support VSMC adhesion and proliferation, 
TGF-β1 may further promote extracellular matrix production24 and the contractile VSMC 
phenotype.25 In view of the above, a synergistic effect in the development of a tissue-
engineered vascular graft was sought.  
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Several key developments in the application of PEAs for vascular tissue engineering are 
herein described. PEAs containing L-aspartic acid were synthesized, characterized and 
evaluated through the in vitro culture of HCASMCs. Nano-scale electrospun fibrous mats 
were prepared from PEAs and the effect of PEA fibrous topography and exogenous TGF-
β1 on contractile phenotype marker protein expression of smooth muscle α-actin (SMαA) 
and calponin by HCASMCs were investigated. Finally, TGF-β1 was successfully 
conjugated onto the surface of PEAs containing functional L-aspartic acid. 
5.3 Materials and Methods 
5.3.1 Materials 
Monomers 2 and 3 and bis-L-aspartic acid-β-(tert-butyl ester) diester 7 were prepared as 
previously reported (Chart 5.1).12,19,26 Solvents were purchased from Caledon Labs 
(Georgetown, ON). All other chemicals were purchased from Sigma Aldrich 
(Milwaukee, WI). Unless noted otherwise, all chemicals were used as received. DCM 
was distilled from CaH2 and dried over molecular sieves 4A. Flash chromatography was 
performed using silica gel 60 with a particle size range of 40-63 µm (SiliCycle Inc, 
Quebec City, QC). Dialysis was performed against DMF with Spectra/Por 6 dialysis 
tubing (Spectrum Laboratories, Inc., Rancho Dominguez, CA), molecular weight cutoff 
of 25 kDa. 
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Chart 5.1: Structures of monomers 2, 3 and 7. 
5.3.2 Methods 
1H (400 MHz) NMR spectra were obtained on a Varian Inova 400 spectrometer (Varian 
Canada Inc., Mississauga, ON). Chemical shifts are reported in parts per million (ppm) 
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and are calibrated against residual solvent signals of chloroform (CDCl3, δ 7.27 ppm) or 
dimethyl sulfoxide (DMSO-d6, δ 2.50 ppm). All coupling constants (J) are reported in 
Hertz (Hz). FTIR spectra were obtained using a Bruker Tensor 27 (Bruker Corporation, 
Milton, ON) from KBr disks. Absorption frequencies of the functional groups are 
reported in wavenumbers (cm-1) and assigned as published by Pavia et al.27 GPC data 
were obtained using a Waters 2695 Separations Module equipped with a Waters 2414 
Refractive Index Detector (Waters Limited, Mississauga, ON) and two PLgel 5 µm 
mixed-D (300 mm × 7.5 mm) columns connected in series (Varian Canada Inc., 
Mississauga, ON). Samples (5 mg/mL) dissolved in the eluent, which comprised of 10 
mM LiBr and 1 % (v/v) NEt3 in DMF at 85°C were injected (100 µL) at a flow rate of 1 
mL/min and calibrated against polystyrene standards. Molecular weights are reported in 
kilograms/mole (kg/mol). TGA was performed on a SDT Q600 (TA Instruments – 
Waters LLC, New Castle, DE) under dry nitrogen at a heating rate of 20°C/min up to 
600°C. DSC was performed on a DSC Q20 (TA Instruments – Waters LLC, New Castle, 
DE) at a heating rate of 10°C/min from -50 to 200°C. All samples prepared ranged from 
2 to 5 mg, and glass transition temperatures (Tgs) were obtained from the second heating 
cycle. 
5.3.3 PEA Nomenclature 
The polymers are labeled by the number of methylene groups contributed by the diacid, 
the three letter amino acid designation, and finally by the number of methylene groups in 
the diol – for example 8-Phe-8. Asp(O-t-Bu) represents the incorporation of the aspartic 
acid monomer 7 as a co-monomer at a mole ratio of 10% relative to the di-p-
toluenesulfonic acid salt monomer 2 or 3 - for example 8-Phe-8-Asp(O-t-Bu)-4. The 4 
represents the number of methylene groups in the butanediol moiety of 7. 
5.3.4 General Procedure for Interfacial Polymerization of the 
Functional Poly(ester amide)s 
The di-p-toluenesulfonic acid salt monomer 2 or 3 (0.9 equiv.) and sodium carbonate (2.0 
equiv.) were dissolved in distilled water (30 mL). Bis-L-aspartic acid β-(t-butyl ester) 
diester, 7 (0.1 equiv.) was dissolved in DCM (15 mL) and added to the aqueous phase 
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and allowed to mix for 30 min. Sebacoyl chloride (1.0 equiv.) diluted in anhydrous DCM 
(15 mL), was added dropwise over 20 min to the biphasic solution and was allowed to 
react for 24 h. Upon completion of the reaction, solvent was removed in vacuo. The 
functional PEA was dissolved in DMF permitting filtration of the insoluble salts. The 
filtrate was then dialyzed against DMF for at least 8 h twice. The solvent was again 
removed in vacuo, reconstituted in chloroform (5 mL) and precipitated in cold ethyl 
acetate (50 mL) and finally collected and dried in vacuo. 
5.3.4.1 8-Phe-4-Asp(O-t-Bu)-4 
This polymer was prepared by the general procedure described above using monomers 2 
(3.5 g, 4.9 mmol), 7 (0.23 g, 0.54 mmol) and sebacoyl chloride (1.2 mL, 5.4 mmol). 
Yield: 1.38 g, 46%. 1H NMR (400 MHz, CDCl3): δ 7.31-7.09 (m, 9H, Ph), 6.51 (d, 0.2H, 
J = 8.2, -C(O)-NH-CαH-CH2-C(O)O-t-Bu), 6.01 (d, 1.8H, J = 7.6, -C(O)-NH-CαH-CH2-
Ph), 4.91-4.84 (m, 1.8H, -CαH-CH2-Ph), 4.83-4.77 (m, 0.2H, -CαH-CH2-C(O)O-t-Bu), 
4.21-3.99 (m, 4H, -C(O)O-CH2-), 3.16-3.04 (m, 3.6H, -CαH-CH2-Ph), 2.91 (dd, 0.2H, J1 
= 17.3, J2 = 4.4, -CαH-CHaHb-C(O)O-t-Bu), 2.76 (dd, 0.2H, J1 = 17.0, J2 = 4.7, -CαH-
CHaHb-C(O)O-t-Bu), 2.25-2.11 (m, 4H, -CH2-C(O)-NH-CαH-CH2-C(O)O-t-Bu, -CH2-
C(O)-NH-CαH-CH2-Ph), 1.74-1.51 (m, 8H, -C(O)O-CH2-CH2-, -CH2-CH2-C(O)-NH-), 
1.43 (br s, 1.8H, t-Bu CH3), 1.36-1.20 (m, 8H, -(CH2)4-CH2-CH2-C(O)-NH-). FTIR (KBr 
pellet, cm-1): 3307 (N-H stretch, amide), 3064 (C-H stretch, aromatic), 3030 (C-H stretch, 
aromatic), 2931 (C-H stretch, aliphatic), 2856 (C-H stretch, aliphatic), 1744 (C=O 
stretch, ester), 1647 (C=O stretch, amide I), 1543 (N-H bend, C-N stretch, amide II), 
1498 (C=C stretch, aromatic), 1455 (CH2, wagging vibration) 1180 (C-O stretch, ester). 
GPC: Mn = 34.7 kg/mol, Mw = 74.4 kg/mol, PDI = 2.15. DSC: Tg = 36.5°C. TGA: Td = 
217°C. 
5.3.4.2 8-Phe-8-Asp(O-t-Bu)-4 
This polymer was prepared by the general procedure described above using monomers 3 
(1.6 g, 2.0 mmol), 7 (0.095 g, 0.22 mmol) and sebacoyl chloride (0.47 mL, 2.2 mmol). 
Yield: 0.62 g, 46%. 1H NMR (400 MHz, CDCl3): δ 7.32-7.08 (m, 9H, Ph), 6.50 (d, 0.2H, 
J = 8.6, -C(O)-NH-CαH-CH2-C(O)O-t-Bu), 5.96 (d, 1.8H, J = 8.2, -C(O)-NH-CαH-CH2-
146 
 
 
Ph), 4.93-4.85 (m, 1.8H, -CαH-CH2-Ph), 4.83-4.77 (m, 0.2H, -CαH-CH2-C(O)O-t-Bu), 
4.22-4.03 (m, 4H, -C(O)O-CH2-), 3.18-3.05 (m, 3.6H, -CαH-CH2-Ph), 2.91 (dd, 0.2H, J1 
= 17.0, J2 = 4.5, -CαH-CHaHb-C(O)O-t-Bu), 2.76 (dd, 0.2H, J1 = 17.2, J2 = 4.7, -CαH-
CHaHb-C(O)O-t-Bu), 2.25-2.10 (m, 4H, -CH2-C(O)-NH-CαH-CH2-C(O)O-t-Bu, -CH2-
C(O)-NH-CαH-CH2-Ph), 1.74-1.50 (m, 8H, -C(O)O-CH2-CH2-, -CH2-CH2-C(O)-NH-), 
1.46-1.41 (m, 1.8H, t-Bu CH3), 1.37-1.20 (m, 15.2H, -C(O)O-CH2-CH2-(CH2)4-, -(CH2)4-
CH2-CH2-C(O)-NH-). FTIR (KBr pellet, cm-1): 3307 (N-H stretch, amide), 3064 (C-H 
stretch, aromatic), 3030 (C-H stretch, aromatic), 2929 (C-H stretch, aliphatic), 2853 (C-H 
stretch, aliphatic), 1737 (C=O stretch, ester), 1649 (C=O stretch, amide I), 1542 (N-H 
bend, C-N stretch, amide II), 1498 (C=C stretch, aromatic), 1455 (CH2, wagging 
vibration) 1181 (C-O stretch, ester). GPC: Mn = 30.8 kg/mol, Mw = 62.4 kg/mol, PDI = 
2.02. DSC: Tg = 21.8°C. TGA: Td = 253°C. 
5.3.5 General Deprotection Procedure 
Each t-Bu-protected functional PEA (0.1–0.2 g) was dissolved in 1:1 trifluoroacetic acid 
(TFA):CH2Cl2 (2 mL) and reacted for 2 h. The solvents were subsequently removed and 
the desired product was precipitated in cold ethyl acetate (50 mL) from chloroform (5 
mL). The precipitate was collected and dried in vacuo, yielding the functional PEA with 
pendant carboxylic acid groups. 
5.3.5.1 8-Phe-4-Asp(OH)-4 
This polymer was prepared by the general deprotection procedure described above. 
Yield: 0.057 g, 46%. 1H NMR (400 MHz, DMSO-d6): δ 8.15 (d, 1.8H, J = 8.2, -C(O)-
NH-CαH-CH2-Ph), 7.98 (d, 0.2H, J = 7.6, -C(O)-NH-CαH-CH2-C(O)OH), 7.40-7.04 (m, 
9H, Ph), 4.60-4.53 (m, 0.2H, -CαH-CH2-C(O)OH), 4.52-4.42 (m, 1.8H, -CαH-CH2-Ph), 
4.11-3.89 (m, 4H, -C(O)O-CH2-), 3.05-2.84 (m, 3.6H, -CαH-CH2-Ph), 2.70-2.55 (m, 
0.4H, -CαH-CH2-C(O)OH), 2.12-1.97 (m, 4H, -CH2-C(O)-NH-CαH-CH2-C(O)OH, -CH2-
C(O)-NH-CαH-CH2-Ph), 1.62-1.31 (m, 8H, -C(O)O-CH2-CH2-, -CH2-CH2-C(O)-NH-), 
1.26-1.05 (m, 8H, -(CH2)4-CH2-CH2-C(O)-NH-). FTIR (KBr pellet, cm-1): 3313 (N-H 
stretch, amide), 3064 (C-H stretch, aromatic), 3030 (C-H stretch, aromatic), 2928 (C-H 
stretch, aliphatic), 2855 (C-H stretch, aliphatic), 1742 (C=O stretch, ester), 1640 (C=O 
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stretch, amide I), 1542 (N-H bend, C-N stretch, amide II), 1498 (C=C stretch, aromatic), 
1455 (CH2, wagging vibration) 1180 (C-O stretch, ester). DSC: Tg = 39.8°C. TGA: Td = 
282°C. 
5.3.5.2 8-Phe-8-Asp(OH)-4 
This polymer was prepared by the general deprotection procedure described above. 
Yield: 0.10 g, 56%. 1H NMR (400 MHz, DMSO-d6): δ 8.14 (d, 1.8H, J = 7.6, -C(O)-NH-
CαH-CH2-Ph), 8.08-8.02 (m, 0.2H, -C(O)-NH-CαH-CH2-C(O)OH), 7.40-7.03 (m, 9H, 
Ph), 4.60-4.52 (br m, 0.2H, -CαH-CH2-C(O)OH), 4.52-4.40 (m, 1.8H, -CαH-CH2-Ph), 
4.12-3.89 (m, 4H, -C(O)O-CH2-), 3.05-2.82 (m, 3.6H, -CαH-CH2-Ph), 2.60-2.47 (m, 
0.4H, -CαH-CH2-C(O)OH), 2.14-1.96 (m, 4H, -CH2-C(O)-NH-CαH-CH2-C(O)OH, -CH2-
C(O)-NH-CαH-CH2-Ph), 1.62-1.33 (m, 8H, -C(O)O-CH2-CH2-, -CH2-CH2-C(O)-NH-), 
1.33-1.03 (m, 15.2H, -C(O)O-CH2-CH2-(CH2)4-, -(CH2)4-CH2-CH2-C(O)-NH-). FTIR 
(KBr pellet, cm-1): 3308 (N-H stretch, amide), 3064 (C-H stretch, aromatic), 3030 (C-H 
stretch, aromatic), 2928 (C-H stretch, aliphatic), 2854 (C-H stretch, aliphatic), 1740 
(C=O stretch, ester), 1651 (C=O stretch, amide I), 1541 (N-H bend, C-N stretch, amide 
II), 1497 (C=C stretch, aromatic), 1455 (CH2, wagging vibration) 1179 (C-O stretch, 
ester). DSC: Tg = 26.3°C. TGA: Td = 241°C.  
5.3.6 Electrospinning 
Three-dimensional fibrous PEA mats were achieved by preparing various concentrations 
of PEA solutions in a co-solvent mixture of chloroform (CHCl3):dimethyl sulfoxide 
(DMSO) or DMF. The viscous solution was transferred to a glass syringe (0.5 mL) 
equipped with a stainless steel 22 gauge needle, which was connected to a high voltage 
(20 kV) supply. The flowrate was maintained at 0.1 mL/h with a syringe pump. The 
fibers were collected on aluminum foil on either a static collector or on a rotating 
mandrel (1000 rpm) 8 cm from the needle tip. 
5.3.7 Scanning Electron Microscopy (SEM) 
The electrospun fiber mats were visualized using scanning electron microscopy (S-2600 
or 3400S, Hitachi, Ltd., Tokyo, Japan). The mats were mounted on carbon-taped 
148 
 
 
aluminum stubs and sputtered with gold (Quorum Emitech K550X, Quorum 
Technologies Ltd, Kent, UK) or a gold-palladium mixture (HummerVI Sputter Coater, 
Anatech USA, Union City, CA) at a current of 15 mA for 90 or 300 sec, respectively. 
Secondary electron detection was achieved at voltages between 5 and 20 kV at various 
magnifications. From these micrographs, fiber diameters were measured using ImageJ 
software (NIH, Bethesda, MD).  
5.3.8 Two-Dimensional Cell Culture and Immunofluorescence 
Microscopy 
Two-dimensional polymer films were obtained by twice dip-coating 12 mm diameter 
glass coverslips into 1% (wt) solutions of the PEAs in DMF and were dried at 60°C 
under reduced pressure overnight. One glass coverslip was placed in each well of a 24-
well culture plate. The films were immersed in 70% ethanol for 30 min and then exposed 
to UV irradiation for 1 h, prior to conditioning overnight in Hank’s Balanced Salt 
Solution (HBSS; Invitrogen Canada Inc., Burlington, ON). Natural, human fibronectin (2 
µg/cm2; Santa Cruz Biotechnology Inc., Santa Cruz, CA) in HBSS was adsorbed to glass 
coverslips for 1 h and the resulting surfaces served as positive controls. Human coronary 
artery smooth muscle cells (HCASMCs; Lonza Walkersville Inc., Walkersville, MD) at a 
density of 2,000 cells/cm2 were seeded directly on the surface of the PEA films in 24-
well culture plates and were cultured for 1 and 7 days before fixation and 
immunostaining. 
Human coronary artery smooth muscle cells were grown in smooth muscle cell basal 
medium (Medium 231; Life Technologies Inc., Burlington, ON) supplemented with 
smooth muscle growth supplement (SMGS, 25 mL, 20X; Life Technologies Inc., 
Burlington, ON) and 10,000 Units/mL Penicillin/Streptomycin (5 mL, 100X, Life 
Technologies Inc., Burlington, ON). HCASMCs were used between passages 5 and 9. 
Cultures were maintained at 37°C in a humidified incubator containing 5% CO2. 
For immunostaining studies, cells were washed with pre-warmed PBS immediately prior 
to fixing at ambient temperature for 15 min in 4% formaldehyde solution (EMD 
Chemicals, Gibbstown, NJ) in divalent cation-free PBS. HCASMCs were then 
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permeabilized with 0.1% Triton X-100 (VWR International, Mississauga, ON) for 5 min 
followed by their incubation with 1% bovine serum albumin (BSA) (Sigma-Aldrich, 
Oakville, ON) for 30 min. Primary antibody incubation with either mouse monoclonal 
anti-vinculin (1:50 dilution, SPM227; Abcam, Cambridge, MA) or monoclonal anti-α-
actin (1:50 dilution, clone 1A4; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) was 
conducted for 1 h prior to the secondary antibody incubation in the dark for 1 h at 
ambient temperature with Alexa Fluor® 488-conjugated goat anti-mouse IgG (1:300 
dilution; Invitrogen Canada Inc., Burlington, ON). The HCASMCs were further 
incubated in the dark at ambient temperature with Alexa Fluor® 568-conjugated 
phalloidin (1:50 dilution; Life Technologies Inc., Burlington, ON) for 20 min in a 1% 
BSA/PBS solution. The HCASMCs were then counterstained with 4’-6-diamidino-2-
phenylindole dihydrochloride (DAPI, 300 nM in PBS; Life Technologies Inc., 
Burlington, ON) for 10 min to label the nuclei. Coverslips were mounted on microscope 
slides with ProLong® Antifade Kit (Life Technologies Inc., Burlington, ON) and sealed 
with nail enamel upon drying. Samples were analyzed with a Zeiss LSM 5 Duo confocal 
microscope with 9 laser lines and appropriate filters (Carl Zeiss Canada Ltd., Toronto, 
ON). 
5.3.9 Cell Toxicity and Proliferation Studies Using MTT Assays 
Colorimetric assays of the metabolic activity of viable cells were used to quantify cell 
toxicity and proliferation and were performed using 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) (Vybrant® MTT Cell Proliferation Assay Kit, 
Invitrogen Canada Inc., Burlington, ON). At predetermined time points, fresh culture 
media was added (100 µL) followed by MTT (10 μL, Component A) and incubated for 4 
h. Sodium dodecyl sulfate (SDS, 100 µL, Component B) was then added and thoroughly 
mixed and incubated for a further 18 h to solubilize the formazan, which was quantified 
using a Biochrom Asys UVM340 Microplate Reader (Biochrom Ltd., Cambridge, U.K.) 
at 570 nm (maximum absorbance). 
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5.3.10 Three-Dimensional Cell Culture, Scanning Electron and 
Laser Scanning Confocal Microscopy 
Three-dimensional polymer scaffolds were cut from electrospun fibrous mats. The 
scaffolds were also immersed in 70% ethanol for 30 min and then exposed to UV 
irradiation for 1 h, prior to conditioning overnight in HBSS. HCASMCs were seeded 
directly on the surface of the PEA scaffolds, at a density of 30,000 cells/scaffold and 
cultured up to 4 days prior to fixation with formaldehyde solution for 15 min. HCASMC 
morphology was preserved prior to SEM analysis by washing the cells with PBS and 
deionized water three times each prior to sequential ethanol dehydration. Samples were 
dehydrated in an increasing series of ethanol concentrations (10, 30, 50, 70, 90, 95 and 
100%) for 5 min each followed by drying with an increasing series of 
hexamethyldisilazane (HMDS, Sigma-Aldrich, Oakville, ON) concentrations in ethanol 
(50, 75 and 100%) for 10 min each. Finally, the cells were air dried prior to sputtering 
and imaging. The three-dimensional Z-stacks of the confocal microscopy images were 
obtained in 2–5 μm slices. Despite not immunostaining, images were also collected in the 
green channel to obtain a background contribution from the polymer to be subtracted 
from the autofluorescence observed in the other channels. The image subtraction was 
conducted in Image-Pro Plus software (Media Cybernetics, Inc., Rockville, MD). The 
resulting 2D images were then re-assembled into a composite 3D image using Imaris 
software (Bitplane Inc., South Windsor, CT). 
5.3.11 Western Blot Analysis 
For human coronary artery smooth muscle cell phenotype marker protein analysis via 
Western blot, HCASMCs were seeded at a density of 2.5 to 5.0 x 105 cells/film or 
scaffold. Protein lysates obtained from a radioimmunoprecipitation assay (RIPA, 50–100 
μL) buffer (bicinconinic acid (BCA) protein assay compatible) supplemented with 
ethylenediaminetetraacetic acid, disodium salt dihydrate (EDTA, 5 mM), 
phenylmethylsulfonyl fluoride (PMSF, 1 mM) and a protease inhibitor mixture (1X, 
Roche Complete Mini EDTA-Free Protease Inhibitor Cocktail, Cedarlane Labs, 
Burlington, ON) were quantified with Pierce BCA Protein Assay (Thermo Fisher 
Scientific Inc., Rockford, IL). The protein lysates were separated by sodium dodecyl 
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sulfate polyacrylamide gel electrophoresis (SDS-PAGE, 12% bis/acrylamide gel, 160 V, 
1 h) using Towbin’s buffer supplemented with 0.1% SDS. The mini-gel was subsequently 
wet transferred to a nitrocellulose blotting membrane (BioTraceTM NT, Pall Corporation, 
Pensacola, FL) in a cooled chamber at 70 V for 2 h in Towbin’s buffer supplemented 
with 0.02% SDS and 20% (v/v) methanol. The transfer efficiency was confirmed by gel 
staining with Coomassie Brilliant Blue (R-250) solution (Bio-Rad Laboratories (Canada, 
Ltd., Mississauga, ON) and reversible Ponceau S staining of the nitrocellulose 
membrane. For immunoblotting of calponin, α-actin and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), blocking was achieved with 5% nonfat dry milk (Blotting 
Grade Blocker, Bio-Rad Laboratories (Canada) Ltd., Mississauga, ON) in Tris-buffered 
saline-Tween-20 (TBST, Tris.HCl: 20 mM, pH 7.6; NaCl: 137 mM; Tween-20: 0.1%) for 
1 h, followed by incubation overnight at 4°C with either rabbit polyclonal calponin 1/2/3 
antibody (1:250 dilution, FL-297; Santa Cruz Biotechnology, Inc., Santa Cruz, CA), 
mouse monoclonal anti-α-actin, (1:250 dilution, clone 1A4; Santa Cruz Biotechnology, 
Inc., Santa Cruz, CA) or mouse monoclonal anti-GAPDH (1:1000 dilution, clone 6C5, 
EMD Millipore Corporation, Temecula, CA) in 5% nonfat dry milk in TBST. 
Membranes were then washed with TBST (3 x 5 min) and incubated for 1 h in a 
horseradish peroxidase (HRP)-conjugated secondary antibody (1:5000 dilution; Thermo 
Fisher Scientific, Rockford, IL) in TBST. Membranes were again washed and then 
incubated for 5 min in SuperSignal® West Pico Chemiluminescent substrate (Thermo 
Fisher Scientific, Rockford, IL) and examined with a Molecular Imager® ChemiDocTM 
XRS+ system (Bio-Rad Laboratories (Canada) Ltd., Mississauga, ON). Re-probing of the 
nitrocellulose membrane was achieved following stripping with mild stripping buffer (10 
mL, 200 mM glycine, 0.1% SDS, 1% Tween-20, pH 2.2) under gentle agitation at 37°C 
for 30 min. 
5.3.12 Transforming Growth Factor-β1 Conjugation 
Protein carrier-free human platelet-derived TGF-β1 (R&D Systems Inc., Minneapolis, 
MN) reconstituted in 4 mM HCl was conjugated to the surface of 8-Phe-4-Asp(OH)-4 
electrospun mats using a conventional peptide conjugation technique. The electrospun 
mat was immersed in 4-morpholineethanesulfonic acid (MES, Sigma-Aldrich, Oakville, 
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ON) buffer (0.1 M, pH 5.0, 4 mL) for 15 min, which contained N-(3-
dimethylaminopropyl)-N'ethylcarbodiimide (EDC, 2 mM; Sigma-Aldrich, Oakville, ON) 
and N-hydroxysulfosuccinimide sodium salt (sulfo-NHS, 5 mM; VWR International, 
Mississauga, ON) to activate the pendant carboxylic acid groups of the 8-Phe-4-
Asp(OH)-4. After 15 min, the activation with EDC was halted with the addition of 2-
mercaptoethanol (2.8 µL, 10 mM; Caledon Laboratories Ltd., Georgetown, ON) for 5 
min. The MES buffer was removed and replaced by phosphate-buffered saline (10 mM, 
pH 8.5, 4 mL) before the reconstituted TGF-β1 was added to provide a final 
concentration of 3 ng/mL and allowed to react for 2 h. The conjugated mats were washed 
three times with 1X PBS (pH 7.4) and then Milli-Q (18.2 MΩ-cm) water for 5 min each. 
Adsorbed samples served as controls, where the activation step with EDC and sulfo-NHS 
was omitted. For X-ray photoelectron spectroscopy (XPS) analysis, conjugated and 
adsorbed mats were dried overnight under reduced pressure at room temperature. For 
laser scanning confocal microscopy images, the conjugated and adsorbed samples were 
blocked with 1% bovine serum albumin (BSA; Sigma-Aldrich, Oakville, ON) in 1X PBS 
for 1 h, followed by primary antibody incubation overnight at 4°C with rabbit TGF-β 
receptor 1 antibody (1:50 dilution, 250 µL; Cell Signaling Technology, Danvers, MA) in 
1% BSA in 1X PBS. Secondary antibody incubation was conducted in the dark for 1 h at 
ambient temperature with Alexa Fluor® 488-conjugated donkey anti-rabbit IgG (1:300 
dilution; Invitrogen Canada Inc., Burlington, ON) prior to three washes with 1X PBS for 
5 min each. Finally, the samples were mounted with ProLong Gold (Invitrogen Canada 
Inc., Burlington, ON), dried overnight and then sealed with nail enamel. Samples were 
analyzed with a Zeiss LSM 5 Duo confocal microscope with nine laser lines and 
appropriate filters (Carl Zeiss Canada, Toronto, ON). 
5.3.13 X-Ray Photoelectron Spectroscopy 
XPS data were obtained using a Kratos Axis Ultra spectrometer (Kratos Analytical Ltd, 
UK, Manchester, UK) with integrated Magnetic Immersion Lens and Charge 
Neutralization System with Spherical Mirror Analyser using a monochromatic Al Kα X-
ray source (15 mA, 14 kV). The Kratos Charge Neutralization System was used on all 
samples, which were analyzed to a depth of 5-7 nm, with detection limits ranging from 
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0.1 to 0.5 atomic percent. Survey scan and high resolution analyses were carried out on 
an analysis area of 300–700 µm at a pass energy of 160 and 20 eV, respectively. Spectra 
have been charge corrected to the main line of the C 1s spectrum (adventitious carbon) 
set to 284.8 eV. X-ray photoelectron spectra were analyzed using CasaXPS version 
2.3.14 software. 
5.3.14 Statistical Analysis 
MTT assay and Western blot data are given as the mean ± standard error for experiments 
conducted in triplicate. Differences between groups were compared using a two-way 
ANOVA analysis with a Bonferroni post-test. The average fiber diameter data is also 
provided as the mean ± standard error, calculated from 30 randomly selected fibers from 
each of three separate SEM images. Differences between groups were compared with a 
one-way ANOVA analysis with a Bonferroni post-test. All statistical analyses were 
conducted with GraphPad Prism, where values of p < 0.05 were considered statistically 
significant. 
5.4 Results and Discussion  
5.4.1 Interfacial Polymerization of L-Aspartic Acid Containing 
Poly(ester amide)s 
Functional poly(ester amide)s containing L-aspartic acid were incorporated into both 8-
Phe-4 and 8-Phe-8 to provide pendant carboxylic acid groups to complement the 
previously reported pendant amine functional PEAs.12 The incorporation of 
complementary functional groups facilitates their conjugation to biomolecules using 
conventional peptide coupling approaches. The functional PEAs were synthesized via the 
interfacial polymerization approach previously developed,12 where the β-carboxylate 
group remained tert-butyl protected during the polycondensation. Following the 
polymerization, the protecting groups were cleaved using TFA. Confirmation of the 
incorporation of aspartic acid into these PEAs was achieved using 1H NMR spectroscopy, 
as shown in Figure 5.1 and Figure 5.2. Due to the low abundance of aspartic acid 
moieties, 13C NMR spectroscopy was not sensitive enough for their detection. In Figure 
5.1, two sets of peaks clearly illustrate the presence of the aspartic acid. The small peaks 
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at 4.5 and 2.6 ppm represent the protons on the α- and β-carbons respectively, denoted as 
15 and 16 in the protected PEA and 20 and 21 in deprotected 8-Phe-4-based functional 
PEAs. These peaks are also visible in the 1H NMR spectra of the 8-Phe-8 functional 
PEAs shown in Figure 5.2, although more overlapped by the DMSO peak at 2.5 ppm. 
 
Figure 5.1: Overlayed 1H NMR spectra of 8-Phe-4-Asp(O-t-Bu)-4 and 8-Phe-4-
Asp(OH)-4 functional PEAs. Note that the unlabeled peaks above correspond to the 
peaks labeled in Figure 3.2. 
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Figure 5.2: Overlayed 1H NMR spectra of 8-Phe-8-Asp(O-t-Bu)-4 and 8-Phe-8-
Asp(OH)-4 functional PEAs. Note that the unlabeled peaks above correspond to the 
peaks labeled in Figure 3.3. 
Upon successful syntheses of the PEAs containing aspartic acid, their thermal properties 
were studied via both thermogravimetric analyses (TGA, Figure 5.3 and Figure 5.4) and 
differential scanning calorimetry (DSC, Figure 5.5 and Figure 5.6); the data is provided 
in Table 5.1. As shown in Figure 5.3 and Figure 5.4, the inclusion of the aspartic acid 
induced a decrease in the onset of decomposition. In the case of the 8-Phe-4-Asp(O-t-
Bu)-4, a 1% mass loss was observed at 217°C, yet the deprotected 8-Phe-4-Asp(OH)-4 
demonstrated an onset of degradation at 282°C, suggesting the initial mass loss was the 
result of thermolysis of the tert-butyl groups.28 In the 8-Phe-8-Asp(O-t-Bu)-4 case, a 
significant reduction in the onset of degradation was also observed, again due to loss of 
the tert-butyl protecting group. However, in comparing the two deprotected PEAs, 8-Phe-
8-Asp(OH)-4 resulted in a lower decomposition temperature (241°C) than the 
corresponding 8-Phe-4-Asp(OH)-4 (282°C), which was attributed to decreased hydrogen 
bonding between polymer chains due to the increased chain length of the diol. 
21
22
19
20 O
O
N O
OH
O
N
OH
O
O O
O
H R4
N
H
O
O
O
N
HO
3 3 3
17
18
15
16
3 3 3
O
O
N O
OHR3
N
H O
N
H
O
OO
N
O
O
O O
H
O
H3C
CH3
CH3
O
156 
 
 
 
Figure 5.3: Overlayed TGA thermographs of aspartic acid containing 8-Phe-4-based 
PEAs. 
 
Figure 5.4: Overlayed TGA thermographs of aspartic acid containing 8-Phe-8-based 
PEAs. 
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The incorporation of the protected functional groups also resulted in a decrease in the 
glass transition temperature, Tg (Figure 5.5 and Figure 5.6), which was attributed to an 
increase in free volume associated with the pendant tert-butyl groups. The inclusion of 
the Asp(O-t-Bu)-4 monomer into 8-Phe-4 resulted in a decrease in Tg from 38.8°C to 
36.5°C. The deprotection of the tert-butyl group then resulted in a subsequent increase in 
the Tg to 39.8°C. Similar behaviour was observed with the 8-Phe-8, where the Tg 
decreased to 21.8°C from 24.5°C with 10 mol% Asp(O-t-Bu)-4. Subsequent cleavage of 
the protecting group again resulted in an increase in the Tg to 26.3°C. Both polymers 
exhibited increased glass transition temperatures such that it was greater than the base 
polymer suggesting improved hydrogen bonding between polymer chains with the free 
carboxylic acid groups. 
 
Figure 5.5: Overlayed DSC traces of aspartic acid containing 8-Phe-4-based PEAs. 
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Figure 5.6: Overlayed DSC traces of aspartic acid containing 8-Phe-8-based PEAs. 
As seen in Figure 5.7 and Figure 5.8, the incorporation of the protected aspartic acid 
monomer delayed the elution of the polymer chains indicative of lower molecular weight 
polymers for both 8-Phe-4 and 8-Phe-8 PEAs. There was an approximately two-fold 
decrease in both the number average (Mn) and weight average (Mw) molecular weight 
(Table 5.1) when 10 mol% of the Asp(O-t-Bu)-4 monomer was incorporated into the 
polymer. The reduction in molecular weight suggests that the aspartic acid functional 
monomer does not polymerize as well as the phenylalanine-based diester monomer. 
Interestingly, the protected functional PEAs exhibited similar PDIs to one another, while 
the 8-Phe-4 and 8-Phe-8 had a PDI value of 2.6 and 1.6 respectively. The decreased PDI 
in the 8-Phe-4-Asp(O-t-Bu)-4 case may be attributed to the increased solubility in DMF 
and thus its removal during dialysis. The increased polydispersity of 8-Phe-8-Asp(O-t-
Bu)-4 may be the result of the variability in the reactivity of the base and functional 
monomer. Molecular weight data was not obtained for the deprotected PEAs, as the 
pendant carboxylic acid groups would interact with the GPC columns. 
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Figure 5.7: Overlayed GPC chromatographs of 8-Phe-4 and 8-Phe-4-Asp(O-t-Bu)-4. 
 
Figure 5.8: Overlayed GPC thermographs of 8-Phe-8 and 8-Phe-8-Asp(O-t-Bu)-4. 
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Table 5.1: Molecular weights and polydispersity indices of functional PEAs. 
PEA Yield (%) 
Mn 
(kg/mol) 
Mw 
(kg/mol) 
PDI Tg (°C) Td (°C) 
8-Phe-4 77.5 63.6 168 2.64 38.8 320 
8-Phe-4-Asp(O-t-Bu)-4 45.9 34.7 74.4 2.15 36.5 217 
8-Phe-4-Asp(OH)-4 46.4 ND ND ND 39.8 282 
8-Phe-8 60.3 71.8 111 1.55 24.5 336 
8-Phe-8-Asp(O-t-Bu)-4 46.0 30.8 62.4 2.03 21.8 253 
8-Phe-8-Asp(OH)-4 55.6 ND ND ND 26.3 241 
5.4.2 Vascular Smooth Muscle Cell Proliferation, Morphology and 
Focal Adhesion Formation on Two-Dimensional Films 
Upon successful syntheses of the PEAs containing aspartic acid, their evaluation with 
human coronary artery smooth muscle cells was sought to ensure their suitability as 
vascular biomaterials. Initially, the SMCs were cultured on 2D films for 7 days to assess 
cell attachment and metabolic activity. As illustrated in Figure 5.9, over the course of the 
week long study, metabolic activity was enhanced as indicated by the cumulative 
increase in absorbance. The cell viability studies were conducted in conjunction with the 
PEAs containing lysine to compare the effects of the pendant carboxylic acid versus 
amine functional groups. At 7 days, more metabolically active HCASMCs were present 
on 8-Phe-4-Asp(OH)-4 than either the base polymer or its cationic counterpart, which 
were very similar to one another. To ascertain whether the reduction in metabolic activity 
was attributed to cell proliferation, the data was also normalized to day 1, shown in 
Figure 5.10(A). Once normalized to the number of metabolically active cells at day 1, it 
became apparent that the PEAs are not retarding cell growth, and thus the decreased cell 
metabolism in 8-Phe-4 and 8-Phe-4-Lys(TFA)-4 at 7 days was a consequence of reduced 
initial cell attachment to these materials. Similar behaviour with 8-Phe-4 and cationic 
functionalized PEAs was previously reported with bovine aortic endothelial cells 
(BAECs),29 but in their study, significantly fewer cells were metabolically active in their 
pendant carboxylic acid functional PEA and those which were viable formed clusters on 
the surface of the PEA, suggesting an inhospitable surface. Moreover, the metabolic 
activity of the BAECs was lower than on glass and appeared to stagnate at 72 hours in the 
carboxylic acid functionalized PEA.11 In Figure 5.9(B), SMC metabolic activity on 8-
Phe-8-Asp(OH)-4 was only significantly greater than the cationic 8-Phe-8-Lys(TFA)-4 at 
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all time points. The increased cell activity is again attributed to the decreased cell 
attachment observed at day 1 as illustrated by the normalized data shown in Figure 
5.10(B). 
 
Figure 5.9: HCASMC metabolic activity as determined by MTT assay. Cells were 
seeded at 20,000 cells/cm2 on 2D 8-Phe-4 (A) and 8-Phe-8 (B) functionalized PEA 
films and measured following 1, 3, 5 and 7 days of culture. Data are expressed as 
mean ± standard error for experiments conducted in triplicate. Statistical 
significance (p < 0.05) is denoted by *. 
Given the ability of the PEAs containing aspartic acid to support HCASMC activity up to 
7 days, the cell-material interactions were further investigated. In particular, the 
capability of the HCASMCs to form focal adhesions with the substrate was studied 
because it is a critical event in cell adhesion, migration and signal transduction.30 
Integrins are transmembrane proteins with surface receptors that bind specific ECM 
ligands. Binding with a surface receptor induces a change in the intracellular component, 
effectively transmitting information from the ECM to the cell. This signal transduction 
allows the cells to respond to their environment. The ability of HCASMCs to 
communicate with the substrate is conditional on the cell being able to form focal 
adhesive plaques, which link the transmembrane integrins with F-actin, the 
microfilamentous cytoskeleton of the cells. Vinculin is one of a number proteins involved 
in anchoring F-actin to integrin adhesive molecules31 and thus its presence was 
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investigated to confirm integrin-mediated communication between the HCASMCs and 
the extracellular matrix. 
 
Figure 5.10: HCASMC metabolic activity as determined by MTT assay. Cells were 
seeded at 20,000 cells/cm2 on 2D 8-Phe-4 (A) and 8-Phe-8 (B) functionalized PEA 
films and measured following 1, 3, 5 and 7 days of culture. Data are normalized to 
day 1 and expressed as mean ± standard error for experiments conducted in 
triplicate. Statistical significance (p < 0.05) is denoted by *. 
Figure 5.11 shows laser scanning confocal microscopy images of the HCASMCs cultured 
for 24 hours and 7 days on 2D PEAs containing aspartic acid. At 24 hours, the 
HCASMCs were stained for F-actin (green), vinculin (red) and nuclei (blue) as shown in 
panels (A)–(D). The 8-Phe-4-Asp(OH)-4, 8-Phe-8-Asp(OH)-4 and control glass coverslip 
(panels A–C) showed vinculin expression at the peripheries of the cells as highlighted by 
the white arrows. In the fibronectin-coated coverslip (D), vinculin expression was 
observed throughout the cell indicative of a more favourable substrate, which was 
anticipated due to the presence of the cell adhesive RGD motif. 
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Figure 5.11: Immunofluorescence microscopy images of HCASMCs after 24 h and 7 
days culture on 2D 8-Phe-4-Asp(OH)-4 and 8-Phe-8-Asp(OH)-4 PEA films. Control 
coverslips with and without fibronectin were used as controls. HCASMCs were 
stained for F-actin (green), vinculin (A – D; red, shown by arrowheads), smooth 
muscle α-actin (E – H, red), and nuclei (blue). Scale bar = 50 μm. 
In addition to supporting focal adhesion, an understanding of the effect of the functional 
PEAs on VSMC phenotype is critical as the smooth muscle cells can adopt one of two 
phenotypes. In the synthetic phenotype, the cells proliferate and secrete much of the 
extracellular matrix, a necessary first step in tissue maturation and remodeling. In the 
contractile phenotype, the cells contract in response to chemical, electrical and 
mechanical stimuli necessary in vasoactive blood vessels. Modulation of their phenotype 
is therefore paramount to the success of any tissue-engineered vascular graft. To examine 
the smooth muscle cell phenotype, the cells were stained for smooth muscle α-actin 
(SMαA, red), a known marker protein of the contractile phenotype. After 7 days of 
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culture, the immunofluorescence images (panels E–H) illustrate robust expression of F-
actin (green), but very little expression of SMαA (red), suggesting the HCASMCS were 
well-spread on the surface and primarily adopted a synthetic phenotype in both the PEAs 
containing aspartic acid and the controls. 
5.4.3 Three-Dimensional Electrospun Fibrous Mats 
Although the HCASMCs proliferate and form focal adhesions on two-dimensional films 
of the functional PEAs, the use of a functional PEA for vascular tissue engineering 
necessitates its fabrication into a three-dimensional scaffold to mimic the extracellular 
matrix. Collagen and elastin fibers, ranging in diameter from tens to hundreds of 
nanometers, serve as the primary structural proteins of the ECM.32 The tissue specific 
fibril arrangement of these proteins can also influence cell function.33 In fact, nano-scale 
topography resulted in differential changes in cytoskeletal organization, focal contact 
formation and subsequent motility, differentiation and gene expression between cell 
types. This nano-topography-dependent signal transduction may also occur independently 
of integrin-mediated signaling,34 thus dictating a nano-scale fibrillar scaffold. 
Electrospinning is a facile and versatile approach to generate nano-fibrous structures that 
can mimic the fibrillar structure of the extracellular matrix. The high porosity and surface 
area to volume ratio obtained from randomly oriented fibers are also ideal for cell 
infiltration, nutrient and waste transport and subsequent vascularization. Few studies have 
investigated electrospun PEAs,14,35-36 and to date, none have electrospun a functional 
PEA that can be further modified. Initial electrospinning studies were conducted with 8-
Phe-4, as it provided higher molecular weights, which was expected to generate more 
uniform fiber diameters.37 8-Phe-4 polymers having two different molecular weight were 
tested to evaluate to the impact of PEA molecular weight on average fiber diameter. 
The PEAs were electrospun from a 9:1 (wt:wt) co-solvent mixture of CHCl3:DMF, at 
varying concentrations to generate uniform fibers of nano-scale size as seen in Figure 
5.12. The lower molecular weight 8-Phe-4 (Mn = 48.4 kg/mol) generated a slightly larger 
average fiber diameter, yet a narrower distribution of fiber diameters (panels A–C) when 
compared to the higher molecular weight 8-Phe-4 (Mn = 70.3 kg/mol, panels D–F) as the 
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average fiber diameters were 294 ± 7 and 274 ± 14 nm, respectively. The statistically 
equivalent average fiber diameters suggest that uniform nano-scaled fibers can be 
obtained reproducibly from 8-Phe-4 PEAs of different molecular weights provided that 
the viscosities of the solutions are comparable. 
 
Figure 5.12: Scanning electron microscopy images of electrospun fibrous mats from 
a solution of 8-Phe-4 or 8-Phe-4-Asp(OH)-4 in a co-solvent mixture of 9:1 (wt:wt) 
CHCl3:DMF. 8-Phe-4 was electrospun at a concentration of 9.2 wt% for a Mn = 48.4 
kg/mol (panels A–C); and 5 wt% for a Mn = 70.3 kg/mol (panels D–F), while 8-Phe-
4-Asp(OH)-4 (panel G–I) was electrospun from a 7.5 wt% solution. Scale bars 
represent 50, 10 and 5 µm, respectively. 
Uniform, bead-free fibers of 8-Phe-4 have been reported previously; however, in the 
study by Li and Chu, the smallest average fiber diameter from a 2:1 (vol:vol) co-solvent 
mixture of CHCl3:DMF obtained was 640 nm. The larger average fiber diameter 
achieved in their study is attributed to their relatively low molecular weight (Mn = 13.6 
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kg/mol) and subsequent need for a high polymer concentration (39% wt/vol).35 In the 8-
Phe-4-Asp(OH)-4 case, an average fiber diameter of 130 ± 5 nm (panels G–I) was 
obtained. The reduced average fiber diameter could be a result of the increased charge 
density from the pendant carboxylic acid groups. As little as 0.1% poly(acrylic acid 
sodium salt) (PAA) and poly(allylamine hydrochloride) (PAH) has shown to significantly 
decrease the average fiber diameter of poly(ethylene oxide) (PEO) fibers.38 Moreover, the 
addition of these polyelectrolytes reduced the concentration of the PEO needed to form 
fibers, further reducing the fiber diameter.38 The molecular weight of the protected 8-Phe-
4-Asp(O-t-Bu)-4 was 34.7 kg/mol, which based on the 8-Phe-4 data, would suggest 
needing a higher concentration than the 9.2 wt% (48.8 kg/mol 8-Phe-4) to maintain the 
same viscosity. Given that uniform fibers were obtained at a concentration of 7.5 wt%, it 
is believed that the increasing charge density from 8-Phe-4-Asp(OH)-4 resulted in a 
increase in whipping instability upon ejection from the needle tip, thus resulting in a 
decreased fiber diameter.37,39 
5.4.4 Vascular Smooth Muscle Cell Morphology on Three-
Dimensional Scaffolds 
The successful electrospinning of both 8-Phe-4 and 8-Phe-4-Asp(OH)-4 enabled the 
study of their interaction with HCASMCs. Initially, a time series analysis was conducted 
to assess the attachment and morphology of the HCASMCs on the surface of the 
electrospun mats. As can be seen from Figure 5.13(A), at 4 h, the HCASMCs are well-
spread on the surface of the 8-Phe-4 electrospun mat. At 8 h (panel C), the fibers begin to 
flatten and fuse together, while at 24 h (panel E), the appearance of a secondary layer 
becomes apparent, presumably the extracellular matrix secreted by the SMCs. At 4 days, 
the fibers are no longer detected, as the fibers are completely covered by the secretion of 
the ECM (panel G). In the 8-Phe-4-Asp(OH)-4 case, fibers were not detected as early as 
4 h (panel B). Although the cells attached and spread on the surface of 8-Phe-4-Asp(OH)-
4, including up to 4 days of culture (panel H), the lack of a fibrous mat suggested an 
interaction of the HCASMCs with a two-dimensional substrate. 
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Figure 5.13: Scanning electron microscopy images of HCASMCs cultured up to 4 
days on fibrous 8-Phe-4 and 8-Phe-4-Asp(OH)-4 electrospun mats. Scale bar 
represents 50 µm. 
The loss of electrospun fibers was further investigated to ascertain whether the cells 
resulted in the loss of the 3D porous scaffold. Individual stages in the culture of the cells 
on the material were investigated and are shown in Figure 5.14. As illustrated, the fibrous 
mat was retained following long-term storage at 4°C (panel A), but following sterilization 
with 70% ethanol and UV irradiation, the fibers had fused together to form a film-like 
structure (panel B). The addition of media (panel C) or culture of cells for 4 h (panel D) 
had no supplemental impact on the surface of the 8-Phe-4-Asp(OH)-4. However, when 
the fibers were exposed to the fixation media and the dehydration and drying steps 
necessary for SEM imaging, again changes in the surface could be observed, in particular 
following the addition of ethanol and hexamethyldisilazane (HMDS). Given the loss of 
the 3D porous network, yet lack of solubility of 8-Phe-4-Asp(OH)-4 during sterilization 
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and post-culture image preparation, a plasticizing effect facilitated by the 10 mol% 
Asp(OH)-4 monomer is proposed. 
 
Figure 5.14: Scanning electron microscopy images of 8-Phe-4-Asp(OH)-4 at 
individual stages of cell culture following – storage at 4°C (A); sterilization with 
70% ethanol and UV irradiation (B); sterilization and exposure to culture media 
(C); 4 hour culture with HCASMCs (D); fixation with 4% formaldehyde (E); and 
dehydration and drying with ethanol and hexamethyldisilazane, respectively (F). 
Scale bar represents 50 µm. 
Despite the inability of the HCASMCs to infiltrate the 8-Phe-4-Asp(OH)-4 scaffold due 
to loss of the 3D network prior to seeding, the porous structure of the 8-Phe-4 electrospun 
mat was retained, and thus cell infiltration was assessed using confocal microscopy. 
Focus stacking (also known as Z-stacking) was employed to provide a greater depth of 
field to include all parts of the cells within the field of view. In Figure 5.15(A), the 
HCASMCs appeared stretched with abundant F-actin expression and could be detected to 
a depth of 45 µm. Upon rotation of the stacked image though, cell penetration was shown 
to be non-uniform (panel B). In an orthogonal view and using the fluorescence of the 8-
Phe-4 (shown in red), the variability in the cell depth was attributed to the surface 
roughness of the electrospun mat as cells were only observed on the surface of the fibrous 
scaffold and not within it (panel C). The diminished migration of VSMCs into porous 
169 
 
 
scaffolds following static seeding has been previously reported. Dynamic seeding using 
spinner flasks or vacuum seeding apparatuses have shown improved smooth muscle cell 
and fibroblast penetration and distribution in PGA and PCL matrices, respectively.40-41 
Despite the lack of cell infiltration from the passive seeding technique though, the porous 
8-Phe-4 structure would still enable nutrient or growth cues to be delivered three-
dimensionally.33 
 
Figure 5.15: Confocal microscopy images of HCASMCs seeded at a density of 
30,000 cells/scaffold and cultured for 4 days on 8-Phe-4 electrospun mats. 
HCASMCs were stained for F-actin (shown in green) and nuclei (blue) with 
fluorescence of the 8-Phe-4 scaffold (shown in red). Composite Z-stack image taken 
up to a depth of 45 μm on 8-Phe-4 (A); rotated to show depths of cells (B); and an 
orthogonal view to demonstrate cells sitting on surface of the electrospun mat (red) 
(C). Scale bar = 100 μm. 
5.4.5 Western Blot Analysis 
The impact of the three-dimensional delivery of nutrients or signaling molecules was 
investigated via Western blot analysis. The loss of the 3D network of the 8-Phe-4-
Asp(OH)-4 prior to HCASMC seeding precluded its examination in the immunoblotting 
studies. Therefore, the cells were cultured on 2D films of 8-Phe-4 and 8-Phe-4-Asp(OH)-
4 and 3D scaffolds of 8-Phe-4 for 4 (Figure 5.16) and 7 days (Figure 5.17) to compare the 
effect the functional amino acid in 2D cultures and the impact of 3D architecture on SMC 
contractile phenotype marker proteins. The exogenous addition of transforming growth 
factor-β1 (TGF-β1) was also tested to assess whether TGF-β1 could up-regulate 
contractile marker protein expression from HCASMCs cultured on the surfaces of the 
PEAs as previously observed with the biostable poly(carbonate urethane).25 
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Figure 5.16: Western blot data following HCASMC culture for 4 days. HCASMC 
contractile phenotype marker proteins smooth muscle α-actin (SMαA) and calponin 
were analyzed from 8-Phe-4 (2D films and 3D electrospun mats), 8-Phe-4-Asp(OH)-
4 (2D films) and normalized to tissue culture polystyrene (TCPS). Protein 
expression was also evaluated following exogenous addition of TGF-β1. 
The addition of TGF-β1 in all 2D films resulted in a modest increase in the expression of 
the contractile phenotype marker proteins SMαA and calponin at four days as shown in 
Figure 5.16. In the absence of TGF-β1, the 3D structure alone suggested an increasing 
trend in contractile phenotype marker protein expression. Despite these trends in the 
immunoblotting data, the results are not significant due to the inherent error in the data, 
in part because of the variability in primary cell culture where primary cells are harvested 
from multiple donors. Although studies have been conducted with TGF-β1 at 
concentrations as little as 1 ng/mL, an exogenous concentration of 3 ng/mL was selected 
for this study based on previous work with HCASMCs. In those studies, the TGF-β1 was 
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reconstituted with carrier molecules bovine serum albumin (BSA) and trehalose,25 while 
in this study, the TGF-β1 was reconstituted in diluted hydrochloric acid in the absence of 
carrier molecules as their presence would have interfered with the subsequent 
conjugation to the functional PEA. The lack of carrier molecules may have affected the 
reconstitution of the growth factor resulting in sub-optimal delivery of the TGF-β1. 
Moreover, the potential presence of TGF-β1 in the fetal bovine serum42 of the media may 
have limited the efficacy of additional growth factor. 
 
Figure 5.17: Western blot data following HCASMC culture for 7 days. HCASMC 
contractile phenotype marker proteins smooth muscle α-actin (SMαA) and calponin 
were analyzed from 8-Phe-4 (2D films and 3D electrospun mats), 8-Phe-4-Asp(OH)-
4 (2D films) and normalized to tissue culture polystyrene (TCPS). Protein 
expression was also evaluated following exogenous addition of TGF-β1. 
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At seven days (Figure 5.17), little change was observed with the addition of TGF-β1. In 
only the 8-Phe-4-Asp(OH)-4 was there an increasing trend in contractile phenotype 
marker protein expression following the addition of TGF-β1, but it too did not reach 
statistical significance. As observed in the Western blot data at four days, enhanced 
contractile phenotype marker protein expression was observed between the 8-Phe-4 films 
and electrospun mats, implying that despite the lack of cell infiltration, the porous 
scaffold may allow the cells to interact with its environment three-dimensionally. 
Although architecture alone suggested an enhanced expression of SMαA and calponin, 
the exogenous addition of TGF-β1 had no effect on the contractile phenotype marker 
protein expression on 3D scaffolds at 7 days. Again, the lack of effect is attributed to the 
inherent variability in the data, potential sub-optimal delivery of the growth factor, its 
saturation due to TGF-β1’s potential presence in the fetal bovine serum or combinations 
thereof. 
5.4.6 TGF-β1 Conjugation to 8-Phe-4-Asp(OH)-4 
The loss of the 3D network of the 8-Phe-4-Asp(OH)-4 electrospun mat did not preclude it 
from being functionalized with TGF-β1. A functional PEA with a pendant carboxylic 
acid group was selected for conjugation in part due to the structure of the TGF-β1. The 
primary structure revealed an equivalent number of pendant amine and carboxylate 
groups at physiologic pH43 and thus did not favour the reaction of one complementary 
group over the other. The bioactivity of the growth factor was believed to be part of the 
octapeptide sequence at the C-terminus of the growth factor as its cleavage resulted in a 
loss of bioactivity.43 The quaternary structure of TGF-β1 suggests the C- and N- termini 
are in close proximity, as shown in Figure 5.18;44 therefore, conjugation to amino acids in 
the heart of the primary structure was sought. Given the flexibility in conjugating to 
TGF-β1, the PEA having pendant carboxylic acid moieties was selected due to its ease in 
activation using a simple EDC/sulfo-NHS conjugation strategy and subsequent reaction 
with a deprotonated amine group of the TGF-β1, as shown in Scheme 5.1. 
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Figure 5.18: Ribbon diagram representing the Cα backbone coordinates of the 
solution structure of the TGF-β1 homodimer. Regular elements of secondary 
structure are identified, along with the N and C termini of the two monomers.44 
Reprinted with permission from (Hinck, A. P.; Archer, S. J.; Qian, S. W. et al. 
Biochemistry 1996, 35 (26), 8517-8534). Copyright (1996) American Chemical 
Society. Protein chains are coloured from the N-terminus to the C-terminus using a 
rainbow (spectral) colour gradient. 
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Scheme 5.1: Conjugation of TGF-β1 to 8-Phe-4-Asp(OH)-4 using EDC/sulfo-NHS 
peptide coupling. 
TGF-β1 
TGF-β1 
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Two approaches were explored to confirm the conjugation of TGF-β1 to 8-Phe-4-
Asp(OH)-4. Initially, the scaffolds were characterized by X-ray photoelectron 
spectroscopy (XPS) to reveal the elemental analysis up to a depth of 5–7 nm from the 
surface. The spectra, shown in Figure 5.19, and their corresponding elemental analyses 
provided in Table 5.2, illustrate the adsorbed and covalently conjugated TGF-β1 to the 
surface of 8-Phe-4-Asp(OH)-4 scaffolds. The scaffolds were treated identically except 
that in the adsorption study, the activation with EDC/sulfo-NHS was omitted. 
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Figure 5.19: Wide-scan X-ray photoelectron spectra of TGF-β1 adsorbed and 
conjugated to the surface of 8-Phe-4-Asp(OH)-4. 
The XPS data revealed both an increase in the sulfur (S 2p) and nitrogen (N 1s) content 
between the adsorbed and conjugated scaffolds suggesting an increase in TGF-β1 
following conjugation. The increase in sulfur content is attributed to the presence of the 
cysteine amino acid, as no sulfur is present in the functional PEA. This atomic 
composition is comparable to a previous finding where fibronectin was conjugated to 3D 
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scaffolds and showed a reaction time-dependent sulfur content of 0.2-0.6%.45 However, 
unlike fibronectin which has 62 cysteine residues per subunit, there are only seven 
cysteine residues in TGF-β1,43 suggesting that its conjugation in the present study was 
more effective than the fibronectin conjugation. The enhanced nitrogen content is 
ascribed to the significant number of peptide bonds from the growth factor. The presence 
of silicon was attributed to silicone grease contamination, which also impacted the atomic 
percentages of oxygen (O 1s) and carbon (C 1s) rendering their comparisons difficult. 
Table 5.2: Elemental analysis from X-ray photoelectron spectra of TGF-β1 
adsorbed and conjugated to the surface of 8-Phe-4-Asp(OH)-4. 
 
Binding 
Energy (eV) 
Adsorbed 
(Atomic %) 
Conjugated 
(Atomic %) 
Na 1s 1067.65 0.1 0.1 
F 1s 686.15 0.3 0.2 
O 1s 528.65 14.7 13.9 
N 1s 396.35 2.2 2.9 
C 1s 281.55 77.8 78.8 
S 2p 164.65 0.0 0.2 
Si 2p 98.15 5.0 2.8 
The increase in TGF-β1 at the surface of 8-Phe-4-Asp(OH)-4 following covalent 
attachment was further evaluated with immunofluorescence as illustrated in Figure 5.20. 
The functional PEA alone (panel A) showed little fluorescence, while the TGF-β1 
adsorption study showed stronger fluorescence (panel B). The smooth surface in the 
adsorbed case appears similar to the film-like structure upon exposure to aqueous media 
(see Figure 5.14). The covalently conjugated surface was rougher and exhibited higher 
fluorescence than the adsorbed TGF-β1 suggesting the successful coordination of the 
fluorescently labeled secondary antibody. The inherent fluorescence of the adsorbed 
study is attributed to the entrapment of the secondary antibody as the surface was 
plasticized in buffer, which would also occur in the TGF-β1-conjugated study, and thus 
the difference between the adsorbed and conjugated studies would provide some 
indication of the true fluorescence contribution from the TGF-β1 grafted functional 
PEAs. 
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Figure 5.20: Immunofluorescence images of 8-Phe-4-Asp(OH)-4 alone (A); TGF-β1 
adsorbed to surface of 8-Phe-4-Asp(OH)-4 (B); and TGF-β1-conjugated to surface 
of 8-Phe-4-Asp(OH)-4 (C). Scale bar represents 50 µm. 
5.5 Conclusions 
Functional poly(ester amide)s containing pendant carboxylic acid groups were 
successfully synthesized by incorporating a protected version of the naturally occurring 
α-amino acid L-aspartic acid into the PEA backbone through a facile interfacial 
polycondensation approach. The molecular weights of the functional PEAs containing 10 
mol% functional monomer were lower than the corresponding base polymers suggesting 
that the functional monomer did not polymerize as effectively as the base monomer. The 
protected functional PEAs had glass transition temperatures lower than the base polymer 
suggesting improved free volume attributed to the tert-butyl group, while the deprotected 
functional PEAs exhibited a Tg greater than the base polymer implying increased 
hydrogen bonding of the pendant carboxylic acid groups. 
Human coronary artery smooth muscle cell attachment and spreading was observed on 
two-dimensional PEA films with robust F-actin expression throughout the cells, while 
vinculin expression was primarily seen at the periphery of the HCASMCs. Vinculin 
expression suggested the cells were forming focal adhesions with the substrate, while the 
lack of smooth muscle α-actin expressed at seven days implied a proliferative phenotype. 
Metabolic activity on 2D films increased throughout the seven day culture, with the 
aspartic acid containing PEAs supporting as many or more metabolically active cells as 
the corresponding base and cationic PEAs. 
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Nano-scale three-dimensional scaffolds were successfully electrospun from low polymer 
concentrations in a co-solvent mixture of CHCl3:DMF of 9:1, where the increasing 
charge density from 8-Phe-4-Asp(OH)-4 resulted in a decreased average fiber diameter. 
HCASMC culture on these 3D scaffolds illustrated cell spreading on the surface of 
electrospun mats as early as four hours, but with little cell infiltration likely due to static 
seeding. 
Immunoblotting studies suggested an increasing trend in smooth muscle α-actin and 
calponin expression from HCASMCs cultured on 2D PEA films with the exogenous 
addition of TGF-β1 at four days. At seven days, increasing contractile phenotype marker 
protein expression was observed between 2D films and 3D scaffolds suggesting 
architecture alone promotes the HCASMC contractile phenotype. Despite the trends in 
the immunoblotting data, significance was not achieved. X-ray photoelectron 
spectroscopy and immunofluorescence demonstrated the conjugation of transforming 
growth factor-β1 to the surface of 8-Phe-4-Asp(OH)-4. Collectively, this study shows 
that the aspartic acid containing PEAs are good candidates as vascular biomaterials 
because they support HCASMC attachment, spreading, proliferation and can be 
electrospun into 3D scaffolds. The pendant carboxylic acid groups also enabled the 
conjugation of TGF-β1 to the surface, warranting further investigation into these 
functional PEAs as biomimetic vascular scaffolds. 
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Chapter 6  
6 General Discussion and Conclusions 
This chapter provides a summary of the research and discusses the strengths and 
limitations of this work and future directions. Significance of the research will also be 
discussed. 
6.1 Summary 
The focus of the research was to develop a biomimetic degradable vascular scaffold that 
would support human coronary artery smooth muscle cell attachment, spreading, 
proliferation and phenotype modulation that could ultimately be considered as part of an 
in vitro tissue-engineered blood vessel strategy. To that end, a family of degradable PEAs 
was initially synthesized to screen them for vascular tissue engineering applications. The 
rationale for investigating PEAs stemmed from the fact that they combine the 
advantageous properties of both polyesters and polyamides – the tunability in the 
degradation rate via the ester groups and mechanical strength via the hydrogen bonding 
of the amide groups. The ester and amide linkages promote both hydrolytic and 
enzymatic degradation, which should ensure a surface degradation mechanism,1-3 
whereby the individual constituents would control the rate of degradation. In addition, the 
careful selection of the monomers would enable the generation of polymers with suitable 
thermal properties. 
The PEAs used in this study were derived from naturally occurring α-amino acids, 
aliphatic diols and diacids. The incorporation of a long chain aliphatic diacid (sebacic 
acid) was selected for two reasons. First, the long range segmental motion of the polymer 
chains yielded PEAs with glass transition temperatures at or below physiologic 
temperature ensuring a degree of pliability.1,4 Secondly, the hydrophobicity of the 
monomer enabled its usage in an interfacial polycondensation reaction,4 conventionally 
used in polyamide syntheses. The acid-catalyzed condensation of L-alanine or L-
phenylalanine with the aliphatic diols 1,4-butanediol or 1,8-octanediol were selected to 
evaluate their impact on the thermal and mechanical properties. It was anticipated that the 
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PEAs based on these monomers would generate polymers with relatively low melting 
temperatures, which would facilitate their processing in the melt.1,5 Additionally, PEAs 
based on L-alanine have demonstrated lower Tgs than those PEAs incorporating the 
bulkier benzyl group of L-phenylalanine;1,5 however, these PEAs also tend to be more 
semi-crystalline,6 which may not offer the elasticity needed of a vascular scaffold. As 
such, a family of PEAs based on these monomers was synthesized to ascertain the most 
suitable PEA for vascular tissue engineering. 
In addition, the synthetic approach adopted in this work permitted the introduction of tri-
functional amino acids such as L-lysine and L-aspartic acid into the polymer backbone 
yielding complementary functional handles for conjugation of biomolecules that can 
modulate host response or direct cell function. Although an acid-catalyzed condensation 
of the functional amino acids could not be adopted due to the acid labile protecting 
groups necessary for selective polymerization of the monomer, a facile condensation 
approach was achieved using dicyclohexylcarbodiimide as a coupling agent that could be 
used for both orthogonally protected functional amino acids.7 
As mentioned, the selection of the aliphatic diacid sebacic acid enabled the 
polymerization to occur at the interface of a heterogeneous mixture. Specifically, the acid 
chloride of sebacic acid (sebacoyl chloride) was selected and added dropwise to a 
solution containing the amine in the presence of base to generate the amide group in a 
reaction known as the Schotten-Baumann reaction.8 In the solution polymerization, 
sebacoyl chloride was not used in the presence of base as the reaction would potentially 
result in unwanted side reactions.9 Consequently, the acid chloride was converted to a 
more stable activated ester to ensure selective polycondensation with the diamine 
monomers.9 Although the polymerization approaches were slightly different, each 
method yielded identical polymer structures, permitting a direct comparison. The PEAs 
derived from each polymerization approach were compared in terms of purity, yield and 
molecular weight. Equally pure PEAs could be obtained from both approaches as 
evidenced by identical 1H and 13C NMR and FTIR spectra. Characterization of the 
polymer molecular weights obtained from GPC revealed that all PEAs synthesized 
interfacially were higher molecular weight. The enhanced polymerization was in part 
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attributed to the improved reactivity of the acid chloride when compared to the activated 
ester.10 Secondly, any impurities from the monomer syntheses would likely remain in the 
bulk phase and have less impact on polymer chain propagation at the interface than in 
solution.8 Of the PEAs tested, 8-Phe-4 yielded the highest weight average molecular 
weights with 8-Ala-8 yielding the lowest. The molecular weight trend was also 
maintained with the functional PEAs, even though the functional PEAs did not 
polymerize as readily. Of the functional monomers, the lysine-based PEAs generated 
greater weight average molecular weights when compared to their corresponding aspartic 
acid containing PEAs.  
The thermal properties were measured using DSC and TGA. As expected, all PEAs had 
glass transition temperatures ranging from 11.8 to 43.5°C with 8-Ala-8 providing the 
lowest Tg and 8-Phe-4 exhibiting the highest Tg. Despite the Tg of 8-Phe-4 being greater 
than physiologic temperature, it is anticipated that in a hydrated state during in vitro 
tissue maturation in a bioreactor, the free volume of the polymer chains would be 
increased through solvation, thus resulting in a lower Tg,11-12 and providing a degree of 
pliability. A comparison to 8-Phe-8 revealed the direct impact of the amino acid and diol 
chain length on the Tg. Compared to 8-Ala-8, the bulky benzyl group of 8-Phe-8 
restricted polymer chain motion increasing the Tg to approximately 25°C. In contrast to 
8-Phe-4, the longer diol limited hydrogen bonding between chains, facilitating long-range 
segmental motion, hence giving a lower Tg than 8-Phe-4.5 Incorporation of the functional 
amino acids generally resulted in an increase in Tg attributed to improved hydrogen 
bonding of the charged functional groups following removal of the protecting groups. 
The increased Tg was observed despite the replacement of the bulky benzyl groups of L-
phenylalanine with the aliphatic functional handles of L-lysine or L-aspartic acid. 
The TGA data revealed that all non-functional PEAs yielded decomposition temperatures 
in excess of 300°C, well above their melting ranges, thus ensuring these PEAs could be 
processed in the melt. The incorporation of lysine into the PEA backbone had little effect 
on the decomposition of the polymer itself. The mass loss attributed to the thermal 
cleavage of the BOC protecting group was also observed in the TFA salts (albeit at lower 
temperatures). The derivative weight demonstrated no change thereafter implying the 
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lysine monomer did alter the bulk decomposition of the PEA. In the aspartic acid 
containing PEAs, again thermal cleavage of the tert-butyl protecting group was observed; 
however, differences in the decomposition of the base and the deprotected aspartic acid 
containing PEAs suggest that the introduction of aspartic acid does ultimately reduce the 
decomposition temperature of the functional PEA. Despite the effect of aspartic acid, 
these functional PEAs still exhibited decomposition temperatures well in excess of 
200°C, suggesting they still could be processed in the melt. 
The consideration of these PEAs for vascular tissue engineering depends not only on the 
polymer’s chemical and thermal properties, but on their ability to support vascular cell 
attachment, proliferation and function. HCASMC attachment and morphology, 
investigated using light and fluorescence microscopy, demonstrated that the cells 
attached and spread well on 2D films of all base PEAs up to 7 days of culture. Abundant 
expression of filamentous actin (F-actin), a cytoskeletal protein necessary in cell motility, 
was also observed in the laser scanning confocal microscopy images. In addition to cell 
morphology, the MTT assay data revealed increased metabolic acitivity of the cells on 
the surface of the 2D films up to 5 days. 
Although the pendant functional groups were ultimately designed for the incorporation of 
signaling molecules, the impact of surface charge on cell behaviour was also studied due 
to the varied response of cells cultured on different surface functionalized materials. 
While hydrophilic surfaces tend to promote cell adhesion, the surface charge appears to 
have a greater impact on the surface adhesion of proteins, which can influence cell 
adhesion, morphology, proliferation and differentiation.13 The lysine-containing 
functional PEAs supported HCASMC proliferation, but generally yielded lower 
metabolic activity at 7 days than the corresponding base and functional PEA containing 
aspartic acid, which was attributed to an initial reduction in metabolic activity, due to the 
trifluoroacetate anion.14 HCASMCs cultured on 2D lysine-containing functional PEAs 
appeared less stretched with a corresponding reduction in F-actin expression than their 
non-functional counterparts. The aspartic acid containing functional PEAs did not inhibit 
either SMC adhesion or metabolic activity. Moreover, the HCASMCs spread well and 
expressed abundant F-actin on the functional PEAs containing aspartic acid, similar to 
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the base PEAs. These results are promising and contradict a previous report, where 
bovine aortic endothelial cells formed clusters on the surface of a functional PEA with 
pendant carboxylic acid groups, while concomitantly reducing metabolic activity.15  
Given the encouraging cell attachment, spreading and metabolic activity data on the 2D 
films, in particular the base and the functional PEAs containing aspartic acid, the ability 
of HCASMCs to form focal adhesions with the substrate was sought. Focal adhesions 
enable the transmission of information from the ECM to the cell, allowing the cells to 
respond to its surroundings.16 Vinculin, a protein involved in anchoring F-actin to the cell 
membrane of focal adhesions was expressed by HCASMCs on all 2D PEA films as 
illustrated by the immunofluorescence studies. The integrin-mediated focal adhesions 
were primarily formed at the peripheries of the cells on all PEA films.  
Although the HCASMCs formed focal adhesions with the substrate, given that protein 
adsorption is typically the first event in cell adhesion to that particular surface,17 cell 
culture was also conducted in the absence of serum to ascertain the direct interaction 
between the HCASMCs and the PEAs. The formation of focal adhesions with the 
underlying PEAs was examined and compared using two separate techniques: waveguide 
evanescent field fluorescence (WEFF) and immunofluorescence. The use of WEFF 
microscopy for analyzing cell-substratum contact regions is a relatively new endeavor, 
whereby an evanescent field can be generated up to 70 nm from a waveguide, resulting in 
excitation of fluorescent molecules within that evanescent field. The examination of the 
interfacial contact region between HCASMCs and the polymer substrate necessitated the 
fabrication of ultrathin PEA films. Neither solvent casting nor spin-coating afforded 
suitable films, and therefore Langmuir-Blodgett technology was adopted to prepare the 
films. Despite the long polymeric chains and propensity to hydrogen bond, closed and 
uniform PEA films could be obtained, with film thicknesses ranging from 11 to 21 nm. 
In the WEFF microscopy studies, no differences in the number of cell adhesions (which 
included both close contacts and focal adhesions) were observed in serum-containing or 
serum-free culture; however, a statistically significant increase in cell adhesions between 
the 8-Phe-8-Lys(TFA)-4 and bare waveguide was observed in both culture conditions. 
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The immunofluorescence studies also revealed a similar number of focal adhesions per 
cell and per unit area in both culture conditions. It was anticipated that the lysine-
containing functional PEA may promote cell adhesion to the polymer surface in the 
absence of serum through electrostatic interactions between the cationic pendant amine 
groups and the negatively charged glycocalyses of the cells. In the presence of serum, the 
cationic surface was expected to interact with adhesive serum proteins fibronectin and 
vitronectin, which are both negatively charged at physiologic pH.18-19 However, only in 
the case of serum-based media and fibronectin-coating, was an increase in the number of 
focal adhesions observed. This suggested that the fibronectin may have facilitated the 
adsorption of a secondary protein from the serum that ultimately improved HCASMC 
focal adhesion formation. 
Even though focal adhesions were formed with all PEA surfaces in the presence or 
absence of serum, smooth muscle α-actin expression was not abundant, suggesting that 
the HCASMCs had adopted a synthetic phenotype, typical of 2D SMC culture.20 
Modulation of the SMC phenotype has been shown through 3D architecture, signaling 
molecules including TGF-β1, mechanical stimulation and co-culture with other cells,21 
suggesting that the quiescent contractile phenotype of SMCs can be realized in vascular 
tissue engineering using one or more of these strategies. 
The 3D network not only modulates SMC phenotype, but the cellular microenvironment 
also influences cytoskeletal organization, focal adhesions, cell motility, differentiation 
and gene expression. This signal transduction from the nano-scale extracellular matrix 
can act independently of integrin-signaling,22 implying that extracellular matrix mimicry 
is a vital tool in the development of vascular tissue. Nano-scale fibrous PEA mats were 
achieved by electrospinning PEA solutions in a co-solvent mixture of 9:1 (wt:wt) CHCl3. 
As higher molecular weight polymers are expected to generate more uniform fibers,23 8-
Phe-4 was initially selected for electrospinning. Statistically equivalent average fiber 
diameters (294 ± 7 and 274 ± 14 nm) were achieved from two different 8-Phe-4 
molecular weights (Mn = 48.4 kg/mol and 70.3 kg/mol, respectively) when comparable 
viscosities were used. These results compare favourably with a previous study where the 
smallest 8-Phe-4 average fiber diameter from a 2:1 (vol:vol) co-solvent mixture of 
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CHCl3:DMF was 640 nm. The larger average fiber diameter is attributed to their 
relatively low molecular weight (Mn = 13.6 kg/mol) and consequently high polymer 
concentration (39% wt/vol)24 compared with polymer concentrations of 9.2 and 5 wt% in 
this study.  
Although non-functional PEAs have been electrospun in previous studies,3,25 to date, 
there are no reported studies of a successfully electrospun functional PEA. The 8-Phe-4-
Asp(OH)-4 PEA was selected for electrospinning due to its facilitation of HCASMC 
attachment, spreading and proliferation compared to the functional PEAs containing 
lysine. Uniform, bead-free fibers with an average fiber diameter of 130 ± 5 nm were 
obtained. The smaller average fiber diameter is attributed to the increased charge density 
from the pendant carboxylic acid groups, increasing the whipping instability of the jet, 
reducing the fiber diameter.23,26 The increase in whipping instability also enabled uniform 
fibers to be generated from lower polymer concentrations further reducing the average 
fiber diameter.27 
The generation of nano-scale fibrous mats enabled the interaction between HCASMCs 
and the PEAs to be studied in a 3D context. A time-course analysis revealed that the cells 
attached and spread well on the surface of the 8-Phe-4 electrospun mats as early as 4 
hours. By 24 hours, the cells began to cover the electrospun mat with their own ECM and 
at 4 days, fibers could no longer be detected. In the 8-Phe-4-Asp(OH)-4 case, HCASMCs 
attached and spread; however, fibers were not detectable. The loss of the fibrillar 
structure was attributed to a plasticizing effect due to the increased hydrophilicity of the 
aspartic acid monomers, potentially due to the hydration of the pendant carboxylic acid 
groups. 
Although the fusion of the 8-Phe-4-Asp(OH)-4 fibers precluded the investigation of cell 
infiltration into these scaffolds, the porous structure of the 8-Phe-4 electrospun mats was 
retained allowing cell penetration to be studied using LSCM. The fluorescence 
contributed by the material illustrated that the HCASMCs were in fact sitting on the 
surface, and did not infiltrate the porous electrospun mat, confirming the SEM data. The 
inability to infiltrate porous scaffolds has been previously observed with static culturing 
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techniques. Although the cells did not migrate into the electrospun mat, the porosity of 
the scaffold would still allow nutrients or signaling molecules to be delivered three-
dimensionally.28 
The 3D delivery of signaling molecules was assessed using Western blot analysis, where 
TGF-β1 was added exogenously to 8-Phe-4 electrospun mats and compared with 2D 
controls to assess the growth factor’s impact on the regulation of the SMC phenotype. 
Although a modest increase in the expression of both smooth muscle α-actin and calponin 
was observed on all 2D films at 4 days, the results were not statistically significant. The 
architecture alone suggested an effect on SMC phenotype with an increasing trend in 
both SMαA and calponin expression in the 3D scaffolds compared to 2D films at 4 and 7 
days, reinforcing the concept that the cellular microenvironment can modulate the SMC 
contractile phenotype. 
To date, most studies demonstrating the beneficial effects of TGF-β1 have used an 
exogenous addition of TGF-β1, but improved elastin synthesis has been demonstrated 
with controlled delivery of TGF-β1 from a fibrin gel.29 For sustained delivery as part of 
an in vitro matured vascular graft construct, the cytokine must be immobilized to the 
surface or embedded within the scaffold. The structure of the growth factor revealed a 
degree in flexibility in conjugating to TGF-β1, thus the free carboxylic acid containing 
PEA was selected due to its ease in activation using a simple EDC/sulfo-NHS 
conjugation strategy. Subsequently, the activated intermediate was reacted with a 
deprotonated amine group of the TGF-β1, affixing the growth factor to the surface of the 
functional PEA, as determined by X-ray photoelectron spectroscopy and 
immunofluorescence. The XPS data showed an increase in both N 1s and S 2p binding 
energies following covalent attachment of the TGF-β1, attributed to the peptide linkages 
and cysteine residues, respectively. The immunofluorescence studies revealed increased 
fluorescence following the conjugation of TGF-β1 to the surface of 8-Phe-4-Asp(OH)-4 
suggesting the successful grafting of the growth factor to the functional PEA. 
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6.2 Strengths and Limitations 
Firstly, this study demonstrated the versatility in the synthetic approach, where 
substituting monomers could achieve polymers with differing properties without having 
to adopt new synthetic routes. The base monomers were generated through a simple acid-
catalyzed condensation reaction,5 while the functional monomers were achieved through 
a dicyclohexylcarbodiimide coupling reaction of orthogonally protected amino acids.7 In 
all cases, polymerization could be achieved through a solution or interfacial 
polycondensation of the selected monomers followed by cleavage of the pendant 
protecting group.30 
Another strength of this work lies in the positive interaction of these PEAs with human 
coronary artery smooth muscle cells. To best evaluate the real interaction between the 
material and cells, HCASMCs were seeded directly on the surfaces of all PEAs. Surfaces 
were not pre-treated nor coated with any cell adhesive proteins or peptides. Vinculin 
immunostaining of the HCASMCs showed that cells expressed vinculin at the periphery 
of the cell implying integrin-mediated signaling with all 2D PEA surfaces30 and that it 
was independent of serum.31 Although fluorescence microscopy may have demonstrated 
that the HCASMCs did not spread as well on the lysine-containing functional PEAs, 
compared to the base30 and functional PEAs containing aspartic acid, this was attributed 
to the trifluoroacetate anion,14 which appeared to inhibit cell attachment. Despite the 
reduction in cell adhesion, metabolic activity increased throughout the culture period, 
suggesting all PEAs served as a favourable surface for HCASMC proliferation. The 
selection of tissue-specific human vascular cells may also serve to better model the 
interactions between the cells and PEAs,32 as demonstrated by the poor cell spreading and 
muted metabolic activity of bovine aortic endothelial cells on a functional PEA with 
pendant carboxylic acid moieties.15 
Given that the nano-scale fibrillar arrangement of extracellular matrix proteins can dictate 
cell function,28 the PEAs were electrospun to achieve a non-woven fibrous mat. Although 
PEAs have also been electrospun from alanine25 and phenylalanine,24 smaller average 
fiber diameters were achieved in this study, in part, due to the higher molecular weight, 
and subsequent reduction in the minimum concentration needed for electrospinning. In 
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fact, over a two-fold decrease in average fiber diameter was achieved with 8-Phe-4 when 
compared to the previously reported study.24 In addition, a functional PEA was 
electrospun for the first time, where the surface charge of the pendant carboxylic acid 
group increased the whipping instability of the jet resulting in a further two-fold decrease 
in average fiber diameter.26 
In addition to the promising interactions with HCASMCs, ultrathin films (11–21 nm in 
thickness) of the PEAs could also be prepared through Langmuir-Blodgett technology, 
despite the long polymeric chains, which can undergo significant hydrogen bonding. The 
generation of ultrathin films enabled the examination of the interfacial region between the 
cell surface and the PEA film using waveguide evanescent field fluorescence (WEFF) 
microscopy, a relatively new technique to investigate the contact region between the cells 
and their substratum.31 
Although positive interactions between the PEAs and HCASMCs were reported, much of 
the work to date has focused on 2D films; however, cells are known to behave differently 
in a 3D context versus 2D culture.13 The initial cell culture work with 8-Phe-4 
electrospun mats has limited cell infiltration either due to impenetrable pore sizes or 
static seeding or a combination thereof. The 8-Phe-4-Asp(OH)-4 could be electrospun, 
but upon exposure to culture conditions, fiber fusion occurred, resulting in loss of the 3D 
network. Despite the lack of cell infiltration, there did appear to be an impact on 
HCASMC behaviour when cultured on 3D scaffolds, as evidenced by the increasing 
expression of contractile phenotype marker proteins SMαA and calponin compared to 2D 
films. This data did not reach statistical significance, and may be the result of a number 
of contributing factors. Primary cell culture is known to induce significant variability as a 
result of harvesting cells from multiple donors. Moreover, the exogenous addition of 
TGF-β1 did not result in statistically significant increases in contractile phenotype marker 
protein expression either, suggesting that carrier-free TGF-β1 may have been delivered at 
a sub-optimal concentration or that the fetal bovine serum of the media contained TGF-
β1, limiting the efficacy of the additional exogenous TGF-β1. 
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Although the selection of HCASMCs may serve to better model the interactions of the 
cells with the PEAs for in vitro vascular tissue engineering, their low proliferation rate 
and difficulty to harvest may preclude them from being used as part of a vascular 
construct strategy.33 The ability of stem cells to self-renew and proliferate rapidly could 
facilitate the maturation of an engineered vascular tissue in vitro, provided their 
differentiation can be controlled. In addition, harvesting adult stem cells from bone 
marrow, adipose tissue, skeletal muscle or more recently through the reprogramming of 
somatic cells to induced pluripotent stem cells would also provide a source of readily 
available autologous cells needed for in vitro vascular tissue engineering.33-34 
6.3 Future Directions 
Future work should focus on the interactions of HCASMCs on 3D scaffolds, to better 
represent the in vivo microenvironment. Improved cell infiltration into the porous 
scaffolds through dynamic seeding techniques such as vacuum or rotational seeding 
should be pursued.35-36 In conjunction with dynamic seeding, increased pore size through 
the use of sacrificial electrospun fibers,37 ice crystals,38 leachable porogens (salts, sugars 
or polymers)39 or other techniques40 should be considered. 
The plasticizing effect of the aspartic acid in the 8-Phe-4-Asp(OH)-4 fibers may suggest 
that a more hydrophobic polymer would be more suitable. In this case, the incorporation 
of aspartic acid into 8-Phe-8 may limit this plasticizing effect and should be explored. 
Alternatively, the non-functional 8-Phe-4 resisted fiber fusion, suggesting that a lower 
percentage of aspartic acid in this PEA may also limit the plasticizing effect. The 
reduction in functional groups though, may limit the ability to conjugate signaling 
molecules such as TGF-β1. 
The retention of the 3D network of a cytokine-conjugated scaffold would enable the 
impact of soluble versus conjugated TGF-β1 on both contractile phenotype marker 
protein expression and elastogenesis. To understand the full extent of these parameters, a 
long-term culture in a bioreactor would be necessary. 
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Although this study has not addressed the mechanical properties of these PEAs, 
preliminary uniaxial tensile testing has been conducted with non-functional PEAs. The 
Young’s modulus, yield strength, ultimate tensile strength and strain at break have all 
been investigated at 23°C for 8-Ala-8, 8-Phe-4 and 8-Phe-8 (data to be published 
shortly). To supplement the current study, mechanical properties of the functional PEAs 
should also be conducted, but the mechanical testing should be conducted at 37°C to 
better represent physiologic temperature. It is anticipated that the critical strain at the 
yield point of PEAs is expected to remain unchanged;41 however, both the Young’s 
modulus and yield strength are expected to decrease at 37°C.42 Given that the glass 
transition temperature impacts the physical properties of the polymers and that hydrated 
samples reduce the Tg, a further reduction in the Young’s modulus and ultimate tensile 
strength can be expected.11 With the ultimate goal of an in vitro tissue-engineered 
vascular graft, the mechanical properties of the matured vascular construct would also 
need to be addressed, with burst strength, suture retention and compliance all needing to 
be further evaluated.43 
6.4 Significance 
This study serves as the foundation for using functional poly(ester amide)s for vascular 
tissue engineering applications, whether it be as in vitro tissue-engineered vascular grafts, 
coating for stents or therapeutic angiogenesis, but does not preclude it from being 
investigated as controlled drug delivery vehicles through its incorporation into micelles44 
or for stimuli-triggered degradation.45 The facile and versatile approach to synthesizing 
these functional degradable polymers may yet lead to other biomedical applications 
where significant control of the polymer’s physicochemical, thermal and mechanical 
properties are of utmost importance. 
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